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Any substance of an acidic nature used to help render 
insoluble base drugs soluble for injection
Short reference for citric acid, a popular acidifier
The spoon or other implement in which the injections 
prepared and heated
The base form of cocaine, made by heating cocaine 
hydrochloride with sodium bicarbonate. This form allows 
the drug to be smoked.
The pattern, or level, of drug use/addiction
Diamorphine
Street drugs, usually refers to heroin
Refers to equipment and materials used in the preparation 
and injection of drugs
A combined injection of a stimulant (amphetamine 
sulphate or cocaine) and heroin. In the context of this 
thesis, the term is used solely to refer to the mixture of 
crack cocaine and heroin.
Term meaning to ‘ingest drugs’
A person who uses drugs
Short for ‘vitamin c’ and referring to ascorbic acid, 
a popular acidifier
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Refers to water produced by a Milli-Q PF Water
This produces ultra-pure water of a higher purity 
than 18.2MOhms/cm.
Inflammation of the wall of a vein, painful and 
tender with surrounding skin feeling hot and 
appearing red. Commonly develops into 
thrombophlebitis.
Inflammation of the wall of a vein, with secondary 
thrombosis occurring within the affected segment 
of vein
A condition in which the blood coagulates forming 




Review of the literature demonstrated that knowledge surrounding the 
process of illicit drug injection preparation is limited. A better understanding of 
the details of injection preparation methods could inform study of the risks and 
complications, as well as the development of harm reduction advice.
This project had two main objectives: To characterise the injection 
preparation process in detail, then to attempt to quantify the risks posed by 
these injections through laboratory investigations. The project had specific focus 
on the use of the acids by injectors to increase the solubility of insoluble illicit 
drugs.
To study injection preparation, a novel interview was designed to record 
the methods that a cohort of injectors used to prepare their injections of heroin 
and ‘crack’ cocaine. The interview incorporated two separate sections: firstly a 
semi-structured questionnaire, then observation of participants preparing an 
inert ‘fake drug’ for injection using their usual preparation procedure for real 
drug.
The injector interviews documented the use of acids by injectors in detail. 
The injection preparation demonstration enabled a complete characterisation of 
the preparation procedures for heroin, crack and speedball injections and 
enabled the development of a standardised method by which injections using 
real drug samples could be reproduced in the laboratory.
Prepared injections were subjected to a number of assays to evaluate 
their properties. These assays allowed a comparison with pharmaceutically 
prepared injections (pharmacopoeia standards) to provide some quantification of 
risk. Investigations were conducted into the drug content, the microflora, the 
particulate content and the physical characteristics of the injections.
Electrospray mass spectrometry was used to identify the components 
within illicit heroin samples. This methodology has never before been used to 
examine illicit drug samples.
The project developed microbiological investigation techniques that 
enabled the isolation and identification of micro-organisms within drug injection 
solutions.
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Particulate content of injection solutions was found to be high, and the 
use of rudimentary illicit filters was shown to add to this. The use of filters made 
specifically for illicit drug users could significantly reduce this content.
Overall, no significant risks were identified and this supports current 
harm reduction advice which was not based on any published research.
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laboratory environment. The thesis concludes with an overall reflection on 
contribution to knowledge from this work.
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1 Literature Review
1.1 Literature search strategy
The references for the following literature review were obtained from 
searches of the databases of Web of Science, MedLine and Embase. A large 
variety of search terms were used, alone and in combination, to build a 
reference base for the study.
Overall, there were a very limited number of references in this specific 
area of study. Additional information was gathered from various sources outside 
of peer-reviewed journal literature, including books, drug user information 
leaflets, and the internet, specifically the World Wide Web, and ‘usenet’ (the 
oldest type of electronic communication, after email, comprising of 
‘Newsgroups’). Anecdotal reports and personal communications are also 
included where their inclusion is of importance. All sources are referenced.
1.2 History of drug use and injecting
1.2.1 Drug use
There is no clear or simple explanation of why people use illicit drugs for 
recreational purposes. By changing the awareness of the user, drugs produce 
feelings of well-being or euphoria- commonly described as the 'high'. This 
explanation provides one obvious reason, but there can be more complex 
motivations. Weil and Rosen (1993) list many reasons why people use drugs to 
change their awareness, including: to aid religious practices, to explore the self, 
to escape boredom and despair, to promote social interaction, to stimulate 
artistic creativity, to rebel, peer pressure, or to self treat illnesses.
Cannabis is the most commonly used drug in British society (Home 
Office 2005), and people from diverse backgrounds choose to use it. It is used 
for a range of reasons including socially, for relaxation, for religious purposes,
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and to ease pain. To this effect it has been suggested that it can become 
dependence forming (Farrell 1999). The choice of drug will depend on its 
pharmacological actions. Many drugs fit in with the social factors present in the 
user’s life. For example, ecstasy and amphetamine are commonly used by 
young people, who only use them occasionally and only when they are going to 
dance music events. Glue, lighter fluid and other volatile substance sniffing is 
popular with young school-age children.
Modern increases in wealth and technology have brought homelessness 
and unemployment, which are two common factors seen amongst drug users. 
Prosperity has also lead to the rise in commercial imports and personal travel 
over the last century. Both of these have increased the availability of illicit drugs; 
heroin is a prime example of a drug in this category. Imports of the drug have 
grown dramatically in the past twenty-five years. Despite apparent increased 
customs seizures, prices have fallen, purity levels have increased and the drug 
is more easily available than ever (EMCDDA 2001). Heroin is suited to use by 
people who are unemployed, it can fill the void in their life, blocking out social 
and financial worries, but its use is not limited to people of this status.
Drug use is an emotive issue. It affects not only the drug users, but 
society as a whole, through crime, anti-social behaviour and associated 
depravation. Taxation funds the NHS which provides treatment for the effects 
and complications associated with drug misuse. Reducing the need for these 
interventions would be of benefit by enabling the NHS to use the funding for 
other purposes. Investigation into the causes of these health complications 
could prevent them occurring in the first instance.
Harm Reduction is a philosophy which aims to lower the harm drug users 
suffer through the use of illicit drugs recognising that cessation of the drug use 
may not be immediately achievable due to various factors motivating the 
continued drug use and dependence. Harm reduction interventions aim to 
protect the drug user and society from the risks associated with illicit drug use.
1.3 Drug injecting
The practice of injecting drugs was established by the medical 
profession. Soon after, the injection of drugs for non-medical purposes began to
18
occur. By the beginning of the twentieth century, the injection of heroin and 
cocaine for recreational purposes was common on both sides of the Atlantic 
Ocean (Karch 1996). The development and refinement of injecting equipment, 
combined with increased availability of illicit drugs throughout the twentieth 
century, led to a continued popularity in illicit drug injecting. From its initial 
stages in developed countries, the process of injecting spread globally. Drucker 
et al.(2001) estimated that there are between 10 and 15 million people who 
inject illicit drugs worldwide, in more then 120 countries. This figure is likely to 
grow if drug use continues to increase.
1.3.1 Illicit drug injection
Drug users choose to use drugs by injection for numerous reasons. 
Factors encouraging the use by injection include the reduction in wastage, 
making the drug more cost effective, and because of the euphoric sensations 
produced on injection.
The wastage of a drug when used by some routes is clear. When 
smoking heroin for instance, it is obvious that a certain amount will escape being 
inhaled. Additionally, good technique is crucial to achieve optimum effects, as 
over heating can result in breakdown of the drug instead of it being vapourised. 
Injecting heroin users are seen to use less heroin than those who smoke it 
(Huizer 1987).
The initiation of new injectors is important for the continued existence of 
an injecting drug population (Crofts et al. 1996). Witnessing friend’s reactions to 
injections of heroin can tempt non-injectors to move to injecting. Stewart (2002) 
gives a comprehensive account of users feelings towards and against initiating 
others into injecting, as well as giving insight into the users psychological 
reasoning and considerations at the time of initiating others.
1.3.2 Drugs injected illicitly
In the United Kingdom at the current time, the most commonly injected 
drugs are heroin, amphetamine and cocaine (Bennett 1998). However, the 
injection of cocaine derived from ‘crack’ is increasing in popularity (Hunter, 
Donoghoe, & Stimson 1995).
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Almost all drugs of abuse have reportedly been injected at some time, 
including: amphetamine/methamphetamine, barbiturates, benzodiazepines 
(Robertson et al. 1987;Ross, Darke, & Hall 1997), cocaine, crack, cyclizine 
(Rubin et al., 1989), Diconal®(Marjot 1978), ketamine, LSD, MDMA (Ecstasy) 
(Wafer 2001), opioids (including methadone, pethidine, buprenorphine and 
fentanyl), opiates (including heroin, morphine and codeine) and phencyclidine 
(PCP).
Alcohol is reported to have been injected (Derricott, Preston, & Hunt 
1999), 'dope' [referring to cannabis] (McBride et al. 2001) and even morning 
glory seeds (a hallucinogen containing LSA), have been boiled up to produce an 
injectable solution (Fink, Goldman, & Lyons 1966). Non drugs have also been 
injected, including victory V sweets (McBride, Pates, Arnold, & Ball 2001). It 
seems the availability of injecting equipment, namely a needle and syringe, 
tempts some users to inject anything to explore the effect it may produce.
When the users run short of drug, some resort to various methods to 
attempt to induce further intoxication. McBride et al. quote two common habits- 
injecting water, and injecting a solution prepared by soaking used filters. The 
injection of water can produce no more than a ‘placebo effect’, and potentially 
demonstrates, to an extent, the psychological component involved in the actual 
effect of the injection process.
Although there have been no investigations into the drug content of used 
filters, residual fluid within used filters will contain drug. Soaking one or more 
used filters in water will enable the extraction of a portion of the drug into the 
water. This is potentially a highly hazardous activity. The filters will have been 
stored since they were first used; this could have been on a table top within an 
injecting environment, or in a dirty pocket. After the initial use, filters will be 
warm and damp, providing suitable environments for bacterial and fungal 
growth. These organisms may then pass into the injection solution and be 
injected. There is also the possibility of blood-borne viral infection if the filter was 
contaminated during its previous use.
1.4 Injecting complications
The injection of any drugs, medical or illicit, can lead to health 
complications. The nature of the injection process is inherently risky as it
20
circumvents the body’s natural defences, introducing materials including drugs, 
inactive substances, particulate matter and micro-organisms directly into the 
body. Drucker et al. (2001) account how the proliferation of the use of injections 
in the Twentieth century has led to epidemic infections of hepatitis B, C and HIV 
amongst IDUs.
Complications also occur due to the nature of the injection solution and 
the manner of the injection. Extravasation of cytotoxic drugs used under medical 
circumstances can be extremely dangerous. This results from a combination of 
drug irritancy and administration problems. Some drugs are simply unsuitable 
for injection, even in pharmaceutical injectable preparations. Langdon, Harlan, & 
Bailey (1973) reported the medicinal intravenous injection of diazepam causing 
thrombophlebitis. Diazepam misuse is common, and injection of crushed tablets 
has been reported (Ross, Darke, & Hall 1997). It is therefore likely that the 
injectors are exposed to problems posed by the diazepam, in addition to those 
posed by an illicit injection of an oral preparation.
Three main factors determine the risk an injection poses. Firstly, the 
injection itself, secondly, the preparation method and the environment under 
which it takes place and finally, with respect to illicit drug use, the social 
circumstances under which the injection is prepared.
1.4.1 Causes of complications
Complications are encountered in the use of pharmaceutical 
preparations in medical use, but the illicit preparation and injection introduces 
further problems.
Injections performed by untrained people, can lead to problems due to 
fundamental lack of understanding regarding injection administration, for 
instance, injecting into arteries instead of veins. This can result in arterial spasm, 
dangerous heavy bleeding, or gangrene as a consequence of particulate matter 
occluding blood vessels.
The injection of preparations not intended for injection, including 
pharmaceutical formulations made for the oral route, poses hazards. Illicitly 
produced drugs are likely to be unsuitable for injection, as they contain unknown 
quantities of drug, impurities, adulterants and micro-organisms.
The reuse and sharing of injecting equipment introduces further risks and 
complications. Viral transmission of HIV and hepatitis through sharing of
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injection equipment is well documented. Repeated use of needles results in 
them blunting, leading to physical damage to veins which does not occur with 
new sharp needles. The end of the needle can form a barb shape which tears 
tissue upon use, especially as it is withdrawn. As outlined above, the storage 
and reuse of filters may facilitate the growth of bacteria and fungi, which could 
enter injection solutions into which the filter comes into contact.
The environment under which an injection is prepared, and subsequently 
administered has an important impact upon its risks. Dirty, unsanitary conditions 
such as public toilet cubicles, outside locations, or unclean housing are likely to 
introduce risk of contamination of the injection itself and/or the equipment, 
leading to problems such as infections. The presence of animals, such as pet 
dogs, in the immediate environment will add to these risks.
The condition of the injector is also important. If the user is intoxicated, or 
withdrawing at the time of injection, harm may increase. Withdrawal can make 
the user shake and sweat, making it more difficult for them to perform the 
injection. The desire to get the drug into their system as soon as possible may 
force them to rush the injection, leading to problems such as missing the vein, 
leading to injection extra-vascularly. Intoxication can lead to lack of coordination 
and poor judgement. Repeated injections of cocaine at the same site can lead to 
tissue damage and missed veins; the local anaesthetic nature of the drug means 
the injector is unaware of pain that would normally warn them of problems. 
Cocaine has a short half-life- approximately 41 minutes when given 
intravenously (Javaid et al. 1983). This has implications for IDUs as it can drive 
frequent injecting. This leads to greater physical damage to veins and increased 
possibility of infections such as abscesses, or blood borne viruses from sharing 
equipment.
1.5 Harm reduction and the injecting drug user
Harm reduction is a set of policy beliefs, essentially accepting that some 
people always have and always will perform activities, such as promiscuous sex 
or drug use that may cause harm. Therefore, there is a moral imperative to 
reduce the harm caused by these risky activities, rather than an ineffective 
blanket prohibition of the harmful activities.
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With regard to injecting drug users, harm reduction in its most obvious 
form exists as needle exchange. In order to reduce the spread of blood borne 
viruses, as well as reduce infections caused by using non-sterile injection 
paraphernalia, needle exchanges provide sterile equipment to injectors.
The supply of clean injecting equipment is only one area of harm 
reduction. The adoption of safer injecting rooms, education sessions about 
injection techniques and the testing of drug material would arguably provide 
further benefits for injecting drug users (IDUs). Although proposals for these 
have been made, they remain to the large part only as model ideals.
In response to calls for changes, the British government recently 
reviewed the Misuse of Drugs legislation with the intention of improving services 
involved in harm reduction work with drug injectors (Home Office 2001). 
Research into the injection preparation methods in use by IDUs will be important 
in the planning these changes required to services. Research into methods of 
drug use this will provide the evidence basis on which to inform and implement 
these changes.
1.6 The preparation of illicit drugs for injection
1.6.1 Literature documentation of injection preparation techniques
There is very little work in the literature documenting the processes of 
preparing illicit drugs for injection. The majority of information available takes the 
form of anecdotal details collected in order to enable the production of safer 
injecting guidelines for drug users. Literature searches revealed only two papers 
to have studied this process, written by Scott et al.(2000) and Strang et al. 
(2001). The nature behind the study by Strang was to ascertain which ‘acids’ 
were favoured for use by the group of respondents in London. Participants were 
also asked about the need to heat the mixtures with regard to the acids they 
used. The paper did not investigate the entirety of the method of preparation, but 
focussed specifically on the decision to use acid and heat in the preparation. No 
quantitative data was recorded such as the amounts of drug, acid and water, nor 
was there any detail about the heating process, such as when heating was 
stopped and why. The work of Scott was the first to outline the complete
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preparation procedure of heroin injections. It records those used by a cohort of 
injectors in Scotland.
A generic outline of the process that drug injectors are advised to follow 
to prepare an injection is given below. It has been compiled with information 
from various sources including: the Safer Injecting Briefing (Derricott, Preston, & 
Hunt 1999), Scott et al.(2000), various safer injecting leaflets from the agencies 
Lifeline (2001) and HIT (2001), and additionally a user guide on the web ('Brown 
Addict' 2002).
The lack of in-depth process details, such as quantities, becomes clear 
when reading these literature sources. None of the documents give a complete 
insight into how users prepare drugs. Furthermore, the reliability of the data for 
the most part is unclear. This is due to the lack of peer-reviewed work in this 
area- most documents available being of a basic nature written solely as safer 
injecting guidelines for drug users.
The actual method an injector follows is variable and will depend on 
many factors, such as the nature of the drug they are using, the choice and 
availability of materials and equipment, the influence of the people who taught 
them to prepare injections, along with that of their current drug using peer group, 
and their own individual habits.






Filter material such as cotton wool
Object to mix and heat the solution such as spoon, sometimes referred 
to as a ‘cooker’
Heat source, such as a matches or a cigarette lighter 
Knife or other implement to measure drug and acid amount
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General procedure outline:
1. Drug is taken out of container, measured to desired dose, and placed in 
cooker
2. Needle is attached to syringe
3. Water is drawn up with syringe and added to cooker
4. Mixture is stirred
5. If drug doesn't appear to dissolve (solution remains cloudy), add acidifier in 
smallest quantity necessary
6. Heat is applied if needed for a short time
7. Filter is placed in solution
8. Solution is drawn up into syringe through the filter
9. Syringe inverted and excess air expelled
10. Injection takes place
Many regional and personal variations of the above process are likely to exist, 
with additions and omissions to this routine, possibly leading to the existence of 
a large number of significantly different techniques. Whether any of these 
methods is safer than any other is an important question.
The above description immediately raises issues if it is to be replicated 
for investigation. For instance, how much water should be used? What size 
needle and syringe? How long is the preparation stirred for, and what with? How 
much acid should be used?
This presents an interesting research question: Exactly how are injections 
prepared by injectors? To investigate the dangers posed by the injections it is 
imperative to understand the nature of the injection preparation and the 
materials from which it is prepared. Specific detail is necessary in order to 
develop a reproducible laboratory method.
1.7 Heroin and cocaine use
Heroin (diamorphine) is used in the United Kingdom for analgesia and 
the treatment of acute pulmonary oedema (BNF 2002). The main reason for its 
use, especially in consideration to its main alternative morphine, is the high 
solubility of diamorphine hydrochloride in water. This allows administration of
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high doses in small volumes, making injections easier and less painful. Cocaine 
is rarely used now except as a topical application in otolaryngology.
1.7.1 Illicit heroin and cocaine
Since 1978-79, the majority of the heroin on the illicit market in the UK 
and mainland Europe has been of the base form (Griffiths, Gossop, & Strang 
1994). There are a number of suggestions why this is the case; it is possible 
because conversion to the hydrochloride salt would add an extra stage to the 
manufacturing process. Alternatively, the base form is produced as it allows 
smoking of the drug. This predominance of the base form of heroin has allowed 
the smoking of heroin to become more common, as it is more volatile (Huizer 
1987). Prior to this predominance, heroin was available as the hydrochloride 
salt, referred to as ‘Chinese heroin’, it was white in colour. The users of this type 
of heroin injected it because it was highly soluble in water and smoking this salt 
form results in only small quantities of the drug in the smoke, as it has a higher 
melting point (Huizer 1987). The higher temperature required to make the 
hydrochloride form volatile results in a large degree of pyrolytic degradation of 
drug molecules (Cook & Jeffcoat 1990).
The visual appearance of these two forms of illicit heroin is shown in 
Figure 1 below. The colour difference between the base form (brown) and the 
hydrochloride salt (white) is clear.
Figure 1 The two different forms of illicit heroin: brown heroin base (left) and white heroin 
hydrochloride
Unlike pharmaceutical grade products, the quality of the drugs on the 
illicit market is highly variable. This is especially true for drugs in powder form,
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where other powders may have been mixed in with the powder to bulk up the 
quantity (Coomber 1997), or to improve characteristics, such as the volatility 
when smoked (Huizer 1987). Along with this, the quantity of the drug in illicit 
powders will also vary depending on a number of factors such as the quality of 
the raw material from which the drug was originally made, the manufacturing 
process used and how well the process was performed.
Cocaine in the form of ‘crack’ has been commonly available since the 
early to mid 1980s (Jones 1990). Before this time, cocaine was available as the 
hydrochloride salt and in the form of freebase. Freebase was rarely found and 
was usually produced directly by the users themselves from the hydrochloride 
salt. Crack and freebase are essentially the same as they are both the base 
form of cocaine. Crack is produced using sodium bicarbonate powder, and some 
of this remains in the final product, freebase is formed using ammonia liquid, 
which is not retained in the final product. Both freebase and crack are formed to 
enable the smoking of cocaine, as it cannot easily be smoked as the 
hydrochloride salt. The base form has a low melting point (80°C, (Jones 1990)) 
meaning the drug is more volatile. Increases in the popularity of crack/freebase 
have resulted in some users choosing to inject it.
1.8 Solubility
For a drug to be injected, its solubility in water is important. If the drug 
will not dissolve this will pose a problem- if a drug is not soluble it is unlikely to 
be used by injection.
Of the three main drugs injected illicitly: amphetamine is found on the 
illicit market is as the sulphate salt. This is freely soluble in water and makes it 
easy to prepare for injection. Cocaine hydrochloride powder also has a high 
solubility, as does pharmaceutical diamorphine hydrochloride, but illicit heroin 
and ‘crack’ cocaine are not so easy to use.
The difficulty with injecting ‘street’ crack cocaine and the majority of illicit 
heroin (Strang, Griffiths, & Gossop 1997), is that neither of them are particularly 
soluble in water. As previously outlined, both drugs are in the base forms.
Heroin base is highly volatile, and therefore is ideal for smoking (Huizer 1987), 
but for injecting users, it presents a problem by being so poorly water soluble- 
1gram in 1700ml (Clarke 1986). Cocaine as ‘crack’ is the base form of the drug 
in a bicarbonate crystalline mixture (Jones 1990) and this too, is poorly soluble
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in w ater-1 in 600ml (Clarke 1986). In comparison, the cocaine hydrochloride 
from which the crack is manufactured, is very soluble-1 in 0.5 of water 
(Martindale 1999), 1 in 0.4 (Merck Index (2003a)).
Tables 1 and 2 show the solubility of diamorphine and cocaine respectively.
Table 1. Diamorphine solubility
Solvent Base Solubility Hydrochloride
solubility
Reference
Water 1g in 1700ml 1g in 2ml Clarkes Isolation and
Ethanol 1g in 31ml 1g in 11ml identification of drugs
Ether 1g in 100ml Practically insoluble (Clarke 1986)
Chloroform 1g in 1.5ml 1g in 1.6ml
Table 2. Cocaine solubility 
Solvent Base solubility Hydrochloride
solubility
Reference
Water 1g in 600ml 1g in 0.5ml Clarkes Isolation and
Ethanol 1g in 7ml 1g in 3.5 to 4.5ml identification of drugs
Ether 1g in 4ml Practically insoluble (Clarke 1986)
Chloroform 1g in about 0.5ml 1g in 15 to 18ml
Water 1g in 600ml 
(270ml at 80°C)
1g in 0.4ml Merck Index (2003a)
Alcohol 1g in 6.5ml 1g in 3.2ml (cold), 
2ml (hot)
Ether 1g in 3.5ml Insoluble
Chloroform 1g in 0.7ml 1g in 12.5ml
This low solubility presents a problem for users when preparing to inject 
these forms of the drugs. To render these drugs soluble for injection, users have 
to convert the base form to an acid-salt form, which increases the solubility. To 
convert diamorphine or cocaine base bought illicitly, injectors utilise acids that 
are easy to obtain.
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1.8.1 The chemistry behind solubility
Not every chemical is soluble in every other chemical. In order for a 
substance (the solute) to be soluble in another (the solvent), it must possess the 
correct chemical properties. This is usually expressed in a simple manner as 
‘like dissolves like’. As the base forms of the drugs do not dissolve in water, it is 
apparent that they are in the wrong state.
Water is a ‘polar solvent’ as it has a permanent dipole moment. The base 
forms of the drugs are the ‘non-polar’ forms. They do not ionise to any great 
extent when in water. The base forms of drugs are soluble in non-polar solvents, 
such as ether, but poorly soluble in polar solvents such as water.
In order for basic drugs to be dissolved in water they need to be 
converted to a polar form. This is done by converting them to an acid-salt. To 
form the acid-salt, drug injectors react the drug base with an acid. This means 
that when the drug is added to water it can dissociate, or split, into an ionised 
form which is soluble in water. The drug becomes ionised by accepting a proton 
(H+) from the acid the salt was formed with, giving the drug molecule a positive 
charge.
Drug Base + Acid------------------------- ► Drug+ + Acid Salt'
This charge enables the drug molecules to dissolve into solution as the water 
molecules are able to surround each drug molecule individually, thus dissolving 
it.
Depending on the acid used, and its propensity to dissociate (quantified 
by its pKa value), an acid molecule may donate different numbers of H+ ions. If 
fully dissociated, ascorbic acid can donate two protons, and citric acid can 
donate three.
The pharmaceutical forms of heroin and cocaine are supplied as the 
hydrochloride salts which are soluble because they accept an H+ ion from the 
hydrochloride molecules.
Injectors could use hydrochloric acid to produce the hydrochloride salt of 
illicit drugs, but it is difficult to obtain, and its use would pose hazards during the 
preparation and injection. In order to form the salt, injectors use acids that are 
easy to obtain, such as vinegar, or lemon juice.
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The use of vinegar (ethanoic acid) will produce the diamorphine 
ethanoate salt. Citric acid will react with diamorphine base to produce 
diamorphine citrate. Vitamin C (ascorbic acid) will produce the ascorbate salt.
1.9 Acidifiers
The use of acidifiers by injecting drug users is confined to regions where 
the drugs are supplied as the base forms. In the UK, the majority of heroin and 
crack require acidifiers to be utilised in the preparation of an injection. In North 
America and Australasia the majority of heroin on the illicit market is the 
hydrochloride salt form and therefore it does not require conversion to an acid- 
salt. This means that in these regions, only crack requires the use of an acid 
during injection preparation. Due to crack injection generally being an 
uncommon practice, the preparation process involving acid-salt conversion is 
much less widely known in these regions (Kinzly 1997). This means people who 
attempt to prepare crack for injection use vinegar (ibid) rather than a purer forms 
of acid such as citric acid. In the UK, people who choose to inject crack may 
have injected heroin previously so they are familiar with the use of acids. 
Alternatively, heroin or crack injectors within their peer group may educate them 
about the process of adding acid when preparing these drugs.
1.9.1 Acidifiers used
Drug users have been reported to utilise many various acids to be used 
as ‘acidifiers’.
Commonly reported acidifiers used include:
□ Citric acid (Roberts & Thomson 2000;Scott et al. 2000;Strang et 
al. 2001)
□ Ascorbic acid (Vitamin C powder) (Scott, Winfield, Kennedy, & 
Bond 2000;Strang, Keaney, Butterworth, Noble, & Best 2001)
□ Lemon juice (Gallo et al. 1985;Hoy & Speed 1983;Page & Fraile 
1999;Shankland & Richardson 1989;Shankland, Richardson, & 
Dutton 1986;Strang, Keaney, Butterworth, Noble, & Best 2001)
n Vinegar (Scott & Bruce 1998;Strang, Griffiths, & Gossop 1997)
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Less commonly used acidic substances/products:
□ Baby bottle sterilizer and Kettle descaler (Roberts & Thomson
2000)
□ Various effervescent tablets (Preston, Derricott, & Scott 2001)
□ Powdered health drink sachets (Roberts & Thomson 2000)
□ Fizzy coatings from children’s sweets (Derricott, 2002, Personal 
communication)
A wide range of substances can be used as acidifiers. There are no 
standards of which one to use, nor, how much should be used, as nothing is 
designed to be used for this purpose. This situation has left drug users very 
vulnerable, and results in complications.
Injections prepared using lemon juice and vinegar have been implicated 
in the cause of Candidal endophthalmitis (Shankland, Richardson and Dutton, 
1986) and fungal endocarditis (Bisbe et al. 1987).
The work by Strang et al. (2001) gave information on the prevalence of 
particular acid use by heroin injectors. They found that for the majority of the 
time most of the users preferred to use either Vitamin C powder (47.1%) or citric 
acid (54.8%). Less popularly used were vinegar (2.9%) and lemon juice (1.9%). 
2.9% of users reportedly used no acid at all. The use of other acidifiers is most 
likely rarer, probably confined to specific geographical regions where it is difficult 
to obtain acids that would normally be preferred.
1.9.2 Choice of acidifier
The reasons why users choose one acidifier in preference to another are 
unknown, and it is possible that are not specific preferences.
Suggestions for use of one acid over another:
□ Works better (in their opinion)
□ Less pain on injection




1.10 Acidifiers in detail
This section details the acidic substances most commonly reported to be 
used by drug injectors. It briefly outlines each acid, describing its content, its 
method of manufacture, its usual uses, and its biological role (if any). It also 
gives some speculation on possible consequences of parenteral use.
1.10.1 Citric Acid
Use by drug injectors
This is one of the most commonly used acid by injectors as it is currently 
the one that is recommended for use by most safer injecting guidelines, 
including the most comprehensive currently available, The Safer Injecting 
Briefing (Derricott, Preston, & Hunt 1999). For this reason, it is supplied to drug 
users at needle exchanges in many parts of the country. The safety of using 
citric acid to prepare injections has never been assessed.
Nature of substance and manufacture
The theoretical reasoning for the safety of this acid is its natural 
abundance in the human body and its integral part in the process of cell 
respiration in the Krebs cycle- also known as the citric acid cycle.
Citric acid was first extracted from lemon juice in 1874. It has been used 
in foods for over one hundred years and is used in many roles including, as a 
sharp-tasting flavouring, as a preservative and in the cheese making, wine and 
brewing industries. The range of foodstuffs it is found in is vast. The Food and 
Agriculture Organisation (FAO) and the World Health Organisation (WHO) 
formed the joint FAO/WHO Joint Expert Committee on food additives (JECFA), 
which issues monographs and other details on the use of food additives. These 
include recommended acceptable daily intakes of such additives. In the case of 
citric acid, they state that it can be used up to a level of 1% of the total mass in
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foods, and they give it an unlimited daily intake level (Doull, Klaassen, & Amdur 
1980).
Typical uses
Medically, citric acid has been used for the treatment of xerostima, to 
dissolve renal calculi, alkalinise the urine, in rectal enemas for constipation and 
to prevent the encrustation of urinary catheters. It has also been used in 
preparations for the treatment of gastro-intestinal disturbances and metabolic 
acidosis (Martindale 1999).
Citric acid is used to produce the effervescence in some mixtures and 
tablets. This has led to the use of such products by some injectors to dissolve 
heroin and crack for injection. This was particularly observed in western 
Scotland up until 1999, involving a health drink called ‘Abdine’ (Roberts & 
Thomson 2000).
Citric acid is available as large boxes of ‘culinary grade’ powder, which 
are commonly purchased from pharmacies. Until the changes in the law that 
allowed the sales of citric acid (Section 1.11.2), sales of citric acid from 
pharmacies were discouraged under ethics guidelines (Royal Pharmaceutical 
Society of Great Britain 2001). Despite the changes in the law some pharmacies 
still refuse the sale of citric acid, either through ignorance or habit (Personal 
observation and (Scott 2005b). Citric acid is also available for purchase from 
Asian food shops. This is of unknown quality.
Citric acid is now available in sterile 100mg sachets, specifically for illicit 
injection preparation, from a number of suppliers.
Safety and Risks
Even though citric acid is commonly used by injectors, this does not 
mean it is safe to use. ‘Burning’ down the limb when using injections prepared 
with citric acid is commonly reported (Scott & Bruce 1998).
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1.10.2 Ascorbic Acid
Use by drug injectors
This is usually purchased in the form of Vitamin C preparations, 
especially the powder (Preston & Derricott 1999). This being a commonly used 
acidifier, it was also listed in the Medicines, Ethics and Practice guide for 
pharmacists, alongside citric acid, to discourage sales. Recent changes have 
legalised the supply of ascorbic acid to injectors (2005b). Like citric acid, it is 
also available in sterile sachets (300mg) for supply from needle exchanges 
facilities.
Nature of substance and manufacture
Vitamin C is a vital constituent of the human diet, as unlike most other 
animals, humans are unable to synthesise it. It is required for the synthesis of 
collagen and intracellular material, as well as performing important antioxidant 
roles. Deficiency leads to scurvy.
Typical uses
To treat deficiency, vitamin C can be given orally as ascorbic acid tablets or as a 
fruit juice mixture. It can also be injected by the IV, IM or SC routes, as sodium 
ascorbate.
Safety and Risks
The use of ascorbic acid to prepare injections may lead to complications 
depending on its source. Pharmacy restrictions have made it difficult to obtain it 
in the pure powder form. This may have led to the use of Vitamin C tablets. The 
use of these will involve the injection of the ingredients used to form the tablets, 
for instance, lubricants, bulking agents and disintegrants.
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1.10.3 Vinegar
Use by drug injectors
The main reason for the use of vinegar by drug injectors is the acetic 
acid content of the solution. Ethanoic (acetic) acid makes up 4-5% of the active 
ingredient in vinegar (Van Nostrand 1995).
Nature of substance and manufacture
Malt vinegar is usually made from malted barley and other cereals. 
Appropriate yeasts are used to ferment sugars in the cereals to ethanol and 
carbon dioxide. The yeasts are then removed and the alcoholic solution is 
treated with Acetobacter sp. bacteria, which acetify the alcohol. The resulting 
solution is then filtered and pasteurised to produce clear vinegar, which is then 
left to mature. This is commonly distilled to produce ‘distilled malt vinegar’ and 
this contains only the volatile constituents of malt vinegar.
‘Non-brewed condiment’ is a popular alternative to vinegar. This is a 
solution of about 4.5% m/v synthetic acetic acid, which is coloured using 
caramel.
Brewed vinegars can contain significant proportions of B vitamins 
including thiamine, riboflavine, nicotinic acid, pantothenic acid and pyridoxine 
(Kirk & Sawyer 1991). These vitamins are absent from the non-brewed products.
All vinegars and artificial alternatives are subject to tests for the 
following: total acidity, ash, preservatives, arsenic, copper, lead, zinc, alkaline 
oxidation value, iodine value, and a qualitative test for mineral acid. It is also 
subject to organoleptic examination looking at the odour and taste of the 
product.
Vinegar can be tainted with growths of vinegar eels (Anguillula aceti), 
which are slender, aquatic nematode worms which grow up to 2mm in size. 
These live in dilute wine and/or vinegar and water solutions. Vinegar can be 
tainted with other micro-organisms, so it is common to find it has preservatives 
added. Sulphur dioxide and sorbic acid, a polyunsaturated fat, are most often 
used for this purpose.
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Typical uses
Vinegar is commonly used in food preparations, particularly in 
vinaigrettes, in pickling processes and it is a condiment.
The purpose of using vinegar to acidify drug mixtures is due to the 
production of the ethanoate salt of the drug. Reaction with diamorphine base in 
heroin powder will produce the salt form, diamorphine ethanoate.
Administration into the body will lead to the ethanoate section of the 
molecule entering the citric acid cycle, and being excreted as water and carbon 
dioxide after the process of cellular respiration.
Safety and Risks
The use of vinegar and non-brewed condiment for the purpose of 
preparation injections is likely to be hazardous due to the non-sterile nature of 
the solution and due to the additional chemicals present. The use of these acids 
from large containers makes them liable to contamination during use from 
bacteria and fungi, and possibly viral contamination introduced by other injectors 
sharing the same container.
1.10.4 Lemon Juice
Nature of substance and manufacture
This is obtained by straining the juice pressed from fresh lemons. Of 
100g of the juice, 91.3g is water, 1.6g is sugar, 0.3g protein according to 
McCance and Widdowson (Paul & Southgate 1978). There are also small 
amounts of the B vitamins thiamine, riboflavin, nicotinic acid, and pyridoxine 
present (ibid).
Fresh lemon juice contains between 40 and 60mg of vitamin C per 100g.
Lemon juice available in the UK is usually obtained in the form of Jif® 
lemon. This is made by reconstitution of the frozen concentrate (Personal 
Communication, Reckitt Benckiser, 2002). The citric acid content of the 
reconstituted form is stated as ‘not less than 5.0grams per 100ml of 
reconstituted lemon juice’ (U.S.Department of Agriculture 1998).
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Therefore, lemon juice contains two acids that are useful in the 
acidification of heroin- ascorbic and citric. Due to its higher concentration, citric 
acid is arguably the more significant of these two.
Typical uses
Lemons are used in cooking, and as a garnish in drinks. Lemon juice is 
added to foods, such as pancakes, and fish dishes where the acidic nature of 
the juice neutralises the taste of the amines.
Use by drug injectors
Page and Fraile (1999) described the use of lemon juice by injectors in 
Valencia, Spain, as being a unique activity. On the contrary, this method of use 
has been reported in the UK and Australia since the late 1970s, after being 
implicated in various infections. It is likely that the main author of the article, who 
is based in Miami, was unfamiliar with the practice due to the general absence 
of heroin base on the US illicit market, and hence the lack of need to use an 
acidifier in injection preparation. The paper shows little understanding of the 
chemistry of different salt forms of heroin and indeed of heroin itself- even 
stating that heroin reacts with citric acid to produce ‘morphine citrate’. The paper 
that Strang et al. produced in 2001 was in part a response to the publication of 
Page et al.. They too refute the conclusions made in the former. Strang et al. 
interviewed 104 people all of whom had used the common ‘brown’ heroin that 
requires acidification-103 of the 104 (99%) had used acid with brown heroin on 
at least one occasion. Referring to the last injecting occasion (n=98), 3 people 
(3.1%) had used lemon juice to prepare it. Overall 89 (85.6%) had used lemon 
juice at some time and of these 82 (92.1%) applied heat. Of these 89, 38 
(36.5%) had used fresh lemon, 23 (22.1%) had used Jif® and 26 (25%) had 
used both.
In contrast to the brown (base) heroin, they report that the white heroin of 
the salt form is also found in London. This is much more soluble and likely to 
dissolve in water by just applying heat. When using white heroin (n=79), the 
number of people using an acidifier at any time was much lower, 28 (35.4%). Of 
these, only 15 (14%) had ever tried to use lemon juice; 11 would also heat the 
mixture.
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These are the only figures that can be found in the literature regarding 
the prevalence and details about the use of lemon juice to prepare injections. It 
shows that it is rarely the acidifier of choice, but most users had used it at some 
point. The information distinguishing lemon juice from juice obtained from a 
fresh lemon is also important. The juice from a freshly cut lemon fruit is unlikely 
to contain bacterial or fungal organisms (but it is possible for organisms to be 
introduced into the juice during the cutting and squeezing process).
The interviewers also recorded the reasons why users did not regularly 
use lemon juice. The majority said it didn’t work, but some were aware that its 
use had been linked to infections.
1.10.5 Lemon juice preservation and the possible link to infections in injectors
Due to its acidity (pH range 2.2-2.6), lemon juice is largely unaffected by 
bacterial spoilage, but it is prone to fungal spoilage, these organisms being more 
tolerant of low pH values (Splittstoesser 1978). To prevent this, the 
manufacturers of Jif® lemon juice add sulphur dioxide to the solution. Over time, 
however, exposure to the air and warm temperatures, leads to this gas gradually 
coming out of solution. This leaves the juice a viable medium for fungal growth. 
These organisms will then pose a potential risk if this solution is used for 
injection preparation. Repeated opening of the container to acquire juice will 
increase the risk of the solution within the container becoming contaminated. 
Combined with a lack of refrigeration, this will provide a suitable environment for 
the growth of fungal organisms.
1.11 The role of acidifiers in health complications
The use of acidifiers to prepare heroin and cocaine for injection 
introduces an additional component to further the risks posed by prepared 
injections.
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1.11.1 Acids and vein damage
The injection of solution into veins, especially small veins as found in the 
hands and feet, can lead to problems if the pH and osmolality of the solutions 
are very different to that of biological fluids. Even in pharmaceutical preparations 
it is difficult to get the characteristics of a solution similar to that of a biological 
fluid- for an illicit injector it would be impossible. A large injection of solution with 
a lower osmotic pressure than blood (hypotonic) can lead to blood cells swelling 
rapidly and bursting. This is dangerous if a large number of cells are affected. In 
a hypertonic solution, the blood cells shrink and crenate, however, this is 
reversible and not as serious as the previous situation. As the solution travels 
along the vein, it is diluted and these effects are countered.
The pH of an injection is also of importance, as a very acid or alkaline 
solution may cause irritation or even tissue necrosis if extravasation occurs upon 
injection. For intravenous injections, this is of lower importance, especially if the 
injection is given slowly as the blood will buffer and dilute the solution quickly. 
The pH is more important for subcutaneous or intramuscular (or any other 
extravascular) injections, this can become very important and lead to further 
problems, for instance those outlines in the microbiological work introduction 
(section 5.1.2).
Thrombophlebitis and phlebitis are commonly reported in intravenous 
drug users and is anecdotally associated with the use of acidifiers, although no 
research has been conducted to confirm this.
The use of acids contained within mixtures, for instance from Vitamin C 
tablets or effervescent drinks, may result in complications caused by the 
injection of the additional extra materials.
1.11.2 Drug paraphernalia laws
Prior to the 1st of August 2003, Section 9a of the Misuse of Drugs Act 
(1971) in Great Britain made the supply of any articles known to be used for the 
administration or the preparation of an illicit drug unlawful. The only exemption 
from this rule was needles and syringes. Section 9a Misuse of Drugs Act made it 
illegal to supply, or offer to supply any article which the supplier believed may be
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used, or adapted to be used, in the unlawful administration (including self 
administration) of drugs. Prosecution for the offence could result in a fine of up 
to £5000, a six month prison sentence, or both. Subsection 2 allowed the supply 
of needles and syringes to reduce the spread of HIV.
On the 1st of August 2003, the Misuse of Drugs (Amendment) (No.2) 
Regulations 2003 (2003b) came into force. This enabled the supply of items 
including swabs, utensils (spoons/'cookers’), filters, sterile water and citric acid 
by certain groups of healthcare staff.
The work within this thesis was conceived and the interviews conducted 
before August 2003. This work therefore describes the use of acids that were 
obtained ‘illicitly’ on the most part. The acids would have been obtained from 
food stores (lemon juice, fresh lemons, vinegar, citric acid) or pharmacies (citric 
acid powder, Vitamin C powder or tablets).
Some acids would have been obtained from needle exchanges during 
this time. Before the change of law, many needle exchanges had agreements 
with their local police force that ensured they would not be prosecuted for 
supplying acids to injectors, even though they were breaking the law through 
making the supply (Burton et al. 2003;Scott 2005a).
That change in the law did not, however, allow for the supply of other 
acids including ascorbic acid. It only states “citric acid”. Citric acid appears to 
have been chosen for supply on the grounds that it is probably the most 
commonly used acid. There was no evidence present at the time of this change 
in the law on which to base this choice on the grounds of risk reduction, safety 
or suitability.
It wasn’t until 2005 that the law was changed again to allow the supply of 
ascorbic acid, thus giving injectors who preferred to use ascorbic acid access to 
the pure powder form.
1.12 The use of acids in the injection preparation 
process- Previous investigations
As mentioned previously in section 1.6.1, many papers have mentioned 
the use of acids in the injection preparation process, but few have actually 
looked at the process itself, the acids used, how they are used and the risks
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involved. Huizer (1987) along with others (Cook & Jeffcoat 1990) have studied 
the smoking of heroin in detail, producing information about the use of different 
salt forms, their absorption and metabolism. Illicit injections have not been 
studied in a similar manner.
The three main papers in the area are by Page (1999), Strang (2001) 
and Scott (2000). Another important document in this area was prepared by the 
Hungerford mobile needle exchange team in London (Wilkinson & Hungerford 
Mobile Needle Exchange 2002).
As described earlier, the paper by Page is concerned with the use of 
lemon juice to dissolve illicit heroin, as they appear to have believed they had 
discovered a new practice. The paper by Strang et al. was a response to this 
correcting the issues over the use of lemon juice by drug injectors, and providing 
insight into the use of acids in the UK.
The work by Scott (2000) is the only piece of work produced so far that 
explores the chemistry behind of the use of acid by injectors, however it does 
not actually look at harm in detail, and does no more than speculate upon 
possible risks. Using samples of street heroin in the lab, this work looked at the 
quantities of citric and ascorbic acids required to dissolve the maximum possible 
amount of diamorphine into the injection solution. The quantities of acids 
calculated in this work are an important factor that will inform the preparation of 
injections for use in this project.
The Hungerford needle exchange operates in the West End of London.
In response to comments about the use of lemon juice by their clients, they 
decided to investigate the level of use.
They found that 28% (number of interviewees not stated in report) of 
their clients used citric or vitamin C all of the time, however mainly due to the 
poor availability of citric and ascorbic acids in the West End area, 68% of clients 
were using lemon juice “some of the time”. This piece of work also looked at 
health problems that users had experienced from the acids they used- no other 
work has done this previously. The interviewees were asked if they had had 
experienced any problems with their eyes after injecting with lemon juice. 56% 
reported that they had experienced problems that included ‘sore eyes’, 
conjunctivitis, blindness, blurred vision, severe headaches and cataracts. 
Whether or not these problems are caused by lemon juice is open to question, 
but of the 44% who had not experienced problems, most were using acidifiers 
other than lemon juice.
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1.12.1 Collecting data from drug injectors- The need for interviews
In order to prepare illicit drug injections in the laboratory in a 
representative manner to that of illicit users, it was imperative to learn their 
preparation methods. As stated, to date, there are no papers in the literature that 
outline the complete injection preparation process including details such as 
quantities used. Partial methods are outlined in a small number of papers (Scott, 
Winfield, Kennedy, & Bond 2000;Strang, Keaney, Butterworth, Noble, & Best 
2001), along with anecdotal techniques outlined in various safer injecting 
guides/leaflets and user writings as previously discussed. None of these sources 
form a complete overview of preparation methods such that it could be 
reproduced in the laboratory setting.
Previous work, such as that conducted by Strang et al., The Caravan 
Project and Speed (Speed 1998;Strang, Keaney, Butterworth, Noble, & Best
2001), have recorded the acidifiers used by the injectors and the sources of 
water for the injection. These indicate the requirement of acid, or the use of 
different water sources, but they do not record the rest of the preparation 
procedure. Insight into the whole procedure might reveal further differences 
related to the use of these substances. For example, does the amount of water 
used to prepare an injection vary depending on the acidifier used, or does the 
heating time change, or are no changes made?
1.13 Research questions
The review of the literature, suggests that there are numerous aspects of 
the injection preparation process by illicit drug users for potential investigation. 
The following hypotheses were raised during the review of the literature:
Exactly how are injections produced?
The use of an acid appears common, and widespread amongst all crack 
and heroin injectors as suggested by previous literature; is this true? If so, what 
acids do injectors use? Do these acids pose risks?
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What filters do injectors use? How effective are these filters, and do they 
themselves pose any risks?
How do illicit injections compare to pharmaceutically produced 
injections? What are the physical characteristics of an illicit injection? For 
instance, the pH, osmolality and particulate content.
What levels of drug are present within an illicit injection, and how does 
this vary through different preparation methods, for instance, with different 
acids?
Previous research has demonstrated the presence of viable micro­
organisms within illicit heroin mixtures. There is a possibility these organisms 
remain viable after the preparation procedure and are found within the injection 
solution prior to injection. What are the microbiological risks posed by illicit 
injections?
Overall, it was aimed for the work to determine whether acid use in 
preparing injections could co-exist with safe injecting, or whether the use of any 
acid is so damaging that it would not be possible for harm reduction workers to 
recommend their use.
1.14 Project structure
In order to investigate the use of illicit drug injections, a two part project 
was devised.
The first section involved researching the methods current injectors use 
to prepare their injections. This required meeting with current injectors to learn 
about the preparation processes they use. This work gathered detailed 
descriptions of the entire process, as used by current injectors. These details 
were then used to form a standardised injection preparation formulation. This 
standard injection preparation process was used to prepare standardised 
injections within the laboratory.
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The second section of work involved assays of these injections studying 
their contents, their microbiological risks and their physical properties. Results 
from these investigations enabled an assessment of the risk posed by these 
injections.
The following chapter describes the interview methods developed to 
investigate the processes used by drug users. The results produced by these 
interviews follow in chapter 3.
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2 Interview design and methodology
2.1 Methodological considerations
To explore the methods of preparing injections used by current IDUs, two 
forms of investigation were considered potentially appropriate: focus groups and 
semi-structured interviews.
Focus groups, or group interviews involve an interviewer and multiple 
interviewees and the interviewees discuss the specific issue in question as a 
group. They would have provided data on the preparation processes and 
promoted the generation of qualitative discussion around methods and choices. 
The discussion of a focus group generates ideas and discusses key points 
surrounding an issue.
Focus groups have disadvantages. Such interviews would be unlikely to 
gather the preparation process of each individual in orderly detailed steps, 
possibly resulting in a random collection of data. This work aimed to record the 
spectrum of user techniques used by all participants. Focus groups can be 
dominated by particular individuals and all techniques may not be discussed due 
to the interactions between the particular individuals present in the group (Asch 
1958). Focus groups can swing on the opinions of the members of the group.
Two of the main problems with the use of focus groups, especially with 
relation to this work, are their lack of direction and their difficulty with personal 
issues. This work required the investigation of an intricate procedure with the 
intention of its replication. Information had to be gathered during the one 
instance as re-interview was not possible. Therefore, control of the data flow by 
the investigator was critical to the collection of all the appropriate details. A focus 
group can lead to data getting confused, mixed up or omitted.
Injecting practices may be seen by some participants as a sensitive and 
personal topic. Some drug users may be embarrassed about their drug use.
This was perceived in some of the interviews that were conducted. Due to this 
factor, some individuals may possibly have been unhappy to express their views 
and their technique (in what is an illegal procedure) in front of people with whom 
they may not know and feel uneasy. This factor could have been addressed by 
holding focus groups of friends, although arranging attendance at the focus
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group at a set ‘appointment time’ could possibly have proved an issue. 
Recruitment of participants from a group of people present at a needle 
exchange at a single time point would negate the need to make prior 
arrangements, but could introduce privacy issues.
Consideration of these factors resulted in the decision to reject the use of 
focus groups.
One to one interviews conducted in a private room with just the 
interviewer and interviewee present were therefore the chosen method. This 
design would enable the interviewer to explore the required information from 
each person in depth, and enable the comparison of the same data collected 
from all of the other injectors interviewed.
2.2 Reliability and validity
An area of issue with any interviews, but especially within this area, is 
that of data reliability. This issue has been in debate in the research areas of 
criminality, drug use and alcoholism.
During this investigation it would have been possible that, for instance, 
the participants may have over estimated the amount of drug they would use. 
The answers given by the interviewees are not verifiable. It is not possible to 
triangulate the data with another source to confirm its reliability.
Maddux and Desmond (1975) found that chronic heroin users tend to 
give reliable and valid life history information when interviewed, although they do 
state that all information should be carefully judged.
By having face to face interviews, it was aimed to build up a degree of 




Potential interview locations would have to meet certain criteria to ensure 
they were suitable for interviewing.
Firstly, it would have to be a place injectors trusted and would feel safe 
to be interviewed. Secondly, it would be crucial to have a private room for the 
interviews.
Needle exchanges which were willing to allow interviewing were the most 
suitable location. It was considered that participants would feel comfortable in 
the surroundings and be willing to discuss their injecting there as they did it on a 
regular basis. It was important that the service would be able to offer a private 
room for the interviews.
During the interview planning stage other locations where current 
injectors were regularly found were considered. These included police stations, 
pharmacies, drug treatment clinics/doctors surgeries and hostels.
Police stations would have been completely inappropriate for these 
interviews as the participants would possibly be in a distressed state, and with 
the nature of the interview, it would make the participants consider the motives 
of the interview.
Pharmacies would provide access to injectors, but possibly in low 
numbers. The environment is appropriate, but the availability of private rooms 
was a critical factor- most pharmacies did not have such facilities at the time the 
work was planned.
Drug treatment clinics where injectors, or former injectors, attend would 
allow access to large numbers of potential participants. However, the perceived 
threat of sanctions from the clinic, such as withholding of substitute medication, 
may have deterred potential participants.
Hostels possibly might have been a suitable location, although the 
prosecutions that followed the discovery of illicit drug supply at the 
Wintercomfort hostel in Cambridgeshire (Rice & Thomas 2001) suggested that 
hostels may have been reluctant to be involved in a study of this nature.
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2.4 Interview outcomes
The aims of the interviews were two-fold. Firstly, the interview would be 
used to collect demographic data. Secondly, the technique employed to prepare 
a drug for injection was to be investigated. The interview was therefore designed 
to meet these goals.
2.5 Methods
2.5.1 Interview locations
Three services that were approached agreed to interviews being 
conducted at their premises. These were:
BADAS - Bath Area Drugs Advisory Service
DASH - Drugs and Alcohol Service Hereford
BDP - Bristol Drugs Project
BADAS and BDP are voluntary sector agencies that receive NHS funding.
DASH is a statutory (NHS) facility.
These services were approached for a number of reasons. Firstly was 
that of convenience and the ability to travel easily to them for interviews to be 
conducted; before interviews commenced it was unclear how long it would 
require the interviewer to be present within the service before a suitable number 
of participants had been interviewed. Frequent travel to distant places would 
raise costs and be impractical. These services were also approached on the 
basis that there were existing contacts with service managers, and they were 
interested in the nature of the work.
The interviews at Bath were conducted first, as ‘pilot’ interviews. This 
enabled going back to the University to implement any required changes, such 
as reprinting questionnaires to remove flaws.
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2.6 Ethics committee approval
Diener and Crandall (1978) outlined four main areas where issues can 
arise within interview work :
Where harm occurs to the participants
Where there is lack of informed consent of the participants
Where there is invasion of privacy
Where deception or coercion is involved
For these reasons interview work is closely scrutinised to protect the 
participants and the researchers. Research involving human subjects should be 
conducted according to appropriate and accepted guidance in order to protect 
both the participant and the researcher.
In 1964, the “World Medical Association Declaration of Helsinki” 
originally outlined ethical principles for researchers in medical research. Since 
then, the document has been revised on a number of occasions to adapt to 
current medical practices. The declaration is the definitive code detailing ethical 
practice in health related research. Included within its principles are the freedom 
of the individual to participate or not, the need for consent to be informed and 
the risks to the individual be minimised and balanced against the need for the 
research and the potential outcomes. Within healthcare, these principles are 
assured by NHS research ethics committee assessment of work before it is 
conducted.
The nature of these interviews could have had negative effects upon the 
interviewees. For instance, the participants may have felt coerced into the work 
by the threat of repercussions for non participation, or where the work may have 
invaded their privacy. This work could possibly have exposed the vulnerabilities 
of the participants.
Research ethics committees assess the safety, appropriateness and 
quality of proposed research in the context of adherence to ethical principles. 
Prior to any research work commencing in a region an application needs to be 
made to the appropriate regional committee. For each of the three interview 
locations for these interviews, applications were made to the Local Research 
Ethics Committee (LREC).
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The interviews, including the questionnaire and demonstration were 
carefully designed to prevent avoid any problems in the four areas (above) 
arising.
The initial application to the Bath LREC included the use consent forms 
to be initialled by the interviewees prior to interview commencement, and 
payment for their time in the form of shop vouchers to the value of ten pounds. 
The committee felt that the use of consent forms would have no legal bearing as 
they were only initialled to prevent anonymity, and therefore there was little point 
in it. Consent was obtained from the participants verbally after they had been 
informed of the nature of the study and what the interview entailed. Additionally, 
the committee felt the payment of volunteers was coercive. The payment of 
volunteers was not adopted during the Bath interviews, however it was 
reintroduced to the applications for the Hereford and Bristol interviews, after 
services requested it and accepted by those LRECs. The payment of volunteers 
was made to compensate them for their time.
In addition to the LREC application, before work could be conducted in 
Hereford, an application had to be made to the local NHS Research Governance 
Committee as the agency in which the work was proposed is an NHS service. 
This is a committee that reviews all work carried out in Trust facilities to ensure 
NHS resources are not used to support research without reimbursement.
The letters of ethical approval from the LRECs and the approval letter 
from Hereford NHS Research Governance Committee can be found in Appendix 
1.
2.7 Interview design
2.7.1 Section One -  Semi-structured questionnaire
To investigate the participant’s background, it was decided to produce a 
semi-structured interview, asking a mixture of closed and open questions. This 
formed the first section of the interview process.
A copy of the list of questions posed to the participants is located in 
Appendix 2. It includes questions exploring the interviewee’s demographics, 
their drug history, their injecting history and then focuses on their use of acids in
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their injection preparation method. The questionnaire consisted of open 
questions, with lists of probes that were read out to the injectors, such as in 
question 20. The probes were included to remind the interviewees of acids that 
are occasionally used that they may have used, but forgotten to declare in the 
first part of the question.
In summary, the interview collected data including age, gender, current 
main drug of use, length of time injecting, in which town/city/locality they first 
learned to prepare injections, the injection site they currently use, and to list all 
the drugs they have ever injected. The questions then focussed primarily upon 
acid use. The participants were asked what acid they preferred to use, which 
they usually used, where they obtained the acids from, what they had ever used, 
and if they had ever had any health problems that they attributed to the use of 
an acid.
Responses to the questionnaire section of the interview would be used to 
investigate any unexpected results in the second stage of the interview. For 
example, the preparation technique of an older injector may have been found to 
be very different to that of younger injectors. Similarly, an interview with an 
injector who had learned to inject a drug in a different country may have 
produced similar results. The recording of the participant’s background would 
highlight any issues such as these, and then any outlying results disregarded if 
necessary.
2.7.2 Section Two- Preparation investigation
To prepare injections in an identical manner to that of current injectors, 
detailed information would be required concerning the process, for instance 
quantities and procedural steps. This information would be collected from 
current injectors, and for this purpose, four main techniques were considered:
i. Injectors could be asked the questions regarding their preparation 
process
ii. The injectors could be asked to describe the process from 
memory
iii. The injectors could be asked about the process (as in either 1. or 
2.) with some quantitative input, for instance using powder to 
demonstrate quantities of substances used
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iv. They could be observed preparing an injection with quantifiable 
data measured and recorded.
Investigation of the process through a series of questions posed by the 
interviewer was the first considered option of detailing the injection preparation 
process. Using a prepared list of questions, at each step of the process the 
participants would be asked what equipment they would use, how they use it, 
how much they would use and so forth.
This method would be very easy to accomplish, and require minimal 
consideration of the entire process for the participants other than to answer to 
the current question, for example: Q: ‘What water do you use?’
A: W ater from a tap.’
The progression of the process would provide structure to the questioning.
The main problem with this approach was that it would assume that all 
injectors prepare injections in a similar sequence, that is, the order of the 
questions being asked would presume the order of the sequence.
The level of detail provided by each participant would be likely to vary as 
well. Using the previous example, one user might state that they acquire their 
water from ‘a tap’, whereas others might state that they get it from the bathroom 
tap, or the kitchen tap. A participant volunteering more information might reveal 
that they get it from a tap, but they pour it into a cup which stays on the lounge 
table until it needs refilling.
Additionally, this type of questioning risks stimulating very little thought 
into the way they perform the complete procedure. This could possibly result in 
actions that they usually performed not being recalled if it was not asked about. 
Other than giving the required answer to the current question they might not 
state important procedural steps, for instance, the wiping down of a spoon with 
an alcohol swab before use. The difficulty in recalling the entire technique in 
detail may result in the description being disjointed. Recall bias such as this was 
of concern in the selection of the interview procedure.
Another flaw in this technique is the lack of quantitative input from the 
interviewees. At best, users would be able to verbally describe how much they 
use e.g. ‘a pinch of acid’, but this is vague and will vary from pinch to pinch, and 
from person to person. This data was a critical requirement of these interviews 
in order to translate it into a laboratory process.
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The second method considered involved less structured interviews, 
using a more open questioning style asking the participants to talk through a 
description of their usual way of preparing an injection. This technique has the 
advantage of allowing in depth detail descriptions of the technique, as well as 
not assuming any particular procedural order. This method has the advantage of 
being unlikely to ‘lead’ the participants and may result in a more thorough 
explanation of all actions performed.
This method would suffer from the same problems associated with recall 
as the direct questioning method, above, possibly even more so as the 
participants would be given no prompting [by the questions]. Additionally, it 
would also provide no quantitative data regarding the materials used during the 
preparation.
In order to obtain quantitative data in interviews, previous researchers in 
this field have provided the interview participants with substances such as salt. 
The participants were then asked to measure out a quantity similar to that of the 
acid that they used. The researchers however, had assumed that the weight of 
salt used was equal to the weight of acid used by the injectors. Having different 
molecular weights and densities this is of course not the case, although 
equivalents could be matched through volume comparisons (this work was 
conducted during the evaluation of the supply of citric acid to injectors in 
Glasgow, although it was not included in the final report (Garden et al. 2003)).
Even though, this was a flaw within the work that employed it, it 
demonstrated that the technique was a viable means of obtaining quantity 
measurements in interviews. The possibility of utilising a similar technique 
incorporated into the above interview designs was explored.
2.7.3 Observation of injection preparation in naturalistic environment
The observation and recording of the preparation of actual drug 
injections by injectors within their usual naturalistic injecting environment was an 
option considered but rejected. This method would have enabled the recoding of 
the procedure with accuracy and detail, limited by the data recording skills of the 
researcher. This type of study is referred to as non-participant observation.
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The major issue with this type of study was with the ethics. The observer 
would be placed into potentially risky situations observing illegal activity. 
Alongside this, there was the risk that they might be present at a police arrest, or 
witness to an overdose. Both of these events would put researchers in a 
precarious position. At the time of interview planning, work of this nature had not 
been previously conducted. In consideration of these points, the possibility of 
acquiring ethics approval by a PhD student for such work was considered low, 
based on previous discussions with ethics committees. Therefore, the design of 
an interview incorporating such observation was not pursued.
Additionally, and very importantly with regard to this work, there would be 
no opportunity for the measurement of quantities of materials used. This would 
have a large impact on the usefulness of the data in the derivation of the 
laboratory injection preparation procedure.
2.7.4 Interview with demonstration of preparation
After consideration, the idea of a practical demonstration of injection 
preparation, in the needle exchange environment, was devised.
The primary advantage of using this procedure was obtaining 
quantitative data (for the materials used including water, acid and drug 
quantities, along with heating time), and the ability to observe and record all 
aspects of the procedure. This would include points that interviewees might not 
recall in an interview. Secondly, by following their usual preparation procedure, 
the participants’ recall of their procedure would be prompted by the process.
It was envisaged that the inclusion of the practical element of the 
interview would make the interview more appealing and interesting to potential 
interviewees and thus improve recruitment.
There were three main disadvantages envisaged in this work. Firstly, 
these interviews would require setting up time beforehand, in addition to the 
usual of questionnaire printing, equipment and materials would need to collected 
and organised. Secondly, the time to prepare an injection could possibly have 
extended the length of the interview beyond an acceptable level.
Most critically, there was the problem of the drug. Using Class A drugs in 
an interview would pose many implications. Legally, there was the possibility of 
theft or robbery of samples, plus the supply of the drug to the participant for
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demonstration would constitute an illegal supply. The possibility that a 
participant may attempt to ingest either the drug or the finished injection solution 
would pose potential problems, and pharmacologically there was risk to both the 
participant and interviewer from exposure to drug material.
The use of real drug within interview circumstances was not an option. In 
order to perform the preparation, inert substances would have to be used in 
place of real drug material.
2.7.5 Imitation drug substances
In order to prepare the injections as realistically as possible, substances 
with similar properties as illicit heroin or crack had to be identified. These 
substances needed to have similar physio-chemical properties as the drugs, 
with regard to water and acid solution solubility. Additionally, the substances 
chosen had to have little, or no, pharmacological activity, be acceptably 
innocuous and inexpensive. The chemical chosen had to be safe for use under 
the circumstances, but also if it got stolen, then consumed, it had to be non­
toxic.
Biologically inactive opiate compounds were explored for use as the 
‘drug’ during the interview, because their chemical properties are very similar to 
that of heroin, however, their legal status prevented serious consideration. 
Thebaine is an ideal substitute physio-chemically, but it is a schedule two 
controlled drug- the same as heroin- even though it is pharmacologically 
inactive.
The selection of a suitable compound proved difficult. In the Glasgow 
area, it is common to find heated and crushed paracetamol tablet powder on the 
illicit drug market as a heroin diluent (Personal Communication, Roberts, 2002). 
Preparing paracetamol tablets in this manner produces a substance visually 
similar to illicit heroin.
Paracetamol is also one of the most commonly used diluents in illicit 
heroin base samples (King 1997), and for that it was considered likely to confer 
some of its physio-chemical properties to that of the illicit heroin powder. At the 
outset of the demonstration, the participants were informed of the fake ‘drug’ 
material not being the real drug. Some of the participants were inquisitive 
enough to ask what the powder they were using was, a few almost seeming to
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believe it actually was real drug, its appearance being so similar. Once they 
were informed of its composition, interest in the powder waned. The nature of 
paracetamol and its commonly known effects proved a disincentive if the 
interviewees enquired about the powder.
Heroin substitute manufacture








Polyvinyl Povidone Pyrrolidone 2mg 
Potassium Sorbate 0.6mg
The first step of the process was to crush the tablets down into powder 
using a mortar and pestle. Each tablet would produce approximately 500mg of 
finished fake drug powder. This powder was then placed on a hotplate. On 
heating, the powder melted to form a liquid, which on continued heating turned 
dark brown in colour. The solution was then immediately poured back into the 
mortar and allowed to cool and solidify. Once the liquid had thoroughly solidified, 
it was re-crushed into a powder. This powder was brown in colour and was the 
finished heroin substitute.
Testing of heroin substitute
The powder produced was measured using melting point apparatus and 
found to be almost the same as that of pure paracetamol (167°C compared to 
169°C of pure paracetamol).
As a test more appropriate to the interviews, the powder was tested in 
the injection preparation situation. Using 100mg of powder, and 50mg of citric 
acid with 1 ml of water, the powder dissolved into solution and was able to be 
drawn up through a Swan filter into the syringe. The end result was a dark 
brown solution in the syringe. The powder had dissolved completely into solution
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without leaving residue in the spoon. The powder was considered suitable as 
the substitute.
The crack substitute
The identification of material to form the crack substitute was more 
difficult than that of the heroin powder. Crack cocaine is almost 100% cocaine 
base- approximately 90% cocaine base, with 10% or less sodium bicarbonate 
(Jones 1990). It may also contain various impurities (that were present in the 
cocaine hydrochloride powder from which it was produced) that have been 
incorporated within it during the manufacturing process. These can include 
lidocaine and procaine (Griffin 2003).
Identification of a compound to simulate crack was even more difficult 
than for heroin. Attempts were made to synthesise fake crack ‘rocks’ that 
resembled those of real crack- these were required to have a similar water 
solubility.
In order to keep the compounds in use simple and safe, the decision was 
made to synthesise the crack from a paracetamol based mixture. Paracetamol 
powder was mixed with sodium bicarbonate powder in water, but this failed to 
produce solid ‘rocks’. The use of paracetamol tablets as the source of 
paracetamol was subsequently attempted. Starting with crushed paracetamol 
tablet powder, sodium bicarbonate was added to make up 10% of the total 
weight. Nine millilitres of water was then added per ten grams of powder to form 
a paste. The paste was then dried forming a block that could be broken into 
‘rocks’ which were hard and did not crumble. These were suitable for the 
interviews.
This fake crack would pose little risk to participants -  no more than that 
posed by a single paracetamol tablet. This was essential in the consideration of 
the required Ethics committee applications in order to prove safety.
2.7.6 Materials use during interview
For use in the interviews, approximately 500mg of fake heroin powder 
was measured out into eppendorf tubes and the weight accurately recorded.
One rock of fake crack was placed in each tube and the weight accurately 
recorded. Citric and ascorbic acids were also measured out in this manner, with
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500mg per tube. For each interview, there was a set of all four tubes available. 
Depending on the injection prepared, either one of the drug tubes would be 
used, or both for a speedball preparation. Also one of the acid tubes would be 
used, depending on the choice. If lemon juice or vinegar was chosen, the 
volume used would be recorded during the interview.
After the interviews, the contents of the tubes were reweighed, and the 
difference calculated to establish the exact quantity of materials used by each 
participant.
2.7.7 Demonstration Equipment
To prepare injections equipment such as lighters, spoons and filters are 
required. It was chosen to supply all equipment that may have been required 
during the process. By supplying all the equipment, there would be no variation 
of the results due to use of different equipment, for instance spoons. A bigger or 
thicker metal spoon would possibly require a longer heating time compared to a 
smaller or thinner spoon. Additionally, the metal alloy would also have such an 
effect.
The equipment was kept out of sight from the participant in a box. To get 
an item for use, they had to request it from the interviewer. The process of this 
blinding was to necessitate the user to consider the equipment they use.
Leaving the equipment on a table in full view, would not have the same effect in 
stimulating the user to think about the item they required. For instance, if there 
was a dessert spoon and a tea spoon on the table they may pick up the nearest 
out of convenience, even though they normally used the other type.
2.8 Craving inducement
Studies on the craving of drugs illustrate that this could potentially be 
induced in the participants during the interview work. This would be of significant 
concern. The potential to induce craving within the participant of the interviews 
was of concern, and it would be considered unethical if steps were not taken to 
forewarn and protect the participants of this risk. It was considered that craving
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could result in ex-injectors being encouraged to return to injecting, or 
encouraging current injectors to inject additional drug doses.
To prevent this occurring, a number of steps were taken. Firstly, 
exclusion criteria during recruitment would ensure ex-injectors would not be 
interviewed. This would prevent the risk of encouraging them to re-pursue 
injecting, and additionally would also ensure that observed preparations were 
current techniques in use, not ones that might be aged, or affected by poor 
memory recall.
When interviewing, before the interview began, and then again before 
the demonstration was started, all participants were warned that craving could 
possibly be induced by the process of preparing an injection. They were asked if 
they thought this would be an issue for them if it occurred. If they said they 
thought it might, or if the interviewer had specific concerns, the interview could 
proceed as a series of questions without the demonstration. The list of questions 
drawn up for these circumstances is found in Appendix 3.
2.9 Data recording
The questions were asked by the interviewer, who wrote down the 
responses. The responses were transcribed verbatim, unless the response was 
long. Long responses had the key points written verbatim. Each questionnaire 
document was marked with an interview site code and an interview number to 
enable identification, and ensure the anonymity of the participant.
2.9.1 Demonstration recording
The method of recording the demonstration techniques posed 
challenges. The chosen method had to be ethically and technically feasible, 
whilst producing suitable data for analysis.
Four main methods were considered:
□ Interviewer observation with note taking
□ Audio tape recording of process narrated by participant or 
researcher, with observations noted
□ Still photography of each significant step
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□ Video tape recording of entire process
The most appropriate method considered was video recording. This 
method would provide a permanent record of the techniques used, with the 
ability to be reviewed on numerous occasions. However, it would not provide 
much data with regards materials used. Amounts would be visible on the 
recording, but not quantifiable.
The confidentiality of video recordings was of additional concern. The 
videos could enable the identification of a person preparing an injection, this 
would breach confidentiality. Even careful camera placement to record only the 
hands could still reveal clues as to the identity of the participant if they had 
identifying features such as scars, tattoos or jewellery. Discussion with members 
of the Research Ethics Committee for the Bath area confirmed this would be 
problematic in obtaining ethical approval.
The final potential anticipated problem with the use of video recording 
would be the effect of the camera on the participants. This could occur in two 
different ways. Firstly, the participant might be anxious of the camera. This 
would possibly induce errors in their preparation process, may have caused 
nervousness and tremor leading to preparation difficulties, or they might rush to 
get it over with. In a similar manner, interviewees might become nervous due the 
prospect of being recorded performing the procedure, either on the grounds of 
legal implications, or embarrassment of demonstrating a part of their private life 
of which they are ashamed. Alternatively, it is possible that the participant might 
‘play up’ for the camera, and proceed through the preparation in an unnatural 
way.
In light of these points, although considered methodologically the best 
means, the use of video recording was rejected as a means of gathering the 
interview data on ethical and practical grounds.
A set of still photographs would lack data regarding what occurred during 
the times between the photographs, in order to overcome this, a large number of 
photographs would be required, and the preparation process might be unduly 
delayed by the stops for the photographs to be taken. Still photography with a 
photographic camera was considered, but the confidentiality of the interviewee 
would still potentially be breached through possible identification from the 
photographs. Use of this method would have been a poor substitute for video 
recording (which is continual and has sound) and would have possibly have 
missed vital information, so the method was rejected.
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Audio recording would have been beneficial for the questionnaire section 
of the interview, but would have been of questionable value for the 
demonstration section. The demonstration would still have required observation 
recording using an additional method. Audio tapes would have required 
transcription after the interviews were conducted in addition to the observational 
reports analysis.
2.9.2 Interviewer observation and recording
Interviewer observation would require watching the process and 
documenting it as it happened.
After consideration and rejection of the alternative methods mentioned 
above, this method was investigated. The method required no electronic 
recording equipment, but would produce a record of all points observed and 
recorded by the observer during the preparation process. There was also the 
option of recording comments made by the participants as they proceeded. The 
simplicity of the technique was attractive, although it was unclear if it was 
feasible in practice.
Trials of this technique demonstrated that this was a difficult task. It 
required rapid note taking with care to ensure all important details were not 
missed. Simply writing down every point as it occurred proved impossible.
In order to speed up the recording process, checklists were produced 
that made it easy to record actions. For example, by ticking a box, rather than 
having to write long-hand ‘dessert spoon’ to record this selection.
2.10 Recruitment
Recruitment of participants was a major factor in determining the 
success of the interviews. The availability and willingness of people to be 
interviewed was critical to the outcome of this work. Lack of potential 
interviewees would increase the overall time taken for this work to be completed,
61
and could reduce the final amount of data collected. Careful consideration was 
therefore given to this matter.
To encourage potential interviewees to participate, the interview was 
designed to be completed in a relatively short time (approximately 15 minutes) 
thus inconveniencing people as little as possible.
Injectors approached to participate may have been suspicious of the 
motives of the interview and/or the reasons for the interview (Matheson 1998). It 
could possibly have been viewed as an undercover police operation to arrest 
drug users. To prevent this, all users were reassured about the confidentiality of 
the interviews. Additionally, before an interview took place, they were explained 
its nature and its purpose in detail. Finally, it was hoped that by conducting the 
interviews at their needle exchange the users would feel some degree of trust 
and security.
Participants were informed at the beginning of every interview that they 
could leave at any point, without needing to give a reason and that if this it 
occurred would not affect their treatment at the needle exchange in any way.
Leaflets and posters were used to promote the research to service users 
and displayed in waiting rooms and needle exchange areas within the 
participating agencies. Exchange users were also informed of the research 
during the exchange process. A copy of the leaflet used is found in Appendix 4.
Needle exchange staff were given briefing talks on the nature of the work 
to inform them of the nature and aims of the work being conducted. This in turn 
enabled them to inform users about the work to aid recruitment.
The recruitment process began two weeks before the interviews. All 
volunteers were given at least twenty-four hours to consider participation before 
consent was obtained.
To ensure appropriate participants were recruited, three inclusion criteria 
were placed upon the volunteers. Firstly, as discussed previously, no ex­
injectors were interviewed, all participants had to be currently injecting.
Secondly, all participants had to be over 18 years old.
Thirdly, the person must have injected for a minimum of 3 months prior 
to interview. The reasoning behind this was two-fold, and aimed to protect both 
the participant as well as the data. A new injector could possibly have been 
exposed to potentially dangerous information, for instance, the acidifier probes 
(especially descalers) would highlight the ability of using these substances. A
62
person who has injected for less than three months was considered to possibly 
have less experience than desired to inform the research about an established 
working process. They may skew results through the use of inaccurate 
procedures or quantities.
Finally, it was important that the person also actually prepared their 
injections themselves. The preparation of their injections could be done by a 
partner or friend. A demonstration of preparation by someone who had only 
observed the process would be likely to include errors or omissions. Volunteers 
were asked whether they produced their own injections before recruitment.
If a volunteer met these criteria, they were suitable for participation.
2.10.1 Sample size selection
The total numbers of participants interviewed was based on the 
qualitative research basis of data saturation. As the interviews were conducted, 
the data being recorded, especially with regard to the demonstrations, was 
monitored. Once the interviewer was seeing or hearing no new information, data 
saturation had been achieved. Further interviewing will only provide excessive 
data, and new results are the exceptions rather than typical.
2.11 The interview process
The interviews were conducted in a private room at each of the 
exchange facilities. Privacy was critical for confidentiality. It would also avoid 
intrusions, interference from other people that could contaminate results and the 
sharing of ‘bad’ practices by demonstration of them to other IDUs. The privacy 
would also offer a level of reassurance to the participants. The process of 
injection preparation is an illicit and illegal practice that the participants may 
have been worried about observation by non-participants, either other injectors 
or service staff. Some participants may have been embarrassed conducting the 
procedure and be reluctant for the process to be witnessed by anyone other 
than the interviewer.
The interviews were designed to last approximately 15 minutes. The 
actual length of the interview would depend on how much detail the respondents
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went into, and how long their injection preparation took. In a three hour 
interviewing session, ten interviews were estimated as possible. The attention 
required from the researcher observing and recording the procedure also limited 
the maximum number, as mental fatigue could impact on recording quality.
At the outset of each interview, the participant was told what would 
happen and the reason the research was being conducted. It appeared that 
many of the volunteers agreed with the cause of the work and understood there 
was potential benefit for all injectors. All volunteers were reminded that they 
could leave the interview at any time without needing to give a reason and doing 
so would not affect their service from the needle exchange. If the volunteer was 
satisfied, the interview commenced.
After the interview concluded the participant was thanked for their time 
and input. They were then offered the ten pound gift voucher (during Hereford 
and Bristol interviews). After the participant had left the room, the fake drug and 
acid powder containing tubes were collected in numbered and coded bags, 
along with the questionnaire and observation checklist. Any additional materials 
of importance were collected such as filters. Used syringes were disposed of in 
sharps bins- there was no risk during this as it had been observed that they had 
not been used for injecting, if there had been (for instance an accidental prick 
with the needle) the participant would have been requested to dispose of it 




3.1.1 Interview piloting and problems encountered
The pilot interviews in Bath highlighted problems with the demonstration 
section of the process, and introduced a problem that was unanticipated.
The interviews in Bath were discussed with BADAS during the 
submission phase of the ethics application. The protocol for work was agreed 
and dates set for the interviews once approval had been obtained. On the first 
day of interviewing, it became apparent that the contact worker at the service 
was under the impression that the interviews would take place with him present. 
The presence of a member of staff in the interview room would breach the 
confidentiality of the participant, and was considered by the research team to be 
unethical.
The member of staff was explained the situation, but stated that after 
consultation with his director, it was agreed that he was required during the 
interviews for health and safety reasons.
This situation was not expected and it was felt that the presence of this 
worker would adversely affect the responses given by the participants. 
Additionally, his presence was not agreed with the ethics committee during the 
application for work, so it was referred back to them for consultation. A new 
information sheet was drafted for potential participants that stated that there 
would be a member of needle exchange staff present during the interviews. The 
LREC decided that the presence of a member of staff, combined with the new 
information sheet was acceptable.
The first design of the checklist for use during the interviews consisted of 
a double page section for each envisaged step of the process. In practice, flaws 
in this design became evident rapidly. The large number of pages and sections, 
combined with the speed of the preparation process by the participants led to 
difficulty in keeping up with the recording of the process, and in the event, 
details not being recorded. To correct this, the checklist was redesigned to 
enable all the text to fit on the two sides of A4 paper. This revised final version 
can be found in appendix 5.
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3.1.2 Interview completion
The interviews were conducted over a total of eleven days, however, 
these days were not consecutive, but spaced out over a period of four months 
due to location changes and delays for ethics committee site specific approval 
(Hereford and Bristol).
3.1.3 Interview analysis
Firstly, the used demonstration materials were accurately weighed and 
the amounts used calculated.
To group data with the same theme, codes were assigned for each 
question and part of the demonstration, but the data for the questionnaire was 
kept separate from the data from that of the demonstration checklist. Both sets 
of data were identifiable by interview number and location if cross-referencing 
was required between the question data and the demonstration data. The 
separation of the data was conducted to make the data files more manageable 
and smaller in size.
This data was then entered into a Microsoft® Access database (Part of 
Office XP Suite. Redmond, Washington, U.S.) for storage and analysis.
Themes and trends from within the results were then grouped and 
explored. Data was further analysed by input into SPSS (Statistical Package for 
Social Scientists, Versions 10 and 11. SPSS Inc. Chicago, Illinois, U.S.).
3.2 Results
In total, sixty five injectors were interviewed. Two of the participants were 
from BADAS (the pilots), twenty-eight from DASH, and thirty-five from BDP. The 
results from the pilot interviews were included in the final results as the changes 
made to the interviews after piloting were very minor (the checklist change) and 
most importantly, it was clear that the results from the pilots were highly similar 
to those obtained in the main interviews.
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3.3 Part 1 - Interview results
3.3.1 Demographics
Eighty percent (n=52) of participants were male, 20% (n=13) were 
female (ratio 4:1). The mean age of all participants was 28.4 years. The mean 
age of the male participants was 29.1 years (range: 20 to 46 years), of the 
females it was 25.8 years (range: 18 to 38 years). 34% (n=22) of the participants 
were under 25 years old, 66% (n=43) were 25 years old or older. Table 3 shows 
the age and gender of the participants per location.
Table 3. Gender and ages of participants by location
Location Gender Number Mean age and range




26.9 (range 20 to 37 years). 




30.7 (range 20 to 46 years) 
27.6 (range 19 to 38 years)
3.3.2 Drug use
Table 4 presents the main drug of use by the interview participants at 
each location.









Drug use by gender
All female participants only injected heroin. The crack and speedball 
injectors interviewed comprised solely of male participants.
Drug use by age:
Table 5 presents the age of the participants in relation to the main drug
of use
Table 5. Age of drug users in relation to the main drug of use
Drug Mean age of users Age Range
Heroin 31.6 years 19 to 46 years (SD 7.18)
Crack 33.7 years 24 to 42 years (SD 9.07)
Speedball____________ 27.4 years_____________ 20 to 39 years (SD 5.73)
3.3.3 Length of time injected
Table 6 presents the time participants have injected for at each location. 
Table 6 Length of time participants at each location have injected
Location Mean time injected
Bath 8.5 years (range 7 to 10 years, SD 2.1)
Hereford 5.7 years (range 3 months to 18 years, SD 4.3)
Bristol 6.8 years (range 3 months to 15 years, SD 4.2)
3.3.4 Drug history
Location of first drug injection
This was separated into local to the interview location, or distant.
Bath
One participant first injected in Bath, one did not.
Hereford
Five of the 28 participants first injected somewhere other than Hereford.
Bristol
Sixteen of the 35 participants were not originally from Bristol and had 
injected for the first time elsewhere.
3.3.5 Drugs ever injected
Participants were asked to list all the drugs they had ever injected, even 
just once. These are listed in Table 7.
(The results for Bristol and Bath have been amalgamated on the basis that they 
are closely located which would potentially lead to similar drug sources, and 
because the number of Bath interviews (n=2) were low, there were no trends.)
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Table 7. Drugs ever injected divided by region






Heroin 28 100% Heroin 37 100%
Amphetamine 19 68% Crack 34 92%
Crack 11 39% ‘Speedball’ * 29 78%
‘Speedball’ 10 36% Amphetamine 27 73%
MDMA (Ecstasy) 8 29% Cocaine 16 46%
Cocaine 8 29% Temazepam (inc 8 22%
‘eggs’)
Diazepam 4 14% Diazepam (inc 6 17%
valium amps)
Diconal1 3 11% Diconal1 7 19%
LSD 4 14% Palfium2 6 17%
Temazepam 3 11% MDMA (Ecstasy) 5 14%
Morphine ampoules 3 11% Dihydrocodeine 4 11%
Palfium2 2 7% Morphine (inc. 3 9%
MST tablets)









Lorazepam amps 1 3%
Mandrax5 1 3%
‘Black Bombers’6 1 3%
Proprietary tablet formulation containing the opioid analgesic dipipanone and the anti-emetic cyclizine 
Proprietary tablet formulation of opioid analgesic dextromoramide 
Proprietary injection formulation of papaveretum (opiate analgesic)
Proprietary tablet formulation of the hypnotic drug zopiclone 
Proprietary tablet formulation of the hypnotic drug methaqualone 
6Slang term referring to defunct tablet formulation of amphetamine tablets
3.3.6 How the participants learned to prepare injections
All participants stated that they had learned to prepare injections by 
being in the presence of other injectors i.e. by watching them. These ranged 
from friends, partners and family members including parents.
Most participants stated that they had: ‘watched others do it’, or they 
‘picked it up from the crowd’.
One participant stated that he had learned the technique by ‘watching his 
parents prepare injections as he was brought up’.
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3.3.7 Materials used to prepare first injection
The participants were asked about the preparation of their first injection, 
and how they gauged the quantities of materials, particularly acid in this 
preparation.
The most common response to this question, by twenty-six participants 
(40%), was that they had a ‘rough idea’ in their heads of how much of each 
material was required.
Twenty (31%) of the participants interviewed described the measurement 
of the quantities as ‘trial and error’. In other words, they guessed the amounts 
required.
Four participants (6%) stated that they had a ‘good idea’, or were 
confident that they knew how much of each component material was required 
for an injection to be prepared. This would assume they were alone or otherwise 
not directed during the conduction of the procedure.
Fourteen (22%) participants were actually shown by another injector, or 
told how much of each component to add.
No answer was recorded for one participant.
3.3.8 The use of acids
The participants were asked if they used an ‘acid’ in the process they 
followed to prepare injections. All 65 replied that they did.
Reasons given for acid use
The participants were then asked to explain why they used an acid in the 
process. The most common reason for using an acid revolved around the idea 
that the powder had to be broken down in some way. The most common 
response was:
‘to break it down’
Similar replies included:
T o  breakdown the heroin/gear/heroin compounds’
‘Nothing happens. Gear doesn’t break down’
‘Citric cuts it down to liquid’
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‘Because it is dirty and you need to break it down’
‘Breaks down what it is cut with’
‘Break it down ‘cos it’s got loads of shit in it’
‘Break it down and kill any germs’
These responses were made by 53 (81.5%) of the participants.
The concept that additional materials are present in drug material was 
expressed in the second set of reasons for using acid:
‘Because of the rubbish and waxy stuff in it’
‘Because of the crap in street heroin’
T o  clean up the shit in heroin’
One participant answered that it was to ‘turn it into gear’ suggesting they 
thought the acid was required to somehow form the drug prior to injection.
One participant stated they used acid because they had been told to. 
Three participants stated that they did not know why they needed to use it. 
These answers suggest that none of these users understand or had any idea 
why they are using it, and that they only use it because they were shown that 
they need to.
Out of all of the participants, only four gave suggestions that described 
the real purpose in detail.
One suggested that as ‘it is an alkaloid, it needs acid to make it go into 
solution’. Two used the word dissolve in their explanation:
T o  help it dissolve’
T o  dissolve the gear’
One participant appeared to have come to the same conclusions as Strang et 
al.(Strang, Keaney, Butterworth, Noble, & Best 2001) and stated:
‘Brown heroin needs acid to dissolve in water’ as opposed to white
heroin.
3.3.9 Acids in use
To explore the use of acids by the sample, the participants were asked 
‘Which acidifier do you prefer to use?’ and then, ‘Which acid do you normally 
use?’.
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It is important to note that the responses have to be split by interview 
location. This is due to the fact that the three exchanges used for the 
interviewing supplied either: citric and ascorbic acid (Hereford), citric acid only 
(Bath), or no acid at all (Bristol). At the time of interviewing, the Bristol exchange 
was unable to (and had never in the past) supplied acids to its users due to 
financial restrictions. Table 8 records the participant’s responses.




Acid normally used 
Acid n (%)
Hereford Citric 16(57) Citric 21 (75)
Ascorbic 12(43) Ascorbic 










Ascorbic 13(37) (Use each equally) 2(6)
Bath Ascorbic 2 (100) Citric 2(100)
3.3.10 Acidifiers ever used
Anecdotal reports suggest that drug injectors use a wide variety of 
substances in order to increase the solubility of illicit drugs. In order to 
investigate this, the participants were asked what they had ever used during 
injection preparation. They were asked what they had ever used, then a list of 
commonly used acids was read out as a prompt. The results are shown in Table 
9.
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Table 9. Substances ever used by injectors interviewed when attempting to 
dissolve illicit drugs.
Acidifier Number of participants ever used (%)
Citric
Lemon Juice 
Ascorbic acid/Vitamin C 
Vinegar 
Fresh Lemon 
Descaler (any sort) 
Fizzy sweet coatings 

























3.4 Part 2 -  Demonstration results and observations
The information collected during this work can be divided into two main 
categories- preparation steps, and details about the equipment and materials 
used to conduct these steps. The preparation steps are the major factors 
regarding the procedure; the materials and equipment details are considered the 
finer details.
3.4.1 Preparation steps
These are the overall order in which the participant prepared the 
injection. They are concerned solely with the major events within the preparation 
procedure. The overall procedure will require certain critical events to occur, 
without these events the preparation would not achieve the goal of preparing a 
viable injection solution.
Using anecdotal details available, the steps that form the injection 
procedure were used to devise the demonstration checklist. Although the 
anecdotal data informed about the steps used during preparation, they did not 
make the order of the steps clear, and variations were seen between the 
reports.
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3.4.2 Heroin injection preparation steps
Forty-five of the forty-seven heroin injectors (96% ) followed the same 
preparation steps to produce their injection. These are outlined below:
H eat applied
Solution Filtered
Heroin pow der 
placed into cooker
Acid added to drug 
pow der in cooker
SOLUTION READY 
FOR INJECTION
W a ter drawn up in 
syringe and added  
to cooker
Figure 2. Steps used to prepare heroin injections by 96% of interview participants
Figure 2 shows the drug being mixed with the acid first, and then the 
addition of the water. The two participants who did not follow these steps 
demonstrated variation in the order they mixed the drug, the acid and the water. 
One of these added the water to the drug powder, before adding the acid 
powder. The second choose to measure out the acid powder, and then add the 
drug powder to it.
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3.4.3 Crack injection preparation
Six of the eight participants (75% ) who prepared crack in the 
demonstration followed the series of steps depicted below in Figure 3:
Crack rock crushed 
into solution
Solution Filtered
Rock of Crack  
placed in cooker




W ater drawn up in 
syringe and added  
to cooker
Figure 3. Steps used by six out of eight participants to prepare crack for injection
The other two participants added the acid after adding the water to the drug in 
the ‘cooker’.
3.4.4 Speed ball injection preparation
All ten of the speedball injections prepared during the demonstrations 
were prepared using the steps outlined in Figure 4 below:
H eat applied
Crack added to 
solution and crushed
Heroin pow der 
placed into cooker
Acid added to drug 
pow der in cooker
Solution Filtered
SO LU TIO N  READ Y 
FO R  IN JEC TIO N
W a te r drawn up in 
syringe and added  
to cooker
Figure 4. Steps used to prepare a 'speedball' by all participants (n=10)
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3.4.5 Equipment used during preparation
The equipment used to complete the same steps of the processes was 
seen to vary.
Syringe/needle
Irrespective of drug used, the use of 1ml insulin syringe with fitted needle 
(29G) was prevalent. The Bath and Bristol needle exchanges only dispense 
insulin syringes in 0.5ml and 1ml, with the 1ml the most popular. DASH also 
supply 2ml and 5ml syringes upon request, in addition to insulin syringes
Of 64 interviews (one result missing), 55 of the participants used 1ml 
syringes, three used 0.5ml insulin syringes, and the remaining six (all from 
Hereford) used 2ml syringes. The variation in syringe use was only seen in 
heroin injectors, the crack and speedball injectors all chose 1 ml syringes (one 
result for crack injector missing).
3.4.6 Heroin preparation 
Cookers
‘Cookers’ used included tea-spoons, dessert spoons and the bottom of 
used drinks cans. Forty five participants (96%) chose to use a spoon of either 
size; the other two used the bottom of a drinks can.
Filters
To filter their injections, 29 (62%) of the participants used material from 
filters made for hand-rolled cigarettes, 14 (30%) used material from filter tip 
cigarettes and four (8%) used cotton wool.
Heat source
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To heat the injection solutions, a disposable cigarette lighter was used by 
41 participants. Three burned pre-injection (isopropyl) alcohol swabs, and one 
used two matches held together side by side. Two results were missing.
The benefit of using swabs appeared to be the freeing up of one hand 
which could be used to stir the solution during heating, as was demonstrated by 
one participant using the needle sheath to stir the solution.
During the preparation only twelve participants stirred the solution, nine 
of these using the needle sheath; two used the plunger end of the syringe, and 
the other used a match.
Materials used during preparation
The majority of participants chose to use citric acid (n=37, 79%), eight 
(17%) chose ascorbic acid as the acid of choice, and two (4%) chose lemon 
juice.
Water was used from a variety of sources. Thirty (64%) used water from 
the tap, seven (15%) used water from bottles, includes bottled mineral waters, 
and tap water stored in a bottle, six (13%) used boiled water and one (2%) 
stated using sterile water from ampoules (source of these unknown). Data on 
water are missing for three participants.
3.4 .7 Crack cocaine preparation
Seven used spoons as cookers; one used the bottom of a drinks can. To 
filter, all eight used material from filter-tip cigarettes.
All crack cocaine injectors (n=8) chose to use citric acid for their 
preparation. Water source varied with three using tap water, one using ‘boiled 
and cooled’ water from the kettle, one using bottled water, and one using water 
obtained from a ‘toilet’ (it is unknown if this refers to the cistern or the bowl).
Data on water is missing for two participants.
The preparation of crack did not involve heating the mixture; therefore no 
heat source was required.
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3.4.8 Speedball preparation
As cookers, eight used spoons, the other two used the bottom of drinks 
cans. To filter, eight speedball injectors used material from filter-tip cigarettes, 
the remaining two chose material from roll-up cigarette filters.
All participants used citric acid for their preparation. Five used tap water 
and three used bottled water. Data on water is missing for two participants.
To perform the heroin heating step of the preparation all participants 
used a cigarette lighter.
3.4.9 Filter use in detail
Table 10 Filters used during preparation by the participants at each location
Location Filter Number
Bath Roll-up cigarette filter 2
Hereford Roll-up cigarette filter 26
Cigarette filter (portion) 2
Bristol Cigarette filter (portion) 28
Cotton Wool 4
Roll-up cigarette filter 3
Table 10, above, shows the choice of filter used by each participant. The 
difference in choice of filters is accounted for by the fact that DASH supply their 
users with Swan roll-up filters for this purpose, neither BADAS nor BDP supplied 
filters to their users at the time of interview.
The choice of the filters used by the users also appears to influence the 
way they use them. The use of the filters is not straight forward.
In Hereford, all the users were seen to use part of a filter, rather than the 
whole thing, this was independent of the filter choice. Roll-up filters had a strip 
torn from them lengthways to provide a much smaller amount of material for 
use. With filter tip cigarettes, filter material was pulled out of the end of the 
cigarette: these measured 7mm wide (the width of a cigarette), by about 2mm 
thick. The length ripped out varied.
The three users in Bristol who chose to use roll-up filters all used them 
differently. One used the whole filter; one tore a strip off as done by those in 
Hereford. The third stripped all the outer ‘skin’ from the Swan filter and used the
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inner core as the filter. The reasoning behind this is unknown, but it is possible it 
was due to dirt on the outside of the filter.
The majority of the participants in Bristol chose to use cigarette filter 
material. This was usually removed from the cigarette by cutting the filter with a 
scissors horizontally, leaving the filter shorter, but otherwise intact (unlike when 
the material is pulled out, which damages the material left on the cigarette). The 
cotton wool users removed a piece from one end of a cotton bud, and rolled this 
into a ball for use.
3.4.10 Heating
The heating of the injections containing heroin (heroin alone, and 
speedballs) was conducted by all 57 participants. As outlined above, the 
majority of these participants chose to use a disposable cigarette lighter for this 
purpose.
For use during the interviews, lighters were purchased from a 
newsagents shop. These were manufactured by the brand ‘Cricket’. Contact 
with Cricket revealed that these lighters contain a mixture of butane and 
propane gases, and that under ambient conditions they produce a flame of 
approximately 850-900°C (Personal Communication, Cricket).
Injections of heroin made using citric acid were heated for 38.7seconds 
on average (standard deviation = 13.6), and injections using ascorbic acid were 
heated for 42.3seconds on average (standard deviation = 15.8). Some injectors 
were asked during the heating how long they would heat for; twenty one stated 
that it was ready ‘when the solution goes clear’ or ’when all the solids have 
dissolved’, the others asked (n=3) replied ‘when the solution bubbles’.
3.4.11 Materials
The materials that were used by the participants during the interviews 
were measured and recorded, enabling the comparison of the quantities. During 
the interviews, problems occurred which rendered some samples unfit for 
measurement, these included spillages, or other loss of sample from the tubes 
for later measurement in the laboratory. In total of the 65 people interviewed, 58 
interviews had fake drug and acid quantities suitable for measurement.
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However, of these 58, eight sets of results were further excluded as the 
participants had been observed to add additional acid to the preparation during 
the process after the initial quantity. These results were excluded on the basis 
that the drug user initially gauged a suitable quantity of acid that was appropriate 
for the amount of drug they were using, but as the preparation proceeded, they 
deemed more acid was necessary. The results were removed because the 
requirement for additional acid may have been falsely suggested by the lower 
solubility of the drug substitute compared to real drug. This observation is 
important to the study of drug preparation as it records the titration of acid 
quantity, depending on the perceived lack of drug dissolution by injectors 
conducting preparations.
3.4.12 Water source data compiled
Table 11 shows the sources of water used at each location, for all 
injections prepared (five responses were not recorded).
Table 11. Source of water used to prepare injections by location
Location W ater Source Number
Hereford Tap 17
Boiled and cooled 5
Bottled (Mineral Water) 5
Bath and Bristol Tap 21





fBottled water includes 
water from a tap that has 
been used to refill a bottle, 
as well as mineral waters. 
This appeared to be a 
common practice in Bristol.
3.4.13 Acid with drug detail
There were five different combinations of acid and drug demonstrated. 
The preparations of crack and ‘speedballs’ were prepared only using citric acid 
powder, however, heroin was prepared using ascorbic acid and lemon juice, as
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well as citric acid. The interviews of the crack and speedball injectors provided 
seven and eight sets of results respectively. Twenty-eight users demonstrated 
the use of citric acid with heroin, this being the most popular acid. The interviews 
in Hereford included seven with suitable data for analysis of the use of ascorbic 
acid. The data for the use of lemon juice was only provided from two interviews, 
therefore is unreliable.
Before the work was conducted, it was hypothesised that there would be 
some correlation between these factors, for instance, if less water was used 
more acid would be used, or vice versa.
The amount of fake drug powder, the amount of acid powder and the 
quantity of water was compared for each combination. To investigate the 
existence of any correlations both Pearson’s correlation and Spearman’s rho 
were used to analyse the results. Pearson’s correlation was used to determine 
the presence of any linear relationships between the sets of data, Spearman’s 
rho was used to assess whether any non-linear relationships between the two 
data sets exist.
The data set for the heroin injectors using citric acid was the largest and 
would therefore prove the most reliable; the other data sets only contained eight 
or less measurements.
Parametric correlations
Table 12 Pearsons correlation coefficient analysis of quantities of materials used by injectors 







Weight of Heroin Pearson Correlation 1 0 .4300 0.183
Sig. (2-tailed) 0.022 0.353
Weight of Citric acid Pearson Correlation 0.430(*) 1 -0.004
Sig. (2-tailed) 0.022 0.984
Amount of Water Pearson Correlation 0.183 -0.004 1
Sig. (2-tailed) 0.353 0.984
* Correlation is significant at the 0.05 level (2-tailed).
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Nonparametric correlations
Table 13 Spearman’s rho analysis of quantities of materials used by injectors preparing 
heroin for injection using citric acid (n=28)
Weight of Weight of Amount of 
________  Heroin Citric acid Water






















* Correlation is significant at the .05 level (2-tailed).
The correlation analysis in Table 12 and Table 13, above, shows that 
there is only a very weak positive correlation between the quantities of the three 
materials used. Therefore there is little to support the hypothesis suggesting a 
relationship between any of material quantities used.
To further compare the results, the amounts of fake heroin identified as 
10 pounds in value were compared alone. This was the closest the results for 
the fake heroin could be limited to one common factor, yet provide a suitable 
number of cases for analysis. The ten pound value bag was the most commonly 
used quantity of heroin- sixteen cases. One case was removed due to the use of 
a significantly large quantity of citric acid. This resulted in fifteen data sets for 
analysis.
Figure 5 shows the amounts of citric acid used to prepare ten pound 





^  0.14 -
T 3 
<D
3  0.12 -
■g 
o
«  0.10 - o
O  0.08 - 
»♦— 
o
c  0.06 - 
o
|  0 .0 4 -  
0.02 -  
0.00 -
0.00 0.02 0.04 0.06 0.08 0.10 0.12 0.14 0.16 0.18 0.20
Amount of 'fake' heroin used /g 
Figure 5 Scatterplot of weight of citric acid used to prepare each £10 in value amount of 
fake heroin
The correlation is very weak, but it is of a positive nature. Table 14 and 
Table 15 show statistical analysis of the same data
Parametric correlation analysis
Table 14 Pearsons correlation coefficient analysis of quantities of materials used by injectors 
preparing a ten pound in value quantity of heroin for injection using citric acid (n=15)
Weight of Weight of Amount of
Heroin Citric acid Water____
Weight of Heroin Pearson Correlation 1 0.430 0.071
Sig. (2-tailed) 0.110 0.802
Weight of Citric acid Pearson Correlation 0.430 1 -0.062
Sig. (2-tailed) 0.110 0.826
Amount of Water Pearson Correlation 0.071 -0.062 1
Sig. (2-tailed) 0.802 0.826
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Nonparametric correlation analysis
Table 15 Spearman’s rho analysis of quantities of materials used by injectors preparing 
a ten pound in value quantity of heroin for injection using citric acid (n=15)
Weight of Weight of Amount of 
    Heroin_____ Citric acid Water






















Again no support is found to suggest any relationship between the 
quantities of the materials used.
3.5 Discussion of results
3.5.1 Findings from interview situations
The questionnaire, and in particular, the preparation demonstrations 
provided a large amount of data, from which numerous key points involving the 
preparation of drug injections were revealed. The data of most importance to 
this work surrounds that which details how drug injectors learned to prepare 
injections, and then the preparation details from the demonstration.
3.5.2 Learning to prepare injections
In order to learn to prepare drugs it was important to investigate how 
current drug injectors prepare their injections.
Exploring this subject within the questionnaire part of the interviews 
revealed that all participants had learned to prepare injections from other
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injectors. These injectors included friends, partners or family. No interviewees 
stated learning from literature, either harm reduction or other sources, nor from 
any other form of media such as films. The learning process occurs due to the 
social nature of illicit drug use; to be initiated into using drugs, and to obtain 
drugs, users will inevitably have to come into contact with other users. These 
interactions are likely to expose the new user to the habits of other users, and 
this is likely to include that of injection preparation.
The process of learning to prepare injections from veteran injectors for 
the laboratory work therefore emulates the process as it occurs within the illicit 
injecting community. This additionally supports the choice of one-to-one 
interviews as opposed to focus groups, as this would more clearly imitate reality- 
observation of the injector, with questioning of details where required.
Demonstration of injection preparation
The demonstration section of the interviews provided a complete 
characterisation of the injection preparation procedure for heroin, crack and 
‘speedballs’. The use of saturation technique as the basis for the qualitative 
assessment of the participant’s methods supports this. Once the trends had 
been noted within the first few interviews, little major variation was seen from 
these.
Preparation steps
The preparation of the three drugs was observed to be conducted in a 
distinct series of steps, and they flowed in the same order for the majority of 
participants. As injectors learn to prepare injections from other users, this would 
suggest that all injectors learn to prepare injections using the same preparation 
method as their mentor(s).
Alternatively, it is possible that the order of the steps is used because it 
is the perceived most effective method, or the quickest method of preparation.
All participants added acid, none tried to prepare without it. This has 
potential implications for instance, should the heroin on the illicit market change 
to the soluble salt form, whilst appearing visually similar, injectors could possibly 
continue to use acids unnecessarily. This would lead to continued, and 
potentially increased, injecting complications due to acid content.
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In order to use the least acid it would be best to put drug into the cooker, 
then add water and heat the mixture. This would give an indication of solubility 
of the drug, and possibly indicate the amount of acid required to be added to 
complete this. In practice this was not seen- one participant did add the water to 
the drug powder before adding acid, but no heating was performed before the 
addition of acid. A number of participants (eight of the forty-seven heroin 
injectors, 17%) were witnessed to add additional acid to the injection mixture 
during or after the heating stage. This suggests they added a small quantity of 
acid to the mixture before assessing the solubility upon heating. Once it was 
clear the drug was not dissolving, they added further acid. This technique will 
reduce the amount of acid used in total, but the participants still presumed that 
acid was required in the first instance. Overall, this is the best technique 
witnessed and a good candidate for harm reduction workers to encourage 
injectors to use, but it needs to be stressed that the initial quantity of acid added 
must be kept to a minimum.
The preparation steps occur in the same order the majority of the time, 
but they are occasionally altered to suit circumstances. For instance, during 
interviews, one participant stated that if preparing in the open air and it was 
windy, that he would put the water into the spoon first, so that when the drug 
was placed into the spoon (next step) it would not blow away. This is unlikely to 
change the resulting drug injection in any, but with limitations on drug available it 
was not possible to investigate and confirm this.
Equipment
The choice of equipment showed a degree of variation between 
participants. This was seen for instance in the choice of cookers where the 
choice was between dessert spoons and tea spoons, between filters, between 
needles/syringes and between choice of heat source. It is clear that these are 
different equipment being used to perform the same purpose, but the variation 
between them may influence the resulting injection. Different heat sources may 
result in different temperatures of the solution at the end of heating; a different 
filter may remove more particles.
Overall, the important factors regarding the equipment is to encourage 
the use of clean, preferably new and sterile, equipment to prevent blood-borne 
virus infections, along with other complications such as bacterial and fungal
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infections, and vascular damage from blunt needles. Cookers, filters and 
needles/syringes are all available for supply to IDUs.
Acids and water quantities
Statistical analysis of the quantitative data obtained during the interviews 
showed very little correlation. There appeared to be no relationship between the 
amounts of water, acid and drug used during the preparation.
Further interviews could be used to investigate this to a greater degree, 
but the identification of clear relationships between the three components might 
not be possible. This would provide support for a theory of individualised 
injection preparations.
The requirement for acid
All sixty-five participants used an acid during the preparation of their 
injection. Without addition of acid, it would be impossible to dissolve the drug 
material in water. No alternative methods were attempted by the participants. 
This result was the expected outcome and reinforces the anecdotal reports, in 
addition to the previously published literature.
Fifty-seven described the drug being made to dissolve due to the use of 
acid; this includes those who stated ‘break the drug down’, as well as those that 
were more precise. The other eight participants could be classed as not having 
an understanding of the reason for its addition.
As previously outlined, all (brown) heroin and crack/freebase is insoluble 
in water. Therefore these results therefore concur with those of Strang et 
al.(Strang, Keaney, Butterworth, Noble, & Best 2001). During the interviews, no 
participants mentioned the use of ‘white’, or pharmaceutical heroin, which is the 
hydrochloride salt, as was the case in the Strang et al. London interviews. This 
suggests a lack of availability of this form of heroin in the interview areas (Bath, 
Hereford and Bristol), compared to London. This makes it unclear whether 
participants interviewed for this work know that they do not require an acid to 
prepare ‘white’ heroin for injection. It is possible that should this form of the drug 
become available to them through illicit channels, injectors may continue to 




During the questionnaire section of the interviews, the questions 
exploring the choice of acid confirmed information found in some anecdotal 
reports. The preference of ascorbic acid to all other acids amongst injectors is 
commonly reported (Derricott, Preston, & Hunt 1999). The majority of the 
participants chose to use citric acid, although some of them stated that they 
preferred to use ascorbic acid. They did this as it was the usual preparation 
procedure having had to resort to citric acid due to the lack of availability of 
ascorbic acid. The high number of injectors stating they prefer to use Vitamin C 
powder is of interest, especially considering the difficulty they would have 
obtaining it.
In contrast to this, some of the participants in Hereford chose to use citric 
acid over ascorbic acid which was readily available from DASH. During 
interviews, some participants (data not recorded) stated that it was better to use 
citric if you had venous access problems. This was on the basis that you would 
feel burning if you were ‘missing’ the vein and injecting into the surrounding 
tissue. This method of detecting extravasation must be considered important to 
the participants who mentioned it, although it is possible this was only for the 
fact that they would lose the rapid onset of the drug (the ‘rush’) effect following 
intravenous injection, rather than on a safety basis. The injection of solutions 
into the tissue surrounding veins leads to the formation of ‘lumps and bumps’. 
These remain until the material is removed, with insoluble material likely to 
remain in the place permanently. The concept that injecting using citric acid that 
‘burns’ (as opposed to ascorbic acid which doesn’t burn) to prevent missing 
veins has never been previously reported. It is possible therefore that the use of 
citric acid in an effort to prevent extra-vascular injection could possibly reduce 
adverse events.
It is considered that it is this burning sensation upon injection, whether 
into, or outside of a vein, that makes injectors consider ascorbic acid the 
preferable acid. As ascorbic acid is less commonly associated with burning the 
injectors may, falsely, assume it is safer to use. To date, there exists no in vitro 
or in vivo data to suggest which acid is less harmful to injection sites, nor for 
which acid is safer generally.
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A potential benefit of using citric acid is the amount required for use 
(Scott, Winfield, Kennedy, & Bond 2000). For citric acid to be used to prepare an 
injection, only a third of the number of acid molecules compared to the number 
of drug molecules are required. However, for ascorbic acid, an equal number of 
acid and drug molecules are required. In principle this appears to be of great 
value, but in practice is likely to be of little benefit.
Firstly, to take advantage of this, the injectors would need to know about 
molecular weights and understand the concept of ‘moles’ of materials. This is 
unlikely for the majority of injectors as it is a complicated concept that many 
would be unlikely to be familiar. In addition to this, the number of molecules of 
each constituent is not clearly visible by looking at the amounts of powder (how 
quantities were observed to be measured during interviews). Different powder 
particle sizes, combined with the variable amount of diamorphine base present 
within a drug sample make this impossible to judge by eye. Secondly it assumes 
that the acids are completely dissociated, which in reality is rarely the case and 
therefore larger numbers of acid molecules are required to compensate for this.
During the interviews in Bristol, two participants stated they used either 
lemon juice or citric acid to prepare their injections, and they used both 
approximately equally. These two participants were in a relationship, and the 
data from other participants suggests that lemon juice isn’t used on a regular 
basis. Importantly, upon discussion, it was clear they were both aware of the 
postulated risks of using lemon juice to prepare injections, yet they still 
continued to do so.
One limitation of the question regarding acid preference is that of the 
availability of acids. If the participants had only used a very limited range of 
acids, had had a bad experience from using a poor quality or contaminated 
batch, or even been given an acid which wasn’t what it was stated to be (i.e. 
given different citric acid but told it was ascorbic acid for instance) they might 
have suggested they preferred a different acid without fair comparison.
The list of acidifiers ever used (section 3.3.10) presents previously 
anecdotally reported substances. More importantly, it lists many previously 
unreported substances. No literature article published to date details acids used 
as acidifiers used by injectors, therefore no figures are available for comparison 
with these findings. The list is not thought to be exhaustive as there are notable 
omissions, such as the use of Abdine® (Roberts & Thomson 2000), which is a 
product only available in Scotland.
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It would be expected that the acidifiers with higher reports of use are 
those which have a better action than those of lower use reports. For instance, 
vinegar and lemon juice contain suitably high amounts of acids as discussed in 
the literature review (section 1.10).
Substances reportedly used by just one participant, for instance, bleach, 
‘Polo’ mint sweet and grapefruit demonstrate that injectors are willing to try 
many substances for the purpose. The fact that they have reported to have been 
used does not mean they work, and it is possible that their use may have 
resulted in unique complications, for example, from the injection of bleach.
The results show the level of ingenuity of IDUs. For instance, the use of 
the coating of the sour sweet (contains citric acid) and of descalers shows that 
injectors must have considered the nature of the product and deemed, correctly, 
that it would be suitable for the purpose. Although, very common as 
demonstrated in the results, the use of lemon juice and vinegar must have 
required some consideration on the part of a user (or groups of users) to 
discover their suitability for the purpose.
The most important factor from a harm reduction point of view 
surrounding these results is that the choice of acidifier appears in no way to be 
linked to the amount of harm they can possibly cause. Lemon juice had been 
used by 93% of those interviewed, yet its potential to cause fungal infections has 
long been suspected. Additionally, 68% of those interviewed had used vinegar 
on at least one occasion, this presents unknown and unexplored risks, but 
anecdotal reports suggest it causes headaches upon injection.
Although the results for preferred and regularly used acids suggest a 
large level of injectors choosing to use what are perceived to be safer 
substances by harm reduction workers, namely citric acid and ascorbic acid, 
there does appear to be scope for continued work in the area of educating 
injectors about the acidifiers they use.
The materials and equipment used by the injectors included those that 
were available from their needle exchange. This refers to filters syringes, 
needles and acids. Only in a small number of cases did injectors use alternative 
equipment, this was demonstrated in the use of filter material from cigarettes. 
The use of these will have an affect on the final injection, for instance the filter 
tip cigarette filter may shed more particulate matter into the injection solution 
than a roll-up cigarette filter. As the majority of exchange users utilised the 
materials available, this allowed the following laboratory work to be based on the
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materials available to them to enable the results to cover the majority of 
prepared injections.
It is worth noting that the use of the items provided by the exchange may 
have been used within the interview situation under the assumption by the 
participants that the interview was actually a ‘test’ under the auspices of an 
interview. Therefore, it is possible that the participants may have followed some 
perceived ‘best preparation technique’ rather than using equipment or materials 
they had been warned against using , for instance, lemon juice, or cotton wool. 
Although this is a possibility, it is not considered to have actually occurred in 
practice, although it is not possible to confirm this.
3.6 The formulation of a standard injection preparation 
procedure for laboratory investigations
This section discusses the above results and concludes by describing 
technique and materials used to prepare injections within the laboratory for 
further investigation.
3.6.1 Materials
Distilled water (Milli-Q, or water for injections (Fresenius Kabi) for particle 
counting work)
Illicit drug material obtained from Avon and Somerset Police 
Variable:
Acids: Citric acid (Sigma)
Ascorbic acid (Sigma)
Jif® lemon juice (Reckitt Benckiser)
3.6.2 Equipment
1ml disposable insulin syringes (B-D)
Tea spoon (Sunnex brand, Series 311 economy tea spoon)
Disposable Cigarette Lighter (Cricket)
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Roll-up cigarette filters (Swan® Extra Slim)
3.6.3 Rationale for materials and equipment used: interpretations from 
interview data
Drug Material
The quantity chosen for the experiments is detailed at the beginning of 




To calculate a suitable quantity of citric acid to use to prepare the heroin, 
the following steps were followed. Firstly, data from the interviews where either 
fake drug or citric acid powder were spilled were discarded. Secondly, data were 
also removed where the interviewee had been observed to have added extra 
acid, during, or after the heating/mixing process. Due to the lower solubility of 
the fake drug mixture, combined with the fact that addition of extra acid would 
not improve its solubility, cases where extra acid were added in attempt to 
dissolve it may have lead to falsely high quantities of acid being added.
To improve the comparison of the data, the results for the use of a ten 
pound bag of heroin only were considered. With the citric acid users this gave 
15 sets of data.
This data indicated that the mean amount of citric acid used was 73.9mg 
in 0.85ml of water. This would produce a citric acid solution of approximately 
87mg/ml.
Table 16. Statistics of injection prepared during the interviews using ‘fake’ heroin and 
citric acid (n=15)
Heroin /g Water /ml Citric /g
Mean .095 .855 .074
Std. Deviation .034 .248 .054
Minimum .053 .600 .018
Maximum .172 1.500 .171
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Alternatively, conversion of all acid and water quantities used to a calculated 
acid solution strength produced the mean solution strength of 92mg/ml.
From these results, the use of 75mg of citric acid was chosen as the 
standard quantity of citric acid used to prepare a quantity of heroin equivalent to 
the average amount of heroin found in a ten pound bag.
Ascorbic Acid
The interview data for the use of ascorbic acid was restricted to a much 
smaller cohort. Only eight interviewees demonstrated the use of ascorbic acid, 
and removal of one data set due to spillages reduced this number to seven. Of 
these seven, only two sets of data were for the use of a ten pound bag of heroin, 
and these values differed significantly-151 mg, and 19mg. Therefore, the 
decision was made to compare all the results to obtain values for use in the 
laboratory.
Comparisons of the means of ascorbic acid and water used suggested a 
solution strength of 194mg/ml.
Table 17. Statistics of injection prepared during the interviews using 'fake’ heroin and 
ascorbic acid (n=7)
Heroin /g Water /ml Ascorbic /g
Mean .169 .907 .175
Std. Deviation .082 .613 .111
Minimum .070 .450 .019
Maximum .287 2.200 .335
Calculation of the acid solutions strengths used resulted in a value of 202mg/ml.
Therefore, for laboratory investigations, the value of 170mg of ascorbic 
acid was chosen as the standard quantity of ascorbic acid used to prepare a 
quantity of heroin equivalent to the average amount of heroin found in a ten 
pound bag.
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The quantities of both acids calculated for use in the laboratory 
experiments were much higher than those used by the only previous work to 
investigate the use of acids by injectors (Scott, 2000). This used 30mg of citric 
acid and 60mg of ascorbic acid as the maximum quantities of acid. Given the 
data from the interviews it suggests that this previous work employed quantities 
far lower than actually used by injectors, and additionally possibly accounts for 
the unexpectedly low quantities of drug measured within the injection solutions 
for that work.
Distilled Water
The majority of demonstration participants (38 of the 65, 58%) stated that 
they usually used water from the tap to prepare injections. In order to replicate 
this, water could have been drawn from the tap in the laboratory. However, the 
use of tap water was not considered to be viable for two reasons. Firstly, the 
effect of the salts present in the water may affect the prepared injection. This is 
likely to be the case, and the effect will be specific to the water in each region. 
Therefore, if the work had been conducted using water from the University taps 
(supplied by Wessex Water) it could be argued that the results are only relevant 
to this region. Secondly, the water in the laboratory is occasionally seen to have 
a faint brown colour due to the piping in the building. This contains unknown 
contaminants that could have additional adverse effects upon prepared 
injections.
In order to standardize the injections, the decision to use distilled and 
deionised water from a Milli-Q purification system was made.
Water Quantity
From the data in Table 16 and Table 17, the mean quantities of water 
used by injectors of citric acid and ascorbic acid can be seen to be 0.85ml and 
0.90ml respectively. The amount of water used by ascorbic acid injectors was 
skewed by the use of a high quantity by one participant, and combined with the 
limited number of data sets; it was decided to use 0.85ml as a standard water 
quantity for use with both acids.
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Syringe
The 1 ml disposable insulin syringe was used as it was the most 
commonly chosen during the demonstrations, and it is the most commonly 
provided syringe by the three services where the interviews were conducted.
‘Cooker’ - Tea Spoon
The use of a tea spoon was chosen in preference to that of the dessert 
spoon. Both were used equally during the interviews and their use appears 
almost interchangeable. The tea spoon has a smaller surface area resulting in 
less particle deposition upon the surface during solution withdrawal from the 
spoon.
The actual tea spoons used for the laboratory injection preparations were 
the same spoons used by the participants during the interviews. For the 
laboratory work, the spoon was modified slightly by having a small metal plate 
soldered onto the end of the handle. This plate minimised the ‘rolling’ effect of 
the spoon when being handled, thus reducing the risk of spillage of the injection 
solutions. This plate would have no effect on the preparation of the injection, nor 
the injection produced.
Filters
The interviews suggested that approximately equal numbers of users 
choose to use roll-up cigarette filter material, compared to filter material from a 
manufactured cigarette. The decision to use Swan® filters throughout the 
experimental work was taken, as these were the ones being dispensed in a 
harm reduction capacity by DASH.
In accordance with interview observations, a ripped section of these 
filters was used in preference to the whole filter as this was demonstrated by all 
but one participant. Tests in the laboratory demonstrated that the use a whole 
filter results in a large fluid retention within the filter body of approximately 0.1ml 
or more. It is possible that injectors have discovered this, and regard this loss of 
fluid as unacceptable, so they developed the use of a smaller portion. The 
ripping of filters in this manner is a trend seen amongst roll-up cigarette smokers 
when they consider these filters to be too big. Figure 6 below shows a filter
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ready for use. The filter to be used is end on to the camera, to show the cross- 
sectional shape, the filter underneath is the remainder of the filter from which it 
was torn.
Figure 6. Ripped Swan brand roll up cigarette filter, showing the cross section of 173rd of 
filter (top) as most commonly used by interview participants.
To standardise the drawing of the solution through the filter, the solution 
was to be drawn perpendicularly to the length of the filter and from the outside 
edge (as opposed to a ripped inner side).
Additional Equipment
The remaining equipment used was identical to that employed in the 
interviews, including the lighters.
3.6.4 Use of Lighters
The height of the lighter flame was variable from use to use, depending 
on the amount of gas present and the time between uses. There was no clear 
method by which to standardise this, but in the interview situation it was never 
expressed to be an issue by the participants. The observation of the participants 
demonstrated that they held the spoon in the tip of the lighter flame with a gentle 
movement around the spoon bowl. The lighter was often held at an angle, it is 
unknown if this is beneficial for any particular reason, although excessive use of 
a disposable lighter can result in melting of the plastic supports for the flint 
striker wheel, resulting in the wheel springing out and hitting the bottom of the 
spoon, resulting in spillage of the injection solution.
In line with that observed during the demonstrations, the solutions were 
heated for at least 30seconds, and until all solids were seen to have dissolved.
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3.7 Photographic depiction of heroin injection preparation 
procedure in the laboratory
The preparation would be conducted following the series of steps as 
outlined above, as demonstrated by the majority of interview participants. The 
diagrams on the following pages depict the steps used to prepare an illicit 
injection for analysis in the laboratory.
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Equipment required ready for 
preparation
Drug, Acid, Water, Syringe, 
Cooker. Lighter. Filter
STEP ONE:
Drug added to ‘cooker’ Drug in ‘cooker’
Drug and Acid in ‘cooker’ Drawing up water into syringe Adding water to ‘cooker’
STEP FOUR;
Heating the mixture Injection mixture bubbling Healed injection mixture
STEP TWO:
Acid added to drug in ‘cooker’
Materials in ‘cooker’
Filter ripped ready for use
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STEPFIYE;
Filter placed ripped side down in 
the solution
Solution drawn up though filter. 
Solution drawn up 
perpendicularly to length of filter
The change of colour of the filter 
is clear as the final traces of 
solution arc pulled into the 
syringe.
Note the bending of the needle, 
this was witnessed on repeated 
occasions throughout the user 
demonstrations.
Final injection solution in 
syringe
4 Laboratory investigations of illicit drug 
injections
The second section of this project investigated the properties of the 
prepared illicit drug injections.
The British Pharmacopoeia sets standards to test aspects of 
formulations to assess factors such as stability, uniformity and ability to deliver 
accurate doses. It also sets standards which define the safety of a formulation.
Prepared illicit injections would be assessed using methods derived from 
those used to analyse pharmaceutical injections as set out in the British 
Pharmacopoeia (2000) where possible. These assays are outlined in the section 
concerning small volume parenterals, as this is the class that the illicit injections 
would be placed if they were a pharmaceutical preparation.
Illicit drug injections were not be expected to pass the stringent 
standards set for pharmaceutical injections, but the results would allow 
benchmarking against the BP standard and allow comparison as to how far the 
injections differed from ‘ideal’ standards.
4.1 Investigations conducted:
Drug sample composition and drug content of the prepared injections 
Microbiological content of the prepared injections 
Particulate Matter within the injection solution 
pH and Osmolality of the prepared injections
Although the interviews investigated the use of crack cocaine in addition 
to heroin, inability to obtain drug samples for investigation restricted the work to 
just heroin injections.
The layout of the thesis from this point presents each of these 
investigations as a separate chapter with an overall conclusions chapter drawing 
all of the findings together.
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4.2 Heroin Samples
In order to produce heroin injections within the laboratory it was 
necessary to obtain illicit heroin. Samples were obtained from the police forensic 
science laboratory based in Portishead, Somerset. This heroin originated as 
seizures from drug users or dealers, at locations within the Avon and Somerset 
region. The provision of drug samples was organised by the supervisor of this 
project (JS).
Initially, the drug was obtained as three separate samples, with a total 
mass of 5.22grams. The samples looked very similar, although they were 
separate seizures. On the scale used by Kaa (1991), they would be described 
as a medium brown colour.
4.2.1 Mass and Density Assessment
The fake heroin used within the demonstrations needed to be compared 
to the real drug powder in order to enable conversion of the mass of ‘fake’ drug, 
into that of real drug. The fake ‘heroin’ employed in the interviews was 
manufactured from paracetamol tablets as outlined previously. This powder 
differed from real heroin. It would have a different density and a different 
consistency, although it is likely that this differs between batches of illicit heroin 
too.
The amounts of fake heroin used by the interview participants was 
carefully weighed and recorded from the interviews. These masses are not 
directly equivalent to that of real heroin powder. To enable comparison of these 
values to the equivalent of illicit heroin, the volume and the density would have 
to be measured.
Pharmaceutical science routinely requires the measurement of density of 
materials. For this purpose, two methods are used- tap density measurement 
and true density measurement. Both of these methods are approved in the 
British Pharmacopoeia. Tap density measurements eliminate the gaps between 
the particles as far as is possible to give a volume measurement of the powder. 
One disadvantage of the technique is that it requires large volumes of powder, 
which were unavailable. True density measurement, or pyncometry, uses helium
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gas via Archimedes' principle of fluid (gas) displacement and the technique of 
gas expansion to measure the volume of powder down to gaps in the powder 
surface to 1 Angstrom (1x10‘1°m). Small powder volumes such as 3cm3 can be 
measured. A major disadvantage with this technique is that it affects the powder 
being analysed. The use of the gas dries any water from the powder, this will 
therefore affect any chemicals present in the hydrate form. Additionally, the 
technique can alter the crystalline form of the chemicals present and alter 
physical characteristics. This could therefore affect the sample subjected to the 
test, resulting in inaccurate results in subsequent experiments conducted using 
this drug material.
To assess the difference between the mass of illicit heroin and the ‘fake’ 
heroin used in the interviews, three different methods were used and the results 
compared. Of importance during this work was the consideration that during all 
of the interviews all participants measured the amount of drug for preparation by 
sight. None measured it in any way such as by weighing it or otherwise. This 
concept formed a basis for the laboratory assessments.
4.2.2 Methods
The first method involved the measuring out of the mean value of ‘fake’ 
heroin used in the interviews. This amount of powder was left in a weighing 
boat, and an approximately equal volume of heroin powder was placed into 
another weighing boat. This was done through visual comparison of the 
quantities and relied on the judgement of the person making the measurements. 
The volume of heroin measured out was then weighed. This was repeated twice 
more and the results compared to the mass of the ‘fake’ heroin. Through this 
comparison, a crude conversion factor could be obtained to translate the mass 
of ‘fake’ heroin into a mass of real heroin.
The second method again involved using a sample the mean mass of 
‘fake’ heroin as measured from the interviews. In this case the powder was 
measured into a 2ml eppendorf tube. The tube was tapped ten times until the 
powder within formed a level surface. A permanent pen was then used to mark 
where the powder surface was within the tube. The powder was then removed 
from the tube, and the tube thoroughly rubbed down inside with clean, dry 
tissue. Real heroin was then placed into the tube to the level of the line marked.
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This powder was also tapped ten times and the level of the powder checked to 
confirm it still met the line. Once a quantity of heroin equal to the ‘fake’ powder 
had been measured to the line, it was weighed. This was compared to the mass 
of fake and another conversion factor obtained.
The third method was similar to the second, but involved using a known 
volume of powder rather than mass. To measure the volume, a 10ml conical 
measure was used. Firstly, the cylinder was weighed and the balance re-zeroed. 
‘Fake’ heroin was then added to the 1ml mark. This powder was tapped ten 
times to ensure a level surface on the powder at the 1 ml mark. The measure 
was then reweighed and the mass of the ‘fake’ drug material obtained. The 
powder was then removed and the cylinder cleaned using a dry tissue. The 
cylinder was then reweighed again and the balance zeroed. Real heroin was 
then added to the 1ml line in an identical manner to the ‘fake’ heroin. A mass of 
1ml of real heroin was then obtained. By using the relationship between mass 
and volume, an approximate of density of each powder could be calculated.
From the results obtained, a crude conversion scale could be drawn up, 
allowing the conversion of all results of mass of fake heroin into that of real 
heroin. By dividing this into regions, it also gives an indication of the variation of 
drug sales in the different areas where the interviews were conducted.
Twenty-two interviews provided weights of ‘fake’ heroin equivalent to the 
visual volume of real heroin.
The weighed masses of fake heroin were (in grams): (n=22)
0.0527; 0.0578; 0.0593; 0.0702; 0.0724; 0.0731; 0.0782; 0.0824; 0.0833;
0.0883; 0.0972; 0.1008; 0.1074; 0.1075; 0.1097; 0.1252; 0.1308; 0.1347;
0.1375; 0.1723; 0.1752; 0.2837.
The mean mass is 0.1091g (n=22), however examination of the figures indicates 
that the largest value (0.2837g) is significantly higher than the rest of the data.
Its removal reduces the mean mass to 0.1008g (n=21).
Therefore, 0.1008g or 100.8mg was the weight used for the above 












Overall Mean 0.1251 g
The means of the results for each person were calculated then the mean 
of the mean of these two values was calculated.
This suggested that during visual assessment, the two participants 
judged that 0.1008g of fake heroin powder resembled 0.1251g of real heroin 
powder.
Method 2
The mass of real heroin measured into the eppendorf tube to the same 
volume as that of 0.1008g of fake heroin was 0.1258g.
Method 3
Mass of 1 ml of fake heroin = 0.6364g
Mass of 1ml of real heroin = 0.8204g




1 g of fake heroin = 1.571 cm3
1g of real heroin = 1.219cm3
Assuming constant powder densities,
Mass of fake heroin x 1.289 = mass of real heroin that would have been used
Therefore, this suggests that the equivalent mass of real heroin to that used in 
the interviews would be 0.1299, or 130mg.
Work by the Independent Drug Monitoring Unit suggests that the 
average weight of a £10 bag of heroin is approximately 150mg (ranging from 
100mg to 250mg). The results therefore fall within the expected range.
130mg was the mass of real heroin used in all experiments.
4.3 Electrospray mass spectrometry analysis of heroin 
samples and known compounds
4.3.1 Introduction
The illicit heroin samples provided by the Avon and Somerset Police 
were of unknown content. They were provided with no data on their level of 
diamorphine content, nor impurity and/or adulterant content. Whether the police 
laboratories had performed these analyses on the samples was unknown. In an 
ideal situation this data would have been supplied alongside the samples to 
eliminate the need for this to be conducted prior to the use of the drug for 
injection preparation, but samples had been subjected to qualitative confirmation 
of diamorphine content only for the purpose of prosecution.
The investigation of illicit drug samples by gas chromatography-mass 
spectrometry is the standard method employed by forensic services, allowing 
quantification and accurate identification of all components of a mixture. 
However GC-MS was not available at the University of Bath. HPLC was an 
alternative method requiring less sophisticated instrumentation with proven 
validated methods such as the normal phase method developed by O’Neil and
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Pitts (1992). Unfortunately, HPLC equipment was not available for use at the 
time of the sample analysis, although this normal phase method was 
subsequently tested later during this project during the attempts to develop a 
method to measure the drug content of injections.
4.3.2 Methodology
To investigate the content of the illicit drug samples, mass spectrometry 
using electrospray ionisation was employed.
Electrospray ionisation mass spectrometry is a so-called ‘soft ionisation’ 
technique and results in very little fragmentation of the compounds in the 
sample. The ‘ionisation’ (they are actually charged molecules, not true ions) of 
the molecules produces peaks only at the molecular weight +1.
The unknown samples were submitted along with known standards to 
compare the analysis results.
4.3.3 Method
The materials were submitted for positive electrospray mass 
spectrometry. This required the samples to be dissolved in a water:methanol 1:1 
solution, with 1% acetic acid. The acetic acid was added to the sample solution 
as it enhances protonation and increases sensitivity.
The solution for submission required only 20 to 40 nanograms of the 
sample substance per microlitre- This equates to 2 to 4 mg per 100ml of 
solution. The technique is therefore ideal where very limited quantities of 
samples are available. This was particularly appealing to this project work where 
very limited quantities of illicit drug samples were available.
The samples were made up to 100ml in volumetric flasks, and a 2ml 
aliquot submitted for analysis. In total, 17 different samples were submitted, 
including two from each of the three illicit samples (taken from different regions 
of the powder) to allow identification of more compounds if the illicit samples 
themselves were not homogenous.
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4.3.4 Instrumentation
The mass spectrometer used was located in the Chemistry department 
of the University of Bath. The system used was a Waters Autospec M272 
system. The equipment was maintained and the samples run by the mass 
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The inclusion of known standards for analysis alongside the illicit 
mixtures proved useful in producing confirmation spectra suspected 
contaminants and adulterants within the illicit samples. The spectra produced by 
each of the samples are presented in appendix 7.
Figure 7 below is an example spectrum. This was the output for the first sample 
of illicit heroin, street heroin from pot A.
File:18820 Ident:l Mer Def 0.25 Acq:26-AUG-2004 08:57:25 +2:43 Cal:ESP 












10 3AOrl 392.1 436.1 7-7E4
60 80 100 120 140 160 180 200 220 240 260 280 300 3i0 340 360 380 400 420 440 460 m / 2
Figure 7. ES-MS spectrum produced by Street Heroin ‘A’
This sample spectrum shows five main peaks. The largest peak is that at 
370.1, this corresponds to diamorphine. It is the molecular mass of diamorphine 
(369), plus the mass of a proton. The majority of peaks correspond to the 
molecular mass of a component present within the sample, plus the mass of a 
proton. There were smaller peaks that corresponded to the molecular mass of a 
component, plus the mass of a Na+ atom. In this example, this is the origin of the 
peak at 392.1.




392.1 Diamorphine + Na+
414.1 Noscapine
436.1 noscapine + Na+
The spectrum also includes a number of very much smaller peaks which are 
more difficult to resolve. These peaks relate to compounds in much lower
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relative abundance. These peaks also include isotope peaks, produced by 
molecules containing an isotope molecule which raises its m/z ratio. The most 
important here was 13C. The diamorphine peak at 370 was followed by a smaller 
peak at 371 (23% of original), and much smaller one at 372 (3% of original).















437 noscapine + Na+
(tapproximate m/z values)








Examination of resulting spectra from the illicit samples, alongside submission of 
standards of other potential components, revealed the samples did not contain 
morphine, codeine, phenobarbitone or lactose.
4.3.7 Discussion
This analysis produced clear results, and the technique, although not 
used routinely by forensic analysts, proved to be of great value. The soft-
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ionisation of the samples produces molecular weight results for compounds 
within the mixtures with little or no fragmentation which would result in complex 
spectra. The other main benefit of this technique is the extremely small amount 
of sample required- as small as 2mg per 100ml of sample solution. The results 
allowed firm statement upon the exact compounds present within the samples 
provided by the police.
Although the results produced by this method were promising, they are 
not conclusive regarding the suitability of the method to the nature of the work. 
The submission of both lactose and phenobarbitone standards for analysis, was 
based on the grounds that they have both been found within illicit heroin 
mixtures (Kaa 1991;Kaa 1994;0'Neil & Pitts 1992). Both of these compounds, 
especially phenobarbitone, produced over twenty peaks each. Phenobarbitone 
also produced a peak at 370.1- the same as diamorphine as seen above. This 
sample was pure and there was no contamination from any diamorphine, the 
peak produced must have been produced by a complex of phenobarbitone 
(molecular weight 232.2). Had phenobarbitone been present within the sample, 
the abundance peak for species with a m/z ratio of 370.1 would have been 
raised, suggesting that the diamorphine was more abundant than it actually was. 
Additionally, and more importantly, it would have made the identification of other 
compounds within the mixture very difficult to identify- it produced significant 
peaks at the same m/z ratio as the major peaks for caffeine (195.0) and 
noscapine (414.1). These problems indicate the advantage of GC-MS, with its 
ability to separate the compounds prior to mass spectra are run.
Literature searches regarding ES-MS revealed a paper by Selby et al. 
(Selby 1998). It outlines the possibility of using ES-MS to both identify, and also 
quantify the content of components within the illicit mixtures. Using drug 
standards, they produced sample illicit mixtures. Running these in conjunction 
with known strength standard solutions, they were able to calculate the quantity 
of compounds within the mixtures.
It was hoped that similar work could have been performed with the aim of 
quantifying the compounds within the illicit mixtures. These results would then 
be confirmed using more traditional methods, such as HPLC. If successful, this 
work would have been the first recorded quantification of illicit heroin samples 
using ES-MS. Unfortunately, access to the ES-MS system ended in September 
2004. This remains an area of potential further work, although it is debatable 
that the availability of GC-MS would limit its use.
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4.4 Determination of drug quantities in illicit drug
injections prepared under laboratory conditions using 
the standardised injection preparation procedure
4.4.1 Introduction
To the injecting drug user, the quantity of drug present within an injection 
is paramount. Any injection preparation procedure that fails to render the 
majority of drug bioavailable will be of little value. This is of interest, not only to 
the user, but also to workers trying to reduce harm during injecting.
In order quantify the ability of each acid to enable the drug material to 
dissolve, the drug content of the final ‘injection’ solutions was measured. 
Investigations of the quantity of drug present in injections prepared using 
different acidifying agents has only been conducted previously by Scott et al. in 
2000. No similar work to this has been conducted according to an extensive 
search of literature databases. This work built on the previous work through the 
use of the injection procedure investigated in detail from the injectors and the 
use methods to explore different properties of the injections. Additionally, new 
methods were used to repeat previously conducted work, such as the particulate 
content measurements.
The qualitative identification of drug is a routine procedure for numbers 
of laboratories. Police forensic services confirm drug content within illicit 
samples that have been seized in order to enable prosecution. Identification of 
drugs in illicit samples is routinely carried out by the forensic service using GC- 
MS. The identification of drugs or metabolites within urine samples are 
commonly performed by employers and drug treatment services. Often these 
tests are performed by using simple urine test strips, although in circumstances 
where a detailed analysis or legally valid results are required, a sample would 
undergo laboratory tests (Griffin 2003). Identification of drugs or metabolites 
within urine samples can be conducted using GC-MS, but this is the most 
sensitive technique. Enzyme immunoassay is more commonly used for initial 
screening, with GC-MS confirmation conducted if necessary. Urine analysis can
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also be carried out using HPLC and capillary electrophoresis (Taylor, Low, & 
Reid 1996).
Quantitative measurement of a drug within samples is performed less 
often, and is mainly done specifically by forensic services to compare drug purity 
trends, and to establish the origin of samples by measuring impurity levels 
(Griffin 2003). HPLC is used where samples of opiates need to be assessed 
quantitatively.
4.4.2 Methodology
Prepared injections were subject to assay to measure the content of 
diamorphine in the solution. This presented a number of obstacles. Firstly, the 
preparation of the sample for analysis may affect the solubility of the drug, giving 
a false measurement. Treatment through dilution, or re-dissolving in a different 
medium may result in an increase or decrease in the quantity of drug measured 
due to differences in solubility. Secondly, the drug samples are impure and 
contain many other substances. The presence of unknown compounds 
complicates the issue of identification and measurement of the drug.
The method used by Scott (Scott, Winfield, Kennedy, & Bond 2000) 
included the use of capillary zone electrophoresis (CZE) to measure the content 
of the drug in the injections. Access to a Dionex capillary electrophoresis 
machine was available. As method development was not an aim of this project 
the use of an existing method would save time and would reduce validation 
requirements.
4.4.3 Method 1- Capillary Zone Electrophoresis 
Training
The member of staff who had initially owned the Dionex machine had left 
the department in 1998, and there were no current members of staff who had 
used the machine. One week was spent at the pharmacy department at 
Derriford hospital, Plymouth where the same model machine is in regular use. 
The week taught how to use the machine, how to perform common service 
procedures and various methods were run including an analysis of morphine 
within oral preparations.
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Following the training, the machine in Bath was prepared for use, and 
methods used in Plymouth were used to test it. It became apparent at this point 
that the machine was not working correctly, and there were blockages within 
some of the tubing lines, leading to pressure build ups and resulting in leaks.
The methods were adjusted to prevent these problems from affecting the results 
albeit through a long winded procedure. This enabled the machine to function 
correctly; however the results produced indicated that the UV bulb was not 
functioning at a suitable level. A new bulb was sourced from Dionex, and fitted 
into the machine. This led to results of a suitable intensity level being obtained 
from the machine, but unfortunately they were not reproducible. This was 
unacceptable.
During further assessment and work with the machine to improve the 
result output, the machine developed a fault with the movement arm (sampling 
head) that prevented the machine from functioning. At this stage work with the 
machine was abandoned.
Two methods were employed for use with the CZE during testing. The 
first was that used for morphine analysis at Plymouth this involved a running 
buffer of 10mM Na2B407, 50mM H3B 03 and 20mM sodium dodecyl sulphate in 
water (pH 8.7). Using an unmodified silicia capillary of 75pm internal diameter, 
375pm outside diameter and 450mm effective length, 5nl of sample was injected 
into the capillary by gravity injection. Separation was performed by a constant 
voltage of 13.5kV, and detection using UV light at 205nm. The run time was 
10minutes, with the morphine detected after approximately 7.5 minutes. This 
method was one the Plymouth staff had previously used to analyse morphine 
samples, it was provided by Dionex. This method would ensure that reliable 
results could be obtained from the system before the testing of any actual 
samples. In order to try and improve the results, the injection was adjusted to 
raise the sample volume, including use of electrokinetic injection. The separation 
voltage was raised and UV settings of 254nm and 280nm were also employed.
The second method tested was that of Taylor et al (1996). This used a 
running buffer of 100mM disodium hydrogenphosphate at pH 6, with a capillary 
of 50pm internal diameter and 600mm effective length. The capillary was air 
cooled to prevent the buffer heating up during the separation by the constant 
voltage of 20kV. A runtime of 20minutes was used. The same UV settings as 
above were tried.
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The outcomes from this work are insufficient to draw any conclusions as 
to the appropriateness of the methods to the work in question. The previous 
work by Scott has indicated the later methods suitability. This method was the 
first choice in the initial instance for this work and would have been used if 
reliable, repeatable results were forthcoming. Due to the experienced problems, 
the search for an alternative method was undertaken. The first alternative used 
HPLC as will now be described.
4.4.4 Method 2 - High Performance Liquid Chromatography (HPLC)
The use of HPLC for quantitative analysis is a first choice for many 
quantification applications, as it is cheaper than, for instance, GLC, is a relatively 
easy process and has high throughput. Within the department of Pharmacy and 
Pharmacology there were functioning machines available for use.
4.4.5 Acetylcodeine and HPLC
Investigation of methods indicate that previous studies in this area were 
able to achieve adequate separation of the majority of the compounds 
commonly found in illicit heroin mixtures, but one compound, acetylcodeine, 
eluted very close to diamorphine, and in some cases co-eluted. The 1986 paper 
by Kaa (Kaa & Bent 1986) uses the HPLC technique pioneered by Love and 
Pannell in 1980 (Love & Pannell 1980) and the chromatograph depicted 
demonstrates how close acetylcodeine elutes to diamorphine. Clear separation 
of these two peaks was vital in any attempt to quantify the diamorphine through 
use of HPLC.
Acetylcodeine is formed by the acetylation of codeine that is present 
within crudely extracted morphine being converted into diamorphine. 
Acetylcodeine can be present from 1-15% in illicit heroin samples, or 1-80% the 
relative to the amount of diamorphine (Baker & Gough 1981;Clarke 1986;Kaa 
1991;0'Neal, Poklis, & Lichtman 2001). To ensure separation of the 
diamorphine from the acetylcodeine that was likely to be present within illicit 
samples, acetylcodeine would be used during the testing of the HPLC method to 
guarantee that separation could be ensured before real sample analysis was 
conducted.
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There were no standards of acetylcodeine available within the 
department, and it is not readily available. Standards were only available from 
Macfarlan Smith Ltd (Edinburgh) the only specialist controlled drug manufacturer 
in the UK. The cost was prohibitively expensive, so as the Pharmacy department 
has stocks of codeine, the decision was made to synthesise acetylcodeine from 
this.
4.4.6 Acetylcodeine synthesis and identification 
Method
100mg of codeine base was weighed and placed into a round bottomed 
flask. To this, 10ml of acetic anhydride and 2ml of pyridine were added. The 
flask was sealed with a stopper and left for twenty-four hours at room 
temperature. Acetic anhydride acetylated the codeine, whilst the pyridine 
maintains a pH basic enough to promote the acetylation reaction, by quenching
the H+ ions produced during the reaction.
At the end of the twenty-four hour period, the flask was placed in beaker 
of warm water (50-60°C) and a stream of nitrogen gas blown lightly over the 
surface of the reaction mixture to evaporate as much of the remaining excess 
acetic anhydride and the pyridine as possible. After two to three hours, 20ml of 
water was added to the mixture to deactivate any remaining acetic anhydride, by 
converting it to acetic acid. Sodium carbonate was added to neutralise the acetic 
acid formed and to raise the pH up to approximately 9.
The solution was then transferred to an evaporating funnel and 20ml of 
dichloromethane added. The mixture was shaken and the dichloromethane layer 
(bottom layer) poured off. Another 20ml of dichloromethane was added and the 
mixture shaken. This layer was added to the previous layer in a beaker. Excess
magnesium sulphate was added as a drying agent.
The reaction mixture was filtered through a simple filter funnel with filter 
paper to remove the magnesium sulphate. The filtered dichloromethane solution 
evaporated in a rotary evaporator to produce the product, which should have 
been acetylcodeine, in the base form. There was a possibility that some pyridine 




In order to confirm the identity of the manufactured product, three tests 
were performed. Firstly, the melting point of the compound was measured. This 
was found to be 134°C. The quoted reference melting point for acetylcodeine is 
134-135°C.
Secondly, a sample of the compound was analysed using the HPLC 
system under investigation for opiate separation at the time. This method used a 
Phenomenex C18 Spherisorb 25cm column, 5pm particle size. The mobile 
phase consisted of 70% Potassium phosphate buffer (15mM; pH 3.5): 30% 
acetonitrile, running at 1ml/min. A sample of codeine was run injected, then the 
manufactured product. The product eluted from the column after 5.38minutes, 
with no other peaks seen. This was significantly later than the codeine which 
eluted at 1.28minutes. Therefore conversion to another compound had 
occurred, and no codeine remained. Additionally, a standard of pyridine was run 
though the HPLC system to record its output peak. This produced a small, 
poorly defined double peak eluting at 1.64min to 2.49min, demonstrating that the 
product peak was not produced by pyridine, and that there was no pyridine 
remaining in the product compound. Diamorphine analysed with the same HPLC 
system eluted at 5.25minutes.
Thirdly, as the most definitive identification, the compound was analysed 
by NMR spectroscopy. A small amount of the compound was dissolved in 
chloroform-c/3 as the lock solvent, and submitted for analysis.
The NMR equipment used was a Varian Mercury-vx running proton at 
399.772 MHz. The samples were referenced to TMS (tetramethyl silane) at 
Oppm.
NMR results
Figure 8 and Figure 9 below show the NMR spectrum from the analysis 
of the sample.
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Figure 9 NMR Spectra of synthesised product (2)
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The spectrum was compared with a standard spectrum for acetylcodeine and it 
confirmed the manufactured product was acetylcodeine. The spectrum 
additionally showed that no pyridine was left within the final product, which had 
been a possibility.
The preparation method produced the required product, with no 
contamination from either unchanged starting material, or process materials, 
specifically pyridine. The process is therefore viable and has been used on 
subsequent occasions to produce additional acetylcodeine when required. 
Additionally the manufacture of acetylcodeine, as opposed to purchasing it, 
saved project funds.
4.4.1 HPLC Methods investigated
HPLC Equipment
Rheodyne manual sample injector with 20pl loop 
Jasco PU-1580 Intelligent HPLC pump 
Jasco CO-965 Column oven 
Jasco UV-1575 Intelligent UV Detector 
Varian 4400 Integrator
Detection of the diamorphine was carried out using ultraviolet detection set at a 
wavelength of 280nm. This is the optimum wavelength according to Clarke and 
this was confirmed as the lambda maximum by analysis of a diamorphine 
standard solution using a Cecil 5000 double beam UV spectrophotometer.
Discovery RP-Amide C16 Column Method
The first method attempted was published by the company ‘Discovery’ 
(Supelco 2004). One of their ‘RP-Amide C16’ columns was available for use in 
the laboratory and these columns have a polar group (amide) which offers less 
retention of polar compounds and different selectivity to a standard C18 column 
for which is a recommended replacement. This method would result in less
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retention of noscapine and papaverine, leading to shorter run times. If 
diamorphine and acetylcodeine could be adequately separated, the method 
would be suitable for use. The column was 150mm with a 4.6mm internal 
diameter and 5pm particle size. The column was maintained at 35°C. The 
method used a pH 3.0 phosphate buffer:methanol (80:20) mobile phase, run at 
2ml/min.
This assay failed to produce any meaningful results though a problem 
with the column available.
Kaa/Love and Pannells method
The second method attempted was that used by Kaa in 1986 (Kaa & 
Bent 1986). The method demonstrated adequate separation of all the 
compounds within the mixture, allowing quantification of all compounds (heroin, 
morphine, monoacetylmorphine, papaverine, noscapine, ascorbic acid, caffeine 
and procaine), except codeine and acetylecodeine, which were quantified using 
gas chromatography. The HPLC method used a 300mm C18 column, with a 
mobile phase of acetonitrile and an aqueous solution of 0.75% ammonium 
acetate. The mobile phase was used in varying compositions from 55:45 to 
47:53 depending on the age of the column. The flow rate used was 1ml/min.
To repeat this work, the 300mm column was replaced by a 250mm 
column as these were available for use without purchase. The column used was 
C18 with 5pm particle size and 4.6mm internal diameter. The improvements in 
column efficiency since the publication of the paper suggest this change was 
justified. The mobile phase was used in a 50:50 composition in the first instance, 
and then varied to attempt separation.
Gough and Baker method
The third method attempted was that published by Gough and Baker in 
1981. This utilised hand-made C18 columns, 250mm in length with 5pm particle 
size and 4mm internal diameter. The mobile phase consisted of acetonitrile:PIC 
A reagent (tetrabutyl-ammonium sulphate, 85:15) running at 1ml/min.
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Holts 1996 method
The final method attempted was the latest to have been published. This, 
by Holt in 1996 was the most recent method found and formed part of a study 
into the size of particles found in illicit heroin seized within the UK rather than 
solely as a measurement of drug content. The paper states that “levels of 
acetylcodeine were too low to have any effect on the determination of heroin by 
HPLC”. Given that acetylcodeine is so commonly found in heroin samples, this 
is considered surprising. It was assumed the authors of the paper had validated 
this separation.
The method used a 250mmC18 Spherisorb column of 5pm particle size 
and 4.6mm internal diameter. The mobile phase consisted of potassium 
phosphate buffer (15mM; pH3.5):acetonitrile, in 70:30 ratio, running at 1ml/min. 
Detection was performed at 235nm by Holt, so this was attempted alongside the 
usual 280nm.
Phenomenex Synergi Fusion-RP Method
In a final attempt to find a suitable HPLC method, advice and 
recommendations on choice of column and attendant method was sought from 
Phenomenex. This is a company specialise in the development, manufacturing 
and supply of columns and accessories for the separation, analysis and 
purification of chemicals and biochemicals. They were willing to select a column 
that they were confident would produce an adequate separation of the 
compounds within the illicit heroin, or they would refund the price of the column. 
They suggested the use of a Synergi Fusion-RP column of 150mm length with a 
4.6mm internal diameter and 5pm particle size, with a 30:70 acetonitrile:water 
mobile phase, running at 1.5ml/min. Detection was again performed using UV 
absorption at 280nm.
HPLC method outcomes
Attempts to reproduce all of the above methods proved unsuccessful. 
Peaks could be obtained from samples of both diamorphine and acetylcodeine 
using all of the methods. Running samples containing both diamorphine and 
acetylcodeine resulted in one large peak for all methods. Altering running
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conditions including changing the mobile phase composition, altering the 
integrator settings and using a column heater were unable to produce 
separation of the peaks.
Depicted are below are the results from the method supplied by 
Phenomenex. The chromatograms are similar to those obtained with all of the 
above methods, that is, peaks for both compounds alone, a one large peak for a 
mixture of the compounds. Figure 10, Figure 11 and Figure 12 below show 




Figure 10. HPLC chromatogram of diamorphine 10pg/ml standard solution. 
(Diamorphine retention time 4.497mins)
mAU
Retention Time (min)
Figure 11. HPLC chromatogram of acetylcodeine lOpg/ml standard solution. 




Figure 12. HPLC chromatogram of standard solution mixture 10|jg/ml of each drug 
(Retention time for both compounds 4.622mins)
The diamorphine eluted at 4.497minutes, the acetylcodeine at 
4.505minutes. A mixture of the two produced a large peak at 
4.622minutes.Clearly the resulting peak was the result of co-elution of the two 
compounds. Adjustment of the mobile phase ratio down as far as using 100% 
H20 , as was able with this specialised column, still showed no ability to separate 
the peaks.
This method was unsuitable for the separation of the two compounds.
Discussion of HPLC work
The use of HPLC to separate these opiate compounds has been 
reported in previous work to have been successfully achieved (Holt 1996;Love & 
Pannell 1980), but none of these methods could be suitably replicated within the 
laboratory.
The inability to repeat the methods proved to be a complex problem. It is 
possible that the inability to reproduce the methods of Love and Pannell, as then 
also used by Kaa could relate to differences in column separation abilities that 
have changed since their work had been conducted. This however does not 
explain why the separation abilities reduced, when column technology has 
improved over time. The separation should have also improved. It is possible 
therefore that current columns of no longer applicable for this work. The 
publication by Holt, which used a similar method, stated that ‘levels of 
acetylcodeine were too low to have an effect on the determination of heroin by
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HPLC’. They do not state whether they confirmed adequate separation of the 
acetylcodeine from the diamorphine with this method. This work has proven that 
separation is not possible, and suggests that Holt was possibly unaware of the 
presence of acetylcodeine as the two were co-eluting.
For future investigations, newer HPLC methods exist than those 
attempted, but use technology not available during this project such as diode 
array detection (Maher, Swift, & Dawson 2001).
4.4.8 Quantitative mass spectrometry
The use of electrospray mass spectrometry in a quantitative matter was 
considered for the purpose of quantifying the level of diamorphine within 
prepared injections. It was considered a potentially viable option, but after the 
retirement of a member of technical staff, the electrospray mass spectrometer 
was no longer available.
4.4.9 The search for a quantitative method
The requirement for a technique to quantify the drug content of injections 
had explored the majority of techniques used in the literature for this purpose.
As described above, the techniques were unavailable, or could not be 
replicated.
The use of NMR analysis during the synthesis of acetylcodeine 
introduced the possibility of the use of it for this work. The availability and 
access to working equipment in the Department of Pharmacy was of benefit.
4.4.10 Methodology
NMR is principally used for the identification, structural characterisation 
and purity assay of compounds; however since the spectral data obtained are 
quantitative, it is possible to use this technique to provide information on the 
relative amounts of different molecules in a given sample. For well resolved 
spectra of mixtures, it is feasible to assign which components are present and 
also how much of each, based on how large the signal is for each of the
125
component peaks in the spectrum. Comparison of the sizes of these peaks 
provides a ready means to determine the ratios of the components. Although 
this method had been used routinely for other purposes, to our knowledge it has 
not been used to identify and quantify opiates within mixtures before.
4.4.11 Quantitative NMR methods
In order to explore the application of quantitative NMR for opiate 
mixtures, a series of model heroin mixtures were prepared from known amounts 
of the seven compounds found in the illicit mixtures by ES-MS analysis.
These mixtures consisted of diamorphine, acetylcodeine, 6- 
monoacetylemorphine, noscapine, papaverine, caffeine and paracetamol. The 
mixtures were made using the powder standards measured out to form mixtures 
with the same percentage of constituents as illicit samples. The powders were 
carefully homogenised with a small mortar and pestle, then placed into a sample 
tube and mixed using a vortex whirlimixer for two minutes.
Portions of the powder were taken and placed into an NMR sample tube. 
Methanol-cf3 was added to dissolve the sample for analysis. The resonance 1H 
spectra were measured at 400 MHz at first, then at 600 MHz as it was found to 
give sharper peaks.
4.4.12 Quantitative NMR resuits
Standards of diamorphine, acetylcodeine, 6-monoacetylmorphine, 
noscapine, papaverine, caffeine and paracetamol were dissolved in methanol-cfe 
and submitted for analysis. The resulting resonance spectra can be found in 
appendix 8.
Inspection of these spectra revealed that each one had peaks in a region 
where none of the other components had a resonance, and thus it was thought 
likely that these resonances could be identified in the spectrum of a mixed 
sample. This would show both the qualitative presence of that component and 
also through the use of integration of the resonance, the relative amount of the 
component with respect of the other compounds.
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Samples of laboratory formulated heroin mixtures were then submitted 
for analysis. These were analysed first at 400Mhz, then 600Mhz. The 600Mhz 
results produced the spectra, Figure 13. Figure 14 and Figure 15 show 
expanded sections of Figure 13, with the labelling of the components:
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Figure 15. Expanded region of the 1H (600 MHz) spectrum of mix 2 (new)
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4.4.13 Analysis of spectra
In order to determine the ability of the method to quantify the compounds 
present, it was necessary to perform the following calculations:
The number of moles of each of the compounds present had to be calculated 
from the actual mass of each constituent. This then allowed the calculation of 
the percentage of each material present, as a percentage of the total number of 
moles of all compounds present.
The NMR spectra vary depending on the number of protons present on 
each compound; this was the requirement for the use of moles. By 
measurement of the integrator trace on each spectrum, you can compare the 
percentage of compounds present
Sample mix 1
This sample was produced for investigation by the mixing of known quantities of 
known standards. It was produced on a small scale, the entire sample weighing 
10mg. It was accepted that there could be a large degree of error in the use of 
such small quantities of the constituents, but in order to test the technique in the 
first instance without wasting large quantities of standards it was necessary. 
Table 20 below shows the results for the analysis.
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Diamorphine 50% 5.0mg (43%) 0.0135 34.4% 34.4% 36%
Acetylcodeine 10% 1.1 mg (9.6%) 0.0032 8.1% 8.1% 0.0%
6-MAM 10% 1.2mg (10.4%) 0.0037 9.4% 9.4% 9.0%
Noscapine 5% 0.7mg (6.0%) 0.0017 4.3% 4.3% 4.5%
Papaverine 5% 1.2mg (10.4%) 0.0035 8.9% 8.9% 18.0%
Paracetamol 10% 1.2mg (10.4%) 0.0079 20.1% 20.1% 23.4%
Caffeine 10% 1.1 mg (9.6% ) 0.0057 14.5% 14.5% 9.0%
Sample mix 2
This sample was also produced for investigation by the mixing of known 
quantities of known standards. It was produced on a larger scale, the entire 
sample weighing 100mg, this would improve the accuracy of the weighing and 
improve the ability to mix the powders. Table 21 below shows the results for the 
analysis.













Diamorphine 50% (52.0mg, 51%) 0.141 41% 41% 39.4%
Acetylcodeine 10% (9.7mg, 9.5%) 0.028 8% 8% 14.2%
6-MAM 10% (10.0mg, 9.5%) 0.031 9% 9% 8.7%
Noscapine 5% (5.0mg, 4.9%) 0.012 3.5% 3.5% 0.1%
Papaverine 5% (5.0mg, 4.9%) 0.015 4.4% 4.4% 4.4%
Paracetamol 10% (10mg, 9.8%) 0.066 19% 19% 19.8%
Caffeine 10% (10mg, 9.8%) 0.051 15% 15% 12.5%
4.4.14 Discussion
This method was devised in order to allow the measurement of 
diamorphine within the illicit drug injection solution. The results above 
demonstrate that the two sample runs conducted were able to measure the 
quantity of diamorphine present reasonably accurately, with each experiment 
being within 1.6% of the expected percentage result. This would equate to mix 1
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being calculated as containing 5.2mg and mix 2 containing 50.0mg. It is possible 
that this technique is suitable for the measurements as developed, but further 
analysis would be required. Further analysis would also need to validate the 
process to establish whether the differences in the measurements are due to the 
technique, or due to variation in the samples due to the mixing process.
The measurement of the other constituents was not a primary 
consideration during the development of the method, but as each component 
produced distinct peaks, it was made possible. The results for these calculations 
are not conclusive, however, and it is not possible from this work to suggest 
whether this technique is suitable for these measurements.
Discussion of all of the methods attempted during the quantitative work 
along with suggestions regarding future investigations are presented in section 
6.1.3.
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5 Microbiology of illicit drug injections
The injection of illicit drugs presents a large number of health risks to the 
users, a proportion of these being due to microbiological infections (Drucker. 
Alcabes, & Marx 2001). These complications result from the injection of non- 
sterile solutions. Infections result from viruses, bacteria and fungi present within 
these injections. Table 22 below shows common illicit drug injecting related 
infections.

















Infections resulting from these three main groups are the most common, 
but those from other organisms have been reported, including a fatal malaria 
(protozoan parasite) epidemic in New York (Helpern 1934).
5.1 Candidal infections
Fungal infections from injecting illicit drugs have been recorded since 
1971 when Sugar, Mandell, and Shalev first described a case of 
endophthalmitis. In 1983, Collignon and Sorrell described the first cases of 
disseminated candidiasis associated with drug use. Since these initial reports, 
many similar cases have been reported (Dally, Thomas, & Danan 1983;Hoy & 
Speed 1983;Shankland, Richardson, & Dutton 1986).
The paper of Collignon and Sorrell identified an outbreak that occurred in 
New South Wales, Australia, in 1982. They described patients suffering from 
hepatitis followed by eye lesions, skin lesions osteomylitis and costochondritis. 
Candida albicans was cultured from multiple skin lesions in all cases.
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Epidemiological investigation found that the seven infected patients were part of 
a group of nine who had injected identical heroin together one night. Two other 
injectors present at the same time had remained well. It was found that these 
two had boiled their heroin solutions before injection. This suggests that boiling 
of drug mixtures renders the fungi inactive.
5.1.1 Candida endophthalmitis
This is a commonly reported fungal complication of injecting drug use. 
Endophthalmitis in an illicit drug injector was first described by Sugar et al. in 
1971 in the United States, the infection being caused by Aspergillus sp.. The 
most commonly involved organism is Candida albicans. Candida 
endophthalmitis has been recorded in the United Kingdom (Scotland), France 
and Australia (Gallo, Playfair, Gregory-Roberts, Grunstein, Clifton-Bligh, & 
Billson 1985;Mellingeretal. 1982;Shankland, Richardson, & Dutton 1986).
In 1985, Gallo et al. published the treatment often intravenous heroin 
injectors with endophthalmitis. Three were confirmed with Candida albicans 
infections, the other seven were treated as presumed fungal infections. 
Treatment involved regimes of miconazole, flucytosine and amphotericin B. 
Vitrectomy was performed in the worst cases. The eyesight of only four of the 
ten improved after treatment. Even in these four, destructive retinal changes had 
already occurred, leading to poor vision improvement. This case additionally 
highlights complications resulting from delays in seeking treatment for medical 
problems, as commonly seen with illicit drug users.
The links between injecting paraphernalia and fungal infections have 
been investigated by Tuazon, Hill & Sheagren (1974), Mellinger, De 
Beauchamp, Gallien, Ingold, & Taboada (1982) and Shankland & Richardson 
(1989; 1986). Tuazon et al. cultured samples of street heroin and injecting 
paraphernalia looking for organisms implicated in infections commonly seen in 
injecting drug users. They found that the second most common organism found 
in street heroin was a fungus - in 30.3% of samples cultured, of which 78.7% 
were Aspergillus sp.. No Candida species were found in the heroin, or on the 
paraphernalia. Mellinger et al. cultured ‘brown’ heroin samples specifically 
looking for Candida albicans. No samples tested were found to contain the 
organism, indicating that the drug was not the source of the infections.
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5.1.2 Clostridium novyi
In the year 2000, an outbreak of a serious infection afflicting injecting 
drug users occurred in the UK and the Republic of Ireland, with similar cases 
also affecting one person in both Norway (Maagaard et al. 2000), and Canada 
(Williamson, Archibald, & Van Vliet 2001). Overall in the UK and Ireland, 109 
cases of infection with Clostridium novyi were reported, with at least thirty 
deaths.
Investigations revealed that a batch of heroin was contaminated with the 
spores of Clostridium novyi (Greater Glasgow NHS 2001 ;McGuigan et al. 2002). 
It was also found that the drug powder required up to six times the theoretical 
quantity of acid required to dissolve it, resulting in injection solutions of a very 
low pH (Greater Glasgow NHS 2001). Epidemiological studies revealed that the 
injectors who suffered the most severe infections injected subcutaneously or 
intramuscularly, and that the intravenous users who had suffered infections had 
missed a vein leading to injection into the surrounding tissue. Intravenous 
injectors who injected drug from this batch (without missing veins) were 
unaffected.
The injection of a low pH solution into the non-venous tissue resulted in 
damage during the prolonged contact; this then provided the ideal growing 
conditions for anaerobic bacteria such as the Clostridium. This outbreak 
demonstrated that the use of acidifiers by drug users can have serious 
consequences.
5.1.3 Research investigating the relationship between injection preparation
and infections
Sources of infection
The occurrence of Candida infections has been linked with the use of 
lemon juice when used as an acidifier. The outbreak in 2000 resulted from 
bacteria present within the illicit drug material. These are two sources of 
infections, but other potential sources exist. These include the injecting
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equipment, the environment the injection is prepared in and the injector 
themselves.
Tuazon et al. (1974) investigated the microflora of heroin samples along 
with injecting paraphernalia. They revealed that Bacillus sp. were the most 
common bacteria found on both equipment and in the drug samples, found on 
47% of paraphernalia and in 32% of drug samples. The study also found 
Staphylococcus (32%), Clostridium perfringens (31%) and Escherichia coli 
(17%) on the equipment, with Aspergillus (26%), Staphylococcus (19%), and 
Clostridium perfringens (11 %) in the drug samples.
More recently in the UK, McLauchlin et al. (McLauchlin et al. 2002) 
conducted an investigation of the microflora of heroin samples in response to 
the 2000 outbreak. Bacillus was the most predominant genus of organism found 
with 95% of samples containing B. cereus and 40% containing B. lichenformis.
In addition to this, 40% of samples were found to contain at least one species of 
Staphylococcus.
Preparation of injections
From the above results, it is clear that bacterial or fungal organisms have 
potential to be injected when these drugs are used.
The work by Colligan and Sorrell suggested an important point. They 
indicated that the heating of the injections prepared with lemon juice prevented 
the injectors contracting fungal infections. The Clostridium novyi that caused the 
2000 outbreak on the other hand, were clearly able to survive the preparation, 
including the use of heat and acidifiers.
To date no work has been published that has investigated the ability of 
organisms to survive the preparation process. The only work conducted in this 
area is that of Clatts et al. (1999) investigating the ability of HIV-1 to remain 
viable after being subjected to a typical injection preparation process.
Investigation of the preparation process and the involvement of micro­
organisms was therefore prudent during a study of the risks posed by drug 
injections.
136
5.2 Investigation into the microflora of prepared heroin 
injections
5.2.1 Microbiology materials and methods 
Training
Prior to the commencement of microbiology work, a University of Bath 
Department of Biology course on good microbiological practice was attended to 
ensure good technique, efficiency and safety throughout the following work.
Methodology
Pharmaceutical preparations are subject to the sterility test set out by the 
British Pharmacopoeia (2000). The object of this method is simply to decide 
whether a preparation is sterile, or whether it contains viable organisms. The 
test does not incorporate identification of any organisms that may be cultured. 
For this project identification of organisms was considered desirable. In addition, 
the drug solution would possibly have inhibitory actions on the growth of 
organisms, as heroin has marked antimicrobial properties (Tuazon, Miller, & 
Shamsuddin 1980).
For these reasons it was decided to use a variation of the method used 
by McLauchlin et al. This method used techniques to encourage the growth of a 
wide range of organisms, and allowed their identification. Most importantly, it 
involves a procedure that removes the heroin from the samples to enable 
microbiological growth. The second part of the procedure utilises a ‘citric acid 
solubilisation’ of the drug in order to remove it from the samples allowing any 
organisms that would be affected by its presence to grow.
The main issue with conducting microbiological research was 
identification of colonies produced. Identification of any isolates to the level of 
McLauchlin’s work was ideal, but was not possible due to insufficient laboratory 
environments and limited expertise. The use of API test strips was considered 
but was financially limiting with the potential requirement of many different sets 
of strips for different organisms. Routine Gram staining, along with simple
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biochemical tests, such as catalase reactions, were available to allow a level of 
identification, down to genus level.
In addition to this method, a second investigation was conducted using a 
method devised during the use of McLauchlin’s method for the first stage of 
work, utilising the same media.
5.2.2 Materials 
Agar plates
The agar media used for all of the microbiology method used are 
detailed within this section.
All seven agar medium plates were made in-house to the following 
formulae. The agar solutions were made up in a microbiology preparation lab, 
then sterilised before pouring into sterile disposable Petri dishes. They were 
kept in cold storage (4°C) until required. No plates older than 14 days were 
used.
Columbia Blood Agar (CBA):
This is a general purpose medium, containing 5% horse blood, for the 
isolation of a range of fastidious micro-organisms. This medium combines the 
virtues of both casein hydrolysate, and meat infusion media resulting in both 
rapid production of large colonies, as well as clearly defined zones of 
haemolysis, and good colonial differentiation.
Preparation
Materials








Agar 5.0 (resulting pH 7.3 ±0.2)
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500ml Distilled Water
5% (25ml) Defibrinated horse blood (Oxoid)
Manufacture
19.5grams of Columbia agar base were weighed out and placed into a 
500ml Pyrex® bottle. 500ml of distilled water was added and the mixture boiled 
to completely dissolve the medium. The mixture was autoclaved at 121°C for 
15minutes. The agar solution was allowed to cool to 50°C, and 5% horse blood 
added aseptically. After shaking, gently to reduce the formation of bubbles, the 
mixture was poured into sterile Petri dishes.
Appearance of the plates was red due to the blood content.
Neomycin Blood Agar (NeoBA):
This medium is made as CBA, but after autoclaving, 75mg/L of neomycin is 
added. Neomycin is an aminoglycoside antibiotic active against many strains of 
Gram negative bacteria, but not Pseudomonas spp. Neomycin is also active 
against many strains of Staphylococcus aureus. NeoBA allows the growth of 
Clostridia and other anaerobes when used in an anaerobic chamber.
Materials
As for CBA agar, along with Neomycin powder (Sigma).
Manufacture
450mg of Neomycin was added to 12ml of sterile water and shaken until 
dissolved. This solution was then filter sterilised through a sterile disposable 
0.2pm filter into a sterile universal vessel.
CBA agar was made as above and after autoclaving and cooling, 10ml of 
the neomycin solution was added to the agar solution, before the addition of the 
blood. The solution was mixed gently and poured into sterile Petri dishes.
The plates were red in colour due to the blood content.
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Sabouraud agar (Sab):
This is a non-selective acid pH medium for the cultivation and differentiation of 








The ingredients were weighed out in quantities suitable to make 500ml of 
medium and placed into a Pyrex® bottle. 500ml of water was added to the bottle 
and the mixture boiled until all components had dissolved. The mixture was 
autoclaved at 121°C for 15mins and poured into sterile Petri dishes after cooling 
to 50°C.
The Sab plates were translucent pale yellow in colour similar to nutrient agar. 
Fastidious Anaerobe Agar (FAA):
A highly nutritious blood agar base for the isolation of all fastidious anaerobes. 
This was chosen to replace the BMBH as used by McLauchlin et al.. In 
discussions, Dr. McLauchlin (Personal Communication) enquiring about the 
formulation of BMBH, he indicated that he felt that the inclusion of BMBH had 
had little value. On this advice FAA was chosen to replace BMBH. The formulas 
are very similar, but using the manufactured powder mix would reduce 
preparation times.
Materials

























Sodium succinate 0.5 (resulting pH 7.2 ±0.2)
500ml Distilled Water
5% (25ml) Defibrinated horse blood (Oxoid)
Manufacture
23grams of the agar mixture was placed into a 500ml Pyrex® bottle and 
500ml of distilled water added. The mixture was left to soak for ten minutes 
before autoclaving at 121°C. After autoclaving the mixture was cooled to 
approximately 45-50°C and the blood added. After mixing, the mixture was 
poured into sterile Petri dishes.
The FAA plates were red in colour due to the addition of the blood.
Clostridium Botulinium Isolation agar (CBI):
Clostridium botulinum isolation agar was developed by Dezfulian et al 
(1981) for the detection of Clostridium botulinum in human faeces. The formula 
is based on that of McClung-Toabe agar, with the addition of yeast extract to 
enhance organism growth. McClung and Toabe developed the agar specifically 









Sodium chloride (BDH) 










25ml sterile egg yolk emulsion (Oxoid)
Manufacture
The ingredients for 500ml of solution were weighed out and placed into a 
500ml Pyrex® bottle. The mixture was gently heated until all ingredients 
dissolved, and the mixture autoclaved at 121°C for 15minutes. After cooling to 
50°C, the egg yolk emulsion was aseptically added to the solution and mixed 
thoroughly. The solution was poured into sterile Petri dishes.
The finished agar plates were translucent yellow in colour.
Antibiotic Ciostridium Botuiinium Isolation agar (ACBI):
ACBI uses CBI agar as the base, with the addition of antibiotics. This 
medium is used to suppress the growth of other organisms whilst still enabling 
the growth of Clostridium botulinum. This was devised after investigations by 
Dezfulian et al. (1981), and separately by Swenson et al. (1980), identified 
resistance to particular antimicrobials by C. botulinum. Inclusion of these agents 
within the media would enable selective growth of C. botulinum, particularly by 
reducing competition from other organisms which are sensitive to the 
antimicrobials.
The materials were the same as for CBI agar, with the addition of the following 
antimicrobials:
Materials
Cycloserine (Sigma) 250mg per litre
Sulfamethoxazole (Sigma) 76mg per litre 
Trimethoprim (APS) 4mg per litre
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Manufacture
Each of the antimicrobials was dissolved in solution in which 5ml 
contained the required quantity of the agent. 350mg of cycloserine was 
dissolved in 7ml of distilled water and filter sterilised with a 0.2pm filter into a 
sterile universal bottle. 106.4mg of sulfamethoxazole was placed in 4ml of 
distilled water and 10% NaOH added until the drug went into solution. The 
solution was made up to 7ml with water, and filter sterilised into a sterile 
universal container. 5.6mg of trimethoprim was placed into 4ml of distilled water 
and warmed to 55°C in a water bath. 0.05M hydrochloric acid was added 
dropwise until the drug dissolved. The solution was made up to 7ml, and filter 
sterilised.
The agar solution mixture was made as above, and after autoclaving and 
cooling, 5ml of each of the antibiotic solutions was aseptically added to the agar 
solution, along with the egg yolk emulsion. The solution was then poured into 
sterile Petri dishes.
The finished plates were translucent yellow in colour.
Polymyxin pyruvate egg yolk mannitol bromothymol blue agar (PEMBA):
(Bacillus cereus selective agar)
This is a selective medium for the isolation and enumeration of Bacillus 
cereus. Developed by Holbrook and Anderson (1980) for the isolation and 
enumeration of B. cereus in foods, it is able to detect small numbers of the 
organisms cells and spores in the presence of large numbers of other food 
contaminants. It allows ready identification of colonies through precipitation of 
egg yolk and a distinctive turquoise to peacock blue colour surrounding the 
colonies (Figure 16).
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Disodium hydrogen phosphate (Fisher)





25ml sterile egg yolk emulsion (Oxoid)
Bacillus cereus selective supplement SR99 (50000IU Polymyxin B) (Oxoid)
Manufacture
The materials above were measured out in quantities sufficient for 500ml 
of solution and placed in a 500ml Pyrex® bottle. 475ml of water was added and 










14.0 (resulting pH 7.2±0.2)
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autoclaved at 121°C for 15minutes. The mixture was cooled to 50°C. One vial of 
the supplement was reconstituted with 2ml of sterile water for injections, and 
aseptically added to the mixture, along with the 25ml of egg yolk emulsion. The 
mixture was poured out into sterile Petri dishes.
The PEMBA plates were a translucent lime green colour once poured.
Other Materials
Phosphate Buffered Saline (PBS)
This was made by adding one PBS tablet (Oxoid) to 100ml of distilled 
water in a bottle, then sterilising by autoclave.
Maximum Recovery Diluent (MRD)
Formula gm/L
Peptone (Oxoid) 1.0
Sodium chloride (BDH) 8.5 (resulting pH 7.0+0.2)
This was made up to one litre, then dispensed into 100ml clear glass bottles and 
sterilised by autoclave.
10% Citric acid solution
Made from citric acid (Sigma) dissolved in distilled water (50g in 500ml), 
and then filter sterilised.
Clostridium Botulinum Isolation Cooked Meat Broth
This broth was used by McLauchlin et al. (McLauchlin, Mithani, Bolton, 
Nichols, Beilis, Syed, Thomson, & Ashton 2002) for the cultivation of the 
organisms in method two of their procedure. They reference a paper stating the 
origin of this formula; however, the reference actually makes no mention to the 
formula. Dr. McLauchlin was contacted for the details of the broth formula. The
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broth includes meat granules to form an anaerobic environment at the bottom of 
the vessel as well as providing nutrients to any organisms.
Materials
Formula











Cooked meat medium granules (Oxoid)
250|ug of Lysozyme (Oxoid) in 1ml of distilled water, filter sterilised.
Manufacture
The ingredients were measured out in quantities to make 500ml of broth 
and placed in a Pyrex® bottle. The 500ml of water was added and the solution 
heated until the all solids were dissolved. One scoop of meat granules was 
placed in a 25ml thick walled universal container, and 23ml of the broth solution 
added. The prepared universal vessels were then autoclaved.
On the day of use, each universal was steamed with the lid loose for 
15minutes to remove oxygen from solution, and cooled back to room 
temperature with the lid tightened. One millilitre of sterile lysozyme solution was 
added to give final concentration of 10pg/ml.
5.3 Investigation method 1
5.3.7 Introduction
The first method used was adapted from the McLauchlin et al. method 
outlined above.
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The method was performed twice, once with 100mg samples of pure 
heroin in order to replicate the work of McLauchlin using the Avon and Wiltshire 
Police samples of illicit heroin. This would give a baseline of the organisms 
within the drug material, which we would be able to compare to McLauchlin’s 
samples (from Merseyside), and then to the results that would be obtained from 
the heroin injections. This work was repeated in duplicate.
To investigate injections prepared from the heroin samples, 130mg was 
taken and prepared using sterile citric acid. Due to lack of material, it was not 
possible to perform the experiment in duplicate. Ideally, this work would have 
been performed at least in duplicate, then with differing quantities of acid and 
different acids.
Additional materials
These materials were used in addition to those outlined above. All 
materials used for the preparation of standard injection, including in this case 
sterile water for injections (ampoules), and sterile citric acid from Exchange 
supplies.




Orange (25G) and Green (21G) needles
Syringe filter holders with 0.2pm filter (sterilised by autoclaving)
Glass spreaders (sterilised, or stored in 70% alcohol between use, then flamed) 
Sterilised beakers for solutions (citric acid and PBS)
50ml sterile disposable tubes for samples
10% Citric acid solution
PBS
MRD
CBI broth (prepared as described, including steaming and addition of lysozyme) 
Plates as previously described
Anaerobic gas jars (2x 15 plate size, 1x 45 plate size) (BBL GasPak)
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Gas generating sachets (Oxoid)
Anaerobic indicator strips (BBL GasPak)
30°C incubation environment (To identify fungi and bacteria that grow
selectively at this temperature, such a B. 
cereus)
37°C incubation environment (To identify human pathogens)
5.3.2 P a rti
A 100mg sample of heroin was placed into 10ml of MRD and placed on a 
vortex mixer to form a suspension. 0.1ml of this was inoculated (spread plated) 
onto two CBA plates, one PEMBA plate and one Sab plate. One of the CBA 
plates, the Sab and the PEMBA plate were incubated aerobically at 37°C, the 
other CBA plate was incubated anaerobically at 30°C.
Next, a 1 ml sample of the MRD solution was taken and filtered through a 
sterile 0.2pm filter. This filter was then aseptically removed from the filter holder 
using a pair of sterilised tweezers, and placed into a universal vessel of CBI 
broth. This was repeated a second time, but the vessel of broth with the filter 
was placed in a water bath at 60°C for 30minutes. After the heating of the 
second broth, both broths were placed in an incubator at 30°C.
After 14 days, both broths were subcultured by spread plating onto ACBI, 
CBI, NeoBA, FAA and CBA plates that were incubated anaerobically. A second 
set of CBA plates were inoculated and incubated aerobically. All plates were 
incubated at 30°C, except the NeoBA plate which was incubated at 37°C. The 
plates were examined daily for four days, except the Sab plate which was 
examined for seven days.
5.3.3 Part 2
A 10Omg sample of heroin was taken and dissolved in 50ml of sterile 
citric acid 10% solution. 0.1ml of this solution was spread plated onto each of 
ACBI, CBI, NeoBA, FAA and CBA plates, which were incubated anaerobically at 
30°C, except the NeoBA plate which was incubated at 37°C, and CBA PEMBA 
and Sab plates which were incubated aerobically at 37°C. All plates were
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examined daily for four days for growth, except the Sab plate which was 
examined for seven days.
10ml of the heroin in citric acid solution was taken and filtered through a 
sterile 0.2pm filter. This filter was then rinsed with 20ml of sterile citric acid 
solution, followed by 40ml of PBS. This filter was then aseptically removed from 
the filter holder using a pair of sterilised tweezers, and placed into a universal 
vessel of CBI broth. This was repeated a second time, however, the vessel of 
broth with the filter was placed in a water bath at 60°C for 30minutes. After the 
heating of the second broth, both broths were placed in an incubator at 30°C.
After 14 days, each of the two broths was subcultured by spread plate 
onto ACBI, CBI, NeoBA, FAA and CBA plates that were incubated 
anaerobically, and CBA plates incubated aerobically. All plates were incubated 
at 30°C, except the NeoBA plate which was incubated at 37°C. The plates were 
examined daily for four days, except the Sab plate which was examined for 
seven days.
5.3.4 Investigation of produced injections
After the identification of bacteria present in the drug sample, the 
presence of these bacteria in a prepared injection was explored. Using 130mg of 
heroin, injections were prepared and tested using the method above, where they 
would replace the 100mg of drug powder. As explained above, the following 
experiment was only performed using citric acid. Ideally, the work would have 
investigated the use of different acids, varying quantities of these acids and 
possibly different filters instead of just the Swan® filter used.
Method
The spoon for the preparation of the injection (stored in a beaker of 70% 
alcohol) was passed through the flame of the Bunsen burner to burn off the 
residual alcohol. 130mg of drug powder was placed in the spoon. 75mg of sterile 
citric acid was added to the drug powder. 0.85ml of water for injections was 
drawn up aseptically from an ampoule using a sterile 1ml insulin syringe and 
added to the powders in the spoon. The mixture was heated using a cigarette 
lighter until all solids had dissolved, which took approximately 38 to 40seconds.
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A fresh tube of Swan filters was removed from package and the top filter 
removed and the second one down squeezed up to the opening of the plastic 
tube. Using a sterile pair of tweezers (stored in 70% alcohol, then flamed before 
use) 1/3rd of the filter was ripped off and placed into the injection solution. The 
solution was drawn up into a new sterile 1 ml insulin syringe.
For part one of the method above, this injection solution was added into 
10ml of MRD. For part two, another injection was prepared as above, and the 
injection solution added to 50ml of 10% citric acid solution. The methods were 
then carried out as for the direct samples of heroin powder.
Outline diagrams of method procedures
The following diagrams depict the procedures conducted in the 
























3 °  
i s I?
!?





























11 " s T T s T l






To establish the ability of organisms to survive the preparation procedure 
and remain viable, the methods were repeated using samples spiked with 
known quantities of certain organisms. McLauchlin et al. used Clostridium 
botulinum (strain R254/02), a strain obtained from an infected wound of an IDU, 
and Clostridium novyi, including a strain obtained from the 2000 outbreak. Both 
of these organisms are Class 2, which means they ‘may cause human disease, 
laboratory use may present a hazard although laboratory exposure rarely 
causes infections and effective prophylaxis and therapy are available’ (1998). 
Although they are class 2 organisms, further conditions in the classification 
system place some class 3 restrictions upon them, specifically regarding the 
laboratories in which they can be used. Due to these restrictions, combined with 
increasing concerns about biological terrorism, the use of these organisms 
within the pharmacy department was not possible. The use of facilities outside 
the pharmacy department was not possible due to time issues. The work of 
McLauchlin et al. validated the procedure, and proved that the growth of these 
organisms under the experimental conditions was possible, but neither of them 
was recovered from their illicit drug samples. The nature of this work was not to 
specifically isolate these Clostridium species, but to identify any pathogenic 
bacteria present within prepared injections. Therefore, validation was conducted 
using organisms available for use within the laboratory constraints that are 
known to be the source of infections in injectors. For this purpose, 
Staphylococcus aureus (NCTC 6571) and Bacillus cereus (NCTC 2599) were 
used.
To conduct this for method one, 0.02ml of broth solution (containing 
approximately 100 colony-forming units, as described in detail in method 2 
(Section 5.3.5) was diluted into 0.8ml of sterile water. This was then used as the 
samples for parts one and two of the method. Specific plates were used for 
culturing the organisms, namely CBA for the S. aureus and PEMBA for B. 
cereus. Growth was confirmed under these conditions.
Further validation was conducted using acid solutions to confirm these 
did not inhibit the growth of the organisms themselves. 0.02ml of inoculated 
broth solution above was placed into a spoon with 0.8ml and acid added in 
powder form. The acids used were citric (75mg) and ascorbic (175mg). They 
were used from sterile sachets to ensure they did not introduce any micro-
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organisms. The solution in the spoon was then heated using a cigarette lighter 
(as per the standard injection preparation procedure) until the powder dissolved 
which took approximately 35seconds for each acid. The prepared solutions were 
then used as the samples and incorporated into the methods as above.
5.3.5 Investigation method 2
This method was devised specifically for this work. It involved the direct 
inoculation of organisms into all the samples in order to assess their viability 
after injection preparation. Growth conditions and media were chosen that were 
most suitable for the organism used. Learning from method 1, filtration of the 
sample was utilised to remove drug from the samples to prevent any inhibition of 
growth.
Firstly, a broth of bacteria was cultured from a colony of the standard for 
the organism. This broth was left static at 37°C for 20 hours. Under these 
conditions, a broth normally contains between 4x108 to 4x109 organisms per 
millilitre. To spike the drug cultures, approximately 100 organisms would be 
added to the injection prior to preparation. The broth would require serial dilution 
to allow addition of this number of organisms.
Table 23 Serial dilution details 
Approximate number of „
108
organisms per ml 
Broth dilution factor 101
Dilution to be 1/100
performed on the broth 
Actual dilution 0.1ml +
9.9ml
In 0.1ml of the final (102) broth, there should be approximately 10 organisms. 
Therefore spread plating out of this should result in the growth of approximately 
10 colonies. From this, the actual number of organisms per ml can be 
calculated. This will ensure the spiking of the samples will occur with a known 
number of organisms. For further spiking experiments, broths will be cultured for 
20 hours and measured with a spectrophotometer (Unicam Helios Gamma UV-
106 105 104 103
10'2 10'3 10-4 10'5
1/10 1/10 1/10 1/10
1 ml + 9ml 1 ml + 9ml 1 ml + 9ml 1 ml + 9ml
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Visible Spectrophotometer) to ensure the addition of an equal number of 
organisms to each drug sample.
The absorbance of the neat broth and that of dilutions of the broth was 
measured using a spectrophotometer set to measure absorbance at 420nm. 
Aliquots of the broth were diluted to 75%, 50% and 25% strength. The 
absorbance of nutrient broth was measured as the zero value. These results 
were then plotted on a graph of concentration against absorbance. 
Approximations of the number of organisms in subsequent 20hr broths were 
possible by measuring the absorbance of the broth, removing the need for serial 
dilutions and plate counts to calculate the number of Colony Forming Units 
(CFUs) - the number of viable organisms.
For use, the cultures would then be serially diluted to a solution a 
suitable strength that would ensure 100 organisms being in approximately 
0.02ml of broth solution. This volume was chosen because it was felt too large a 
volume of broth may adversely affect the production of the injection.
Samples
The inoculation technique was first used to investigate the ability of the 
organisms to survive heat and acid solutions without drug. ‘Injections’ were 
prepared using water for injections alone, 75mg of citric acid in WFI, 175mg 
ascorbic acid in WFI, and undiluted lemon juice.
Heroin injections were prepared using the standardised injection 
preparation procedure, using 130mg of heroin. The heroin was prepared using 
75mg citric acid as one sample set, and 175mg of ascorbic acid as a second 
sample set. Sterilising the illicit drug samples to prevent introduction of 
organisms within them would have been impractical and could have adversely 
affected the drug material. If a different organism was found in broths or on 
plates, this would be deemed to have survived the procedure as it was likely to 
have been introduced by the drug material.
Sample preparation
All work was carried out aseptically on a bench in the presence of a 
Bunsen burner flame to protect against airborne bacteria. The bench was 
swabbed prior to work.
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The injection was prepared in an identical manner as method 1, 
observing all aseptic precautions. Before heating, the volume of broth containing 
approximately 100 organisms was added to the mixture.
The water and lemon juice solutions were heated until they bubbled, 
heating for at least thirty seconds. The citric and ascorbic acid samples were 
heated until the acid powder had dissolved, continuing to heat for at least thirty 
seconds if the acid dissolved quickly. The drug solutions were heated until the 
drug powder was seen to dissolve into solution which took just over 30seconds.
The solutions were filtered though 1/3^ of a Swan® roll-up filter into a 
new sterile 1 ml syringe with a removable orange needle, not the insulin type as 
used to draw up the water at the start of the method. This type of syringe would 
allow the connection of filter holders to produce sample set 2 (below).
Stage 1
This was the direct inoculation of undiluted solutions onto the agar 
plates. 0.1ml of the prepared injection solution was spread plated onto an 
appropriate medium for the inoculated organism- PEMBA for B. cereus, and 
CBA for S. aureus. This was then incubated for 4 days under conditions to 
encourage the growth of the organism.
Stage 2
A sterile filter holder containing a 0.2pm filter was used to remove 
bacteria from the remaining injection solution, and the filter washed with 20ml of 
10% citric acid solution to remove any residual heroin from the filter, followed by 
40ml phosphate buffered saline to rinse off the acid solution.
The filter was removed aseptically from the holder and inoculated into 
nutrient broth and incubated at 37°C overnight. The following day, 0.1ml of the 
broth was spread plated onto the appropriate agar, and this left in suitable 
conditions to encourage growth of the organism spiked into the drug injection.
Any growth on the plates was identified to establish whether the 
organism had survived the preparation process.
Controls
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Controls were used in stage one for both the organism and the lemon 
juice solutions. The same volume of broth solution as inoculated into the 
samples (~0.02ml) was spread plated onto the appropriate agar to ensure the 
organism was viable. 0.1ml of undiluted lemon juice was also spread plated out 
to confirm that no organisms were present within it.
In order to confirm the presence of the organism in the broth, 0.02ml of 
the serial dilution was spread plated onto the appropriate agar for the organism 
and overnight growth confirmed.
Organisms investigated
Staphylococcus aureus (Commonly found on skin, especially nose and 
perineum. In context with injection- can cause boils, septicaemia, toxic shock 
syndrome and endocarditis)
B cereus (most common organism found in heroin samples in McLauchlin’s 
work. Implicated in a wide range of conditions including eye infections, abscess 
formation, wound infections and septicaemia)
Further investigations
These were conducted during work on the outlined method making use 
of the surplus drug solution that otherwise would have gone to waste and the 
filter used to prepare the injections.
Drug in MRD
The preparation of the drug and injection in MRD for part one of the 
method resulted in approximately 7ml of solution remaining at the end of the 
experiment. To further explore the presence of viable organisms within this, 
0.1ml was placed into 20ml of nutrient broth. This broth was incubated at 37°C 
for 4 days. This method was not outlined in any previously recorded 
experimental procedures, but was conducted as the solution would only have 
been discarded at this point. Given the limited supplies of drug material, this was 
considered a waste, hence this further exploration of the liquid.
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Direct inoculation of 0.1ml of the broth onto CBA plates one incubated 
aerobically at 37°C and one incubated anaerobically at 30°C, and a Sab plate 
incubated aerobically at 37°C produced no growth.
Injection filter
The filters used in the spoon to filter the injections may have trapped 
organisms from within the injection solution. To investigate this, the filters were 
aseptically removed from the spoon and placed into 20ml of nutrient broth. 
These were incubated at 37°C for 4 days.
Direct inoculation of 0.1ml of the broth onto CBA plates one incubated 
aerobically at 37°C and one incubated anaerobically at 30°C, and a Sab plate 
incubated aerobically at 37°C produced no growth.
5.3.6 Identification of isolates
Any growth found on plates was subcultured by streak plating onto an 
identical type of agar plate and incubated under the same circumstances as the 
original plate. By allowing the growth of individual colonies, the colony 
morphology would usually allow the judgement of whether there was just one, or 
more than one, types of organism present on the original plate.
Samples from each different colony were examined microscopically 
using Gram staining. Suspected Staphylococci sp. were identified through 
catalase reaction- the release of oxygen bubbles on contact with hydrogen 
peroxide solution (3%).
5.4 Results
5.4.1 S. aureus validation
Initial Liquid Samples:
Growth seen on 8 of 8 plates (100%)
All Gram positive cocci, catalase positive.
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Broth Samples:
Growth on 6 of 8 plates.
Growth did NOT occur from: Citric acid method 2 steamed 
Ascorbic acid method 2 unsteamed
Identification
All colonies were identified as S. aureus through microscopic examination and 
catalase tests, except the growth in the citric acid method 1 tube. These were 
found to be small Gram negative rods, with a weak catalase reaction. Use of API 
test strips identified these organisms as E. coli. Due to incubator maintenance, 
these broths had been incubated in an alternative incubator alongside the work 
of another member of staff who was working with E. coli, it was therefore 
probable that this was the cause of this growth. In no other experiments was E. 
coli recovered.
5.4.2 B. cereus validation
Initial Liquid Samples:
Growth on all 8 plates (100%)
All identified as B. cereus through blue colour on plates and microscopic 
examination.
Broth Samples: Growth seen on only 3 plates out of 8
Growth was on citric method 1 unsteamed,
Ascorbic method 1 unsteamed 
Ascorbic method 1 steamed 
All identified as B. cereus through blue colour on plates and microscopic 
examination.
5.4.3 Ascorbic and citric sachets
Initial Liquid Samples: No growth seen on any plate
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Broth Samples: Growth on six out of 56 plates (6/56)
5.4.4 Citric and ascorbic acid from lab stocks
Initial Liquid Samples: One growth out of 32 plates. (1/32, %)
Broth Samples: 17 growths from 56 plates
Identification
Citric method 1 steamed, Aerobic CBA (Plate number 8): motile rods
Citric method 2 unsteamed, Aerobic CBA (15): Gram positive cocci 
Citric method 2 unsteamed, CBI (20): Gram positive cocci 
Citric method 2 unsteamed, ACBI (21): Gram positive cocci 
Citric method 2 unsteamed, Anaerobic CBA (17): Gram positive cocci 
Citric method 2 unsteamed, PEMBA (18): Gram positive cocci 
Citric method 2 unsteamed, FAA (19): Gram positive cocci
14 Day samples 
17 growths on 56 plates
5.4.5 Lemon juice samples
Experiment performed using fresh lemon juice from Jif® lemon shaped 
container
Initial Liquid Samples: No growth seen on any plate
Broth Samples:
Filtering of the old lemon juice proved troublesome as the filter blocked very 
easily. Therefore method 2 was impossible to carry out.
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Three plates out of twenty-eight produced growth. (3/28,11% )
Identification:
Fresh Lemon Juice, unsteamed, Aerobic CBA (17): Gram positive rods, 
anaerobic
Fresh Lemon Juice, unsteamed, FAA (19): Gram positive rods, anaerobic and 
Gram positive cocci, anaerobic
Fresh Lemon Juice, unsteamed, CBI (20): Gram positive rods, anaerobic
5.4.6 Heroin samples
This work was conducted in duplicate, the sampled being named heroin 
‘Vand ‘2’.
Initial Liquid Samples: No growth observed. Most likely due to the
inhibitory effect of the heroin
Broth Samples: Growth seen on 21 of 56 plates
Identification:
Heroin 1, method 1 unsteamed Anaerobic CBA (3): Gram positive cocci 
Heroin 1, method 1 unsteamed FAA (5): Gram variable rods 
Heroin 1, method 1 unsteamed CBI (6): Gram positive cocci
Heroin 1, method 2 unsteamed Aerobic CBA (15): FEW Gram positive cocci 
Heroin 1, method 2 unsteamed Anaerobic CBA (17): Gram positive rods 
Heroin 1, method 2 unsteamed FAA (19): Gram positive rods 
Heroin 1, method 2 unsteamed CBI (20): Gram positive rods with spores
Heroin 2 method 1 unsteamed Anaerobic CBA (31): Gram positive cocci 
Heroin 2 method 1 unsteamed FAA (33): Gram positive cocci + Gram negative 
rods
Heroin 2 method 1 unsteamed CBI (34): Gram positive cocci 
Heroin 2 method 1 steamed Anaerobic CBA (38): Gram positive cocci
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Heroin 2 method 1 steamed FAA (40): Gram positive rods 
Heroin 2 method 1 steamed CBI (41): Gram positive cocci
Heroin 2 method 2 unsteamed Aerobic CBA (43): Two types of growth:
Small milky colonies, no haemolysis 
Large colonies with haemolysis 
Both were Gram positive cocci 
Heroin 2 method 2 unsteamed Anaerobic CBA (45): Gram positive cocci 
Heroin 2 method 2 unsteamed PEMBA (46): Gram positive cocci 
Heroin 2 method 2 unsteamed FAA (47): Gram positive cocci 
Heroin 2 method 2 unsteamed CBI (48): Gram positive cocci
Heroin 2 method 2 steamed Anaerobic CBA (52): Gram positive rods 
Heroin 2 method 2 steamed (54): FAA Gram positive rods 
Heroin 2 method 2 steamed (55): CBI Gram positive cocci
5.4.7 Heroin injections
Initial Liquid Samples: Growth seen on one plate out of 8. The fact that
this was a single colony and was not seen on the 
replication plate suggests this was external 
contamination and not significant.
Broth Samples: No Growth seen
5.5 Microbiological investigation method 2
5.5.1 Resuits of number of CFUs in overnight broths
Serial Dilutions of the broth solutions incubated at 37°C for 20hours.
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B. cereus
Growth from 0.1 ml of 10'6 culture 3.5 colonies (Average of two plates)
Growth from 0.1 ml of 10'5 culture 36 colonies
Therefore the concentration of the original broth was approximately 3.6x107 per 
millilitre. Dilution of this of this broth to the 10-4 dilution would result in 
approximately 100 organisms in 27pl.
Spectrophotometer readings (420nm): 
Nutrient Broth (0%) 0.0000A
25% B. cereus culture 0.1120A
50% B. cereus culture 0.2220A
75% B. cereus culture 0.3170A
100% B. cereus culture 0.3980A
The following graph was plotted:
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S. aureus
Spectrophotometer readings (420nm): 
Nutrient Broth (0%) 0.0000A
25% S. aureus culture 0.151OA
50% S. aureus culture 0.2960A
75% S. aureus culture 0.4320A
100% S. aureus culture 0.5370A
Growth from 0.1 ml of 10'6 culture 40 colonies (Average of two plates)
Growth from 0.1 ml of 10"5 culture approx. 294 colonies
Therefore the concentration of the original broth was approximately 4x108 per 
millilitre. Dilution of this of this broth to the 10'5 dilution would result in 
approximately 100 organisms in 25pl.
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5.5 .2 Spiked preparation resuits
Acid Soiutions 
B. cereus
All samples were cultured on PEMBA medium at 30°C
Results from 0.1ml of neat solution
WFI No Growth
Citric Acid 75mg No Growth
Ascorbic Acid 175mg No Growth
Lemon Juice (undiluted) No Growth
Controls:
0.025ml of B. cereus solution Growth (approximately 80 colonies)
0.1ml Lemon Juice (unprepared) No Growth
Broths
After incubation, broth containing filters of the remaining injection solution all 
appeared clear.
0.1ml of broth spread plate results:
WFI No Growth
Citric Acid 75mg No Growth
Ascorbic Acid 175mg No Growth
Lemon Juice (undiluted) No Growth
Control: 0.02ml of B. cereus in broth Growth
Identification
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The growths on the control PEMBA and In the control broth were both 
confirmed as B. cereus.
S. aureus
All samples were cultured on Columbia Blood Agar (5% defibrinated horse 
blood) at 37°C
Results from 0.1ml of neat solution
WFI No Growth
Citric Acid 75mg No Growth
Ascorbic Acid 175mg No Growth
Lemon Juice (undiluted) Growth
Controls:
0.025ml of S. aureus solution Growth (approximately 150
colonies)
0.1 ml Lemon Juice (unprepared) No Growth
After incubation, the citric acid and lemon juice broths were distinctly 
cloudy, and the WFI broth had a possible cloudiness.
0.1ml of broth spread plate results:
Broths
WFI
Citric Acid 75mg 






Control: 0.02ml of S. aureus in broth Growth
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Identification
The growth on the control agar and in the control broth were confirmed 
as S. aureus.
The growth from the lemon juice which was taken straight from the bottle 
indicated that the lemon juice from a bottle opened less than a month earlier 
was non-sterile. The growth covered over 75% of the plate surface, and was 
found to be a mixture of Gram variable rods, along with spores. The growth from 
0.1ml of prepared lemon juice was restricted to three large colonies. The first of 
these consisted of Gram variable rods along with spores, similar to that on the 
unprepared plate. The second colony was found to consist of Gram variable 
rods. The third colony was markedly different from the others and consisted of 
Gram positive cocci.
The growth produced by the broth from the citric acid filter covered the 
entire surface of the plate and consisted of Gram positive cocci, which were 
identified as S. aureus through microscope and catalase reaction test. The broth 
from the filter used for the prepared lemon juice produced a yellow/gold film over 
the whole of the agar plate. This film was found to consist of Gram negative 
rods, with spores.
Heroin injections
The standard injection preparation procedure was used, including the 
addition of 130mg of illicit heroin powder to the preparation. This was performed 





All samples were cultured on PEMBA medium at 30°C
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Results from 0.1ml of neat solution
Citric Acid 75mg No Growth
Ascorbic Acid 175mg No Growth
Controls:
0.025ml of B. cereus solution Growth (approximately 110
colonies)
Broths
After incubation, both broths appeared slightly cloudy.
0.1ml of broth spread plate results:
Citric Acid 75mg No Growth
Ascorbic Acid 175mg [plate dried up overnight in incubator, result
unclear]
Streak plate results
Citric Acid 75mg Growth
Ascorbic Acid 175mg Growth
Control: 0.02ml of B. cereus in broth Growth
Identification
The growth from the streak plates of the ascorbic acid injection produced 
a separation of two apparently distinct organisms. There were colonies with a 
fine ‘cotton wool’ appearance, which produced a slight blue tinge to the PEMBA 
agar, not as obvious as a culture of B. cereus, but suggesting they were related 
to B. cereus. The second colonies observed were very small white colonies. 
These produced no blue colour from the agar.
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Microscopic examination of these colonies found that they were different 
organisms. The cotton wool type colonies were observed to be Gram variable 
rods. The white colonies were Gram positive rods, with spores. Both organisms 
were found to be catalase positive.
The injection produced using citric acid a homogenous culture of white 
colonies. Under the microscope, they were found to be Gram positive rods with 
spores. These were also catalase positive.
S. aureus
All samples were cultured on CBA medium at 37°C
Results from 0.1ml of neat solution
Citric Acid 75mg No Growth
Ascorbic Acid 175mg Growth (Two colonies)
Controls:
0.025ml of S. aureus solution Growth (approximately 100
colonies)
Broths
After incubation, both broths appeared slightly cloudy.
0.1 ml of broth spread plate results:
Citric Acid 75mg Growth
Ascorbic Acid 175mg Growth
Streak plate results
Citric Acid 75mg Growth
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Ascorbic Acid 175mg Growth
Control: 0.02ml of S. aureus in broth Growth 
Identification
The growth from the spread plate of broth from the ascorbic acid 
injection grew two separate colonies, as shown in Figure 19.
Figure 19 Colonies grown on the CBA spread plate o f ascorbic acid solution spiked with 
S. aureus
They were both identified as Gram variable rods, even though the colonies 
appeared different. This is possibly due to the effect of the injection solution 
upon the colony growth. No growth of S. aureus was evident.
Additionally, the effect of the injection solution upon the blood within the agar 
can clearly be seen in the photograph. The greying of the agar was clearly 
caused by the solution, and is especially evident where the initial sample was 
dropped onto the agar as the round circle in the centre.
The spread plates of the broth solutions both produced golden growths 
covering the entire surface of the plate. The growths on both plates appeared 
visually to resemble the growth of S. aureus. To investigate this further, the 
broths were streak plated out to assess whether the cultures within the broths 
were a mixture of organisms or one single type.
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The streak plates from both plates indicated that both broths contained 
homogenous cultures. The cultures produced from the ascorbic acid injection 
consisted of catalase positive Gram variable rods. The cultures from the citric 
acid injection also consisted of catalyse positive Gram variable rods, possibly 
with a larger number of Gram positives.
5.6 Discussion
The literature review has demonstrated that bacterial and fungal 
infections contracted through the use of illicit injections are of common 
occurrence. Not only do they lead to severe morbidity and mortality, but they 
increase they increase the workload of medical services that have to provide 
treatment. Viral infections including HIV/AIDS and hepatitis C result in long term 
health complications, which have high treatment costs. For this reason, a large 
amount of harm reduction information is directed at users to reduce their spread. 
Bacterial and fungal infections are less publicised, possibly on account of the 
acute, rather than chronic, nature of their infections. However, they are both 
responsible for afflictions and deaths.
5.6.1 Method 1
This section of the microbiological investigation repeated the work of 
McLauchlin et al. using the same methods and equipment. The one difference 
from the original work was the culturing of the broth after fourteen days only, 
rather than at seven and fourteen days. This was conducted due to initial tests 
suggesting that contamination of the samples could occur during the sampling at 
seven days despite strict precautions being undertaken to prevent this occurring. 
It could have been possible to prepare separate broth samples for culturing at 
seven days, but this would have added to the complexity of the work by doubling 
the number of broths prepared. Although this was a deviation from the original 
procedure, it was felt that the most dominant organism would be the only one 
present at 14days, and this was the one desired for identification. The risk of 
introducing an extraneous organism from the environment was too great.
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The validation of the method using the organisms prepared within acid 
solutions to confirmed the ability of the organisms to grow in the presence of the 
acids which would be used to prepare drug injections. This validation confirmed 
that both B. cereus and S. aureus were able to grow from acid solutions 
prepared in a similar manner to illicit injections, minus the drug, from the initial 
broth samples.
The isolation of these organisms from the incubated broths was less 
successful. S. aureus remained viable within the broth from six out of eight of 
the acid solutions. The growth of B. cereus from the incubated broth samples 
was seen in only three out of the eight samples. Although unsuccessful, it is not 
particularly significant. The organisms were confirmed present within the 
solutions immediately after preparation. This was the most important result. It 
demonstrates the solutions still contained viable organisms at the point at which 
it would be injected. Methodologically, it is possible that the conditions were not 
ideal for the growth of these organisms, this is understandable as the broth 
formula and its treatment was designed for the cultivation of anaerobic 
organisms, specifically Clostridia.
Sterile sachet results
The sterile sachets made for supply to drug users, are ‘sterilised by 
gamma radiation at a dose that guarantees sterility’ (Personal communication, 
Andrew Preston, 2004). Therefore, the investigation of these sachets should 
have produced no results. The spread plates from the initial liquid samples 
confirmed this and no growth was seen. The results from the broth samples 
were unexpected. Growth occurred on three plates on each of the citric and 
ascorbic acids (method 2, unsteamed).
This should not have occurred. If the sterility of these sachets is to be 
assumed, then the growth indicates contamination introduced during the sample 
preparation. The manufacturers of the sachets maintain they are sterile, 
therefore the results were assumed to be false and introduced during the 
laboratory analysis. Following these results, the conduction of the laboratory 
work was reassessed to attempt to identify the source of the error and eliminate 
it from future work.
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Acids from lab stock
These were sampled from the pots used for experimental work within the 
laboratory. The aim was to attempt a pseudo-analysis of citric and ascorbic acid 
samples that had been exposed to the air and objects (spatulas). These acids 
are available for purchase in large quantities, for instance, Care branded citric 
acid which comes as a 50g quantity in a plastic bag within a cardboard box 
when purchased from pharmacies. This is sold to injectors requesting it. This 
container contains enough acid to prepare many injections. The powder itself is 
not sterile when purchased, it is classed as for ‘culinary use’, and once it is 
opened for use it will be liable to contamination from airborne micro-organisms.
In addition, organisms may be introduced by implements the users use to 
remove acid for preparation, or fingers used to pick ‘pinches’ of acid. In lieu of 
collecting samples of acids in use by users, the acids used for laboratory work 
were investigated for their microbiological content. These acids were a poor 
substitute on the basis that they had been treated very carefully during use, only 
coming into contact with clean laboratory spatulas, and stored in a cool, dark, 
dry environment. Therefore, the only means of potential contamination was from 
airborne organisms, so this work only provided an insight into organisms that 
could potentially survive in the acid material before its use to prepare injections. 
Investigation into acid samples from drug injecting environments would be 
important future work for identifying the risks posed by the use of these 
materials in this manner, as opposed to sterilised single use sachets.
Lemon juice samples
This was a separate exploration into the microflora of the lemon juice 
samples using the McLauchlin method. It would not be followed up by 
investigations into microflora within actual drug injections due to lack of available 
drug, however this would be suitable future work.
The lemon juice was investigated in respect to a number of reports 
(Gallo, Playfair, Gregory-Roberts, Grunstein, Clifton-Bligh, & Billson 
1985;Mellinger, De Beauchamp, Gallien, Ingold, & Taboada 1982;Shankland, 
Richardson, & Dutton 1986) that indicated that the use of lemon juice to prepare 
injections was responsible for systemic, ophthalmic and other Candida 
infections. Investigations attempting to isolate fungal organisms from lemon juice
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samples have previously been conducted, but this work differed from that 
through the use of a different method. Although the method uses many different 
types of media, the Sabouraud agar is specific to encourage the growth of fungi 
so was the most important media during this section of work.
Previous work (Collignon & Sorrell 1983;Shankland & Richardson 
1989;Shankland, Richardson, & Dutton 1986) has suggested that the growth of 
fungi occurred within the lemon juice container after opening and use. This was 
suggested on the grounds that the preservative escapes from the container 
once the seal has been broken. Therefore the older the container, the more 
likely there was to be fungal growth within the juice (assuming that an organism 
had entered the container). For this work, newly purchased containers of lemon 
juice were compared with containers that were six months old (still within best 
before date). The old containers had been opened previously for particulate 
matter investigations, therefore they would have possibly been exposed to 
contamination.
During the initial phases of the investigation, it was clear that there were 
differences between the two different types of juice. The new juice was light 
yellow in colour, slightly cloudy, with a lemon odour. The old juice was orange- 
yellow in colour, heavily cloudy with a putrid smell.
As with the other samples, the two different types of lemon juice were 
prepared using the two parts of method 1. The spread plating of the first liquid 
samples from each of the lemon juice types resulted in no growth at all.
The second part of the sample treatment involving the filtration was 
impossible to conduct using the old lemon juice as it blocked the 0.2pm filter 
required in both instances. This was due to particles within the solution. Given 
that the filtration was incorporated into the procedure to remove the organisms 
from the drug solution to provide them with a drug free environment in which to 
grow, it was considered that it was less crucial during this drug free 
investigation. Additionally, the organisms of interest within the lemon juice 
samples were fungi, and these would be grown on the Sab agar from the initial 
samples.
The initial samples from both lemon juices produced no growth on any 
plate. This was the point at which fungal growth would be expected on the Sab 
plate. Although the old lemon juice was particularly cloudy and foul smelling, it 
appeared that none of these changes occurred due to bacterial action as none 
were found.
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The samples of fresh lemon juice treated through the second sections of 
the produced growth on three plates from one sample- the method 2, 
unsteamed broth. These were not seen to be fungi, but bacterial rods. It is 
expected these were due to contamination of the samples.
The heroin powder
This was straight forward replication of the main work of McLauchlin. It 
was intended to provide a characterisation of the microflora present within the 
heroin samples provided by the police for this work.
The initial liquid samples produced no results. This demonstrated that 
either there were no viable organisms present within the drug samples, or that 
the drug present had an inhibitory effect upon the organisms present as has 
been suggested (Tuazon, Miller, & Shamsuddin 1980).
The broth samples produced the largest amount of results seen so far 
during the microbiology work. Growth was seen on 21 of 56 plates. It was clear 
that there were organisms present within the drug samples, and that the method 
successfully enabled their growth. This would enable the detection of these 
organisms from the prepared injections. If the organisms were able to survive 
the injection preparation method, then the results for the heroin injections would 
have been identical. Alternatively, the process might have affected certain 
organisms but not others, producing a different result to organisms seen from 
the drug itself.
Heroin injections
This investigation was conducted to a limited degree, but the results for 
this work were very promising, especially for the injecting drug user. There were 
no organisms detected from neither the initial samples, nor the incubated broths. 
Although one colony was seen, it was thought this occurred from external 
contamination, especially due to its location at the outer edge of the plate.
If repetition of this work produces the same results, from heroin with 
varied microflora, it would conclusive that the preparation of heroin in the 
manner demonstrated by the interview participants has beneficial effects in 
preventing the injection of many forms of bacterial and fungal contamination.
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5.6.2 Limitations
Although these results are insightful, it would be unwise to draw any 
conclusions from the outcomes recorded here without further work, especially 
repetition of the work. The inability, primarily due to time constraints, to repeat 
the work at least three times makes the results inconclusive.
5.6.3 Method 2
This investigation had two distinct parts, firstly the investigation of the 
ability of organisms introduced to survive in a heated acid solution, and secondly 
the ability of the organism to survive a drug injection preparation.
B. cereus was seen to not grow on spread plates of any of the neat 
solutions. It was also not found within the broth solutions. This suggests that the 
preparation process of heating alone must inactivate it. Given that McLauchlin 
found B. cereus in 95% of heroin samples tested, this is very positive with 
regard to heroin injectors.
The S. aureus results were less promising. Growth was found in the 
spread plate of the lemon juice solution, and also in the broths from citric acid 
and lemon juice solutions. The growth from the citric acid was confirmed as S. 
aureus. The growth from the neat solution of lemon juice was seen to consist of 
two organisms one of which was possibility S. aureus, the other was a Gram 
variable rod. The growth from the broth was found to only consist of Gram 
negative rods. It would appear that this organism was introduced by the use of 
the lemon juice, given its ability to survive the injection preparation, combined 
with the possibility that at least one S. aureus appeared to survive within the 
neat solution, lemon juice use amongst injectors should be more actively 
discouraged than it is currently.
The injection preparation has a less acidic pH than the acid solution 
alone, but as has previously been demonstrated by Tuazon (Tuazon, Miller, & 
Shamsuddin 1980), heroin has antimicrobial activity. Whether this would lead to 
organisms being inactivated during the injection preparation was unclear. 
Organisms may have been inhibited by the heroin or the environment within the 
injection solution, but not killed by the process. Once injected into the body they 
would be free to proliferate given the right conditions, as they would be removed
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from the injection environment. The first part of the this method assessed the 
affect the injection environment had upon the growth of these organisms, the 
second stage explored the growth of organisms that had survived the injection 
preparation out of the injection environment, hence postulating what organisms 
could proliferate after injection.
B. cereus was not seen to grow within the injection solution, suggesting it 
was inhibited by the environment. Spread plates of the broth suggested no 
growth from the citric acid solution, the ascorbic acid result being unclear. Streak 
plating of the broths produced growth results from both injections. Neither of the 
results were clearly B. cereus, but it indicates that at least two organisms, 
possibly three survived the injection process. In the absence of B. cereus it is 
likely the organisms were introduced within the drug sample.
The S. aureus samples produced growth from the neat ascorbic acid 
(none from the citric acid injection) and the broth samples showed clear growth 
of S. aureus on both the spread plates and the streak plates. Therefore it 
appears that it can survive the injection preparation. This has important 
implication for injectors. McLauchlin found Staphylococcus sp. in 40% of their 
heroin samples and Tuazon found them in 32% of samples, in addition they are 
very commonly found on the skin, so it is possible that they might transfer to 
injecting equipment when it is handled, for instance a spoon, and permeate an 
injection produced within it. This is of particular interest as Methicillin Resistant 
Staphylococcus aureus has been found in ulcers resulting from illicit injecting 
(Lettington 2002).
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5.7 Pharmaceutics and Physical Characteristics of illicit 
drug injections
5 .7.1 Pharmaceutical considerations of injection preparation
Parenteral administration of a substance into the body circumvents the 
natural defences of the body. It enables an injected product to come into direct 
contact with organs and tissues, which are protected from such interactions 
under all other circumstances.
The injection preparation is likely to present additional problems for the 
illicit drug injector. In addition to this, unsuitable substances and unsuitable 
injecting environment will be likely to compound issues. Factors such as 
insoluble particulate matter, or materials with extremes of pH when in solution, 
will lead to the preparation of a solution that may be dangerous to administer by 
the parenteral route.
All pharmaceutical products have to meet stringent criteria as set out in 
the corresponding pharmacopoeia such as the British or European 
Pharmacopoeia.
Aulton (Aulton 1988) suggests many factors that are important in the 
preparation of a parenteral product. Of these, the following appear to be the 
most relevant in the preparation of injections by drug users:
□ The proposed route of the injection (IV/IM/SC)
□ The volume to be injected
□ The vehicle in which the drug is dissolved
□ Particulate contamination
□ The pH and osmolality of the injection solution
The route of administration
The injection route can vary; it is not limited to the intravenous route 
which is commonly used. Intravenous injectors with reduced venous access may 
resort to using the subcutaneous route. This can prove more dangerous than the 
iv route, as the damage caused by subcutaneous injection is much greater 
(Derricott, Preston, & Hunt 1999) and can lead to problems such as abscesses.
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Subcutaneous and intramuscular injections carry the risk of infection by 
anaerobic organisms, which would not occur if the same preparation was used 
intravenously, including botulism (1995) and Clostridium novyi as discussed in 
section 5.1.2. Particulate matter will stay at the site of an extravascular injection 
over time, forming granuloma (Posner & Guill, III 1985).
Injection volume
The volume of injection solution is highly important. The volume to be 
injected tends to prescribe the route used- large volumes have to be 
administered intravenously, as they would be too painful subcutaneously or 
intramuscularly. To inject into muscle or subcutaneously, it is necessary to use a 
small volume which could be more concentrated, with a higher osmotic 
pressure, and therefore potentially more damaging. Injection of large volumes 
into an unsuitable site will increase the risk of physical damage to the tissue- 
injection of a large volume into a small vein, such as those in the feet, is a 
hazardous practice. In addition to this, the larger the injection volume, the longer 
the time the injection time will be, leading to more opportunity for damage to 
occur to the tissue being injected into, for instance, the longer the needle is in a 
vein the higher the risk of movement of the needle causing damage to the inside 
of the vein.
The common use of 1ml insulin syringes suggests many users tend to 
inject small volumes, however, injection of larger volumes will occur under 
certain circumstances, for example during the injection of solutions made from 
crushed tablets. Cyclizine tablets have a very low solubility and it is 
recommended that each tablet be dissolved in 1ml of water (Pearson, Gilman, & 
Traynor 1990). As users may inject ten to fifteen at once (ibid), this will result in 
an injection of a very high volume. Similarly, to discourage injection, oral 
methadone solutions are made relatively dilute. For any suitable dose of these 
to be injected, a large volume will have used.
Injection vehicle
The vehicle in which the drug is dissolved is important with regard to 
safety in terms of infection risk. Depending on its source, water may introduce 
contamination to an injection solution, for instance, dirty water, or water that has
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been sitting in an open container. Distilled water or bottled mineral waters are 
potentially more hazardous than fresh water straight from the tap. Tap water has 
been chlorinated to kill micro-organisms to prevent diseases such as cholera.
Water for injections is the most suitable type of water, but as this is 
classified as a prescription only medicine (1968), it cannot easily be obtained for 
use, although June 2005 changes in legislation have its supply from needle 
exchanges (2005a). Harm reduction advice (Derricott, Preston, & Hunt 1999) 
recommends boiling water in a pan with a lid then leaving it to cool.
Sharing sources of water is another opportunity for infective organism 
transmission between injectors. Sharing can lead to the transmission of all major 
blood-borne viruses including Hepatitis B & C and HIV/AIDS, and it has been an 
important area in which harm reduction workers have focused in attempt to 
reduce these infections.
Pharmaceutics -  Drug constituents
The preparation of any drug for injection introduces problems regard to 
its chemical form. Drugs found on the illicit market are rarely pure (Kaa 
1994;King 1997;0'Neil & Pitts 1992). They are usually a combination of the 
drug, in varying concentrations depending on many factors such as which drug it 
is and its source, along with production by-products (impurities), various diluents 
that may have been added to increase the volume of drug, and general 
dirt/contamination that has mixed with the drug during its manufacture, 
transportation and storage.
The injection of oral preparations such as tablets and solutions pose 
particular hazards. Tablets have many excipients added to produce different 
pharmaceutical effects, such as slow release, or simply to hold the tablet 
together. These substances never normally enter the blood stream from oral 
ingestion of the tablet as they are insoluble, but when injected pose a high risk. 
Examples of such products include dicalcium phosphate (a diluent), 
microcrystalline cellulose (diluent), fumed/colloidal silica (a glidant), magnesium 
stearate (a lubricant), talc (lubricant) and stearic acid (lubricant)- at least one of 
these products is likely to be found in any given tablet, and they are all insoluble 
in water.
Commonly injected oral formulations include benzodiazepine tablets 
(Ross, Darke, & Hall 1997), sublingual buprenorphine tablets (Vidal-Trecan et al.
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2003), Diconal® (a combination tablet containing an analgesic (dipipanone), and 
an anti-sickness drug (cyclizine)) and temazepam. The hazards of injecting 
Diconal were noted by Marjot (1978), who reported complications such as 
damage at the site of injection, including thrombosis and inflammation, vascular 
damage to lungs, lymphoedema, as well as deaths.
The injection of the hypnotic drug temazepam from liquid-filled capsules 
led to a spate of problems in the late 1980s. Its intravenous injection was first 
reported by Robertson et al. in 1987, and detailed by Stark et al. (1987), who 
noted that users had progressed from swallowing the liquid filled capsules, to 
extracting their contents with a syringe and injecting it. At the peak time of the 
message of HIV spread though heroin injecting, these temazepam injectors 
believed they were safe from infection as they were not using heroin (ibid). The 
liquid had a high viscosity, therefore a wide bore needle was required to draw it 
up and inject it. There were reports of users injecting up to ninety 20mg 
capsules per day (Farrell & Strang 1988) with many resulting complications such 
as abscesses and thrombophlebitis.
In an effort to cut down this abuse, the pharmaceutical companies 
reformulated the capsules to contain a thick gel (Gelthix®) instead of the liquid. 
This was done as it was impossible to draw the gel up into a syringe. Despite 
this, injectors of temazepam developed measures that enabled the gel to be 
injected. Most shook the gel in the syringe with boiling water, but other 
techniques used include heating it in a spoon, heating it with citric acid and 
vinegar, or using the alcohol from pre-injection swabs to liquefy it (Ruben & 
Morrison 1992). Injection of both liquid and gel filled capsules caused problems 
such as thrombosis and abscesses, and 25% of people interviewed by Ruben 
and Morrison who had injected the contents of gel-filled capsules had suffered a 
deep vein thrombosis. In an effort to use the thick solutions, the users turned to 
using large veins, such as the groin, to accommodate the large needles required 
to prevent blockage. This also led to accidental arterial injections, due to the 
anatomical proximity of these two femoral vessels. Once injected, the solubility 
of the gel decreased leading to it resolidifying after entering the vein. This effect 
resulted in serious complications such as compartment syndrome, 
rhabdomyolysis, deep vein thrombosis (DVT) and pulmonary embolisms. 
Treatments employed to treat the intra-arterial injections involved patients 
undergoing fasciotomies, amputations and haemodialysis (Scott et al. 1992).
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Particulate contamination
In 1963, Garvan and Gunner published an article on extraneous 
particulate matter within injectable products. This was the first paper addressing 
the issue are particles within injectable products. This brought the matter to the 
attention of regulators and industry. Subsequent work investigated the effects of 
injection of particles of various sizes.
Standards for particulate content within injectable products were 
introduced into the British Pharmacopoeia in 1973.
The danger posed by particulate matter within injections is a matter of 
debate. The exact risks posed by injections containing small numbers of small 
particles are unclear, but injection large particles will clearly present more harm. 
The use of illicit injections is one of the main sources of information on the 
subject as drug injectors, especially those injecting crushed tablets, have 
enabled the observation of the results of high particulate injections.
Particulate matter injected into veins passes through the venous system, 
into the pulmonary artery to the lung where they will lodge in the arterioles or 
capillaries depending on their size. Smaller particles, less than approximately 
8pm, will pass through the capillaries, back to the heart and then travel round 
the body via the arterial circulation. Depending on its size, the particles will lodge 
in a capillary vessel, or be ingested by circulating phagocytic cells or tissue 
phagocytes, such as the Kupffer cells within the liver.
Accidental injection into an artery is a serious event, especially if the 
injection solution contains a large amount of particulate contamination. 
Accidental injection into the femoral artery is commonly reported in illicit drug 
injectors who use the femoral vein. This leads to particulate matter obstructing 
the arterioles and capillaries down the leg, into the feet and toes. These 
blockages result in reduced blood flow, leading to widespread ischaemic 
damage, gangrene, deep vein thrombosis and may require amputation of the 
limb.
The effect of pH and osmolality of an injection upon veins
The pH and osmolality (Osmotic pressure) of an injection can be used to 
determine how irritant an injection will be upon administration (Kuwahara et al. 
1998). The majority of work conducted in this area has investigated large
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volume parenterals, particularly nutrition fluids. The effect these have is more 
profound as the blood vessels have extended contact with the solution due to 
the continuous flow. Smaller volume injections are expected to have less of an 
effect due to the rapid dilution of the solution once injected into a vein. The effect 
of injecting illicit drug solutions has shown that despite their small volume they 
are able to produce phlebitis, which can lead to thrombophlebitis (Derricott, 
Preston, & Hunt 1999;Scott & Bruce 1998).
Osmotic pressure is measured in units of milli-osmoles per litre 
(mOsmol/l). The osmotic pressure of plasma is within the range of 290- 
310mOsmo/l. It is recommended that any fluid with an osmotic pressure above 
550 mOsmo/l should not be injected rapidly as this would increase venous 
damage and ideally injections and infusions should be between 300-500 
mOsmo/l (Florence & Attwood 1998). Injections with a higher osmolality should 
ideally be administered very slowly to allow adequate time for dilution in blood.
5.7.2 Illicit injection investigations
To explore the risk posed by injection posed by illicit heroin injections, 
three areas of risk were assessed. These were the particulate content of the 
injections, the pH of the injections, and the osmolality of the injections.
5.8 Sub-visible particle investigations
5.8.1 Methodology
Previous work exploring particulate matter within illicit drug injections 
(Scott et al. 1997) used the electrical zone sensing (Coulter) principle. This 
process allows the determination of the size and number of particles in a 
solution. It achieves this by passing the solution through a small orifice that 
separates two electrodes, as the particles pass through the orifice, the change in 
resistance can be measured. This change in resistance allows the calculation of 
the particle size, and the number of resistance changes corresponds to the 
number of particles present.
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The main drawback of this method is that the solution must conduct 
electrical current. If the sample does not conduct current sufficiently, it requires 
dilution with an electrolyte solution, usually sterile saline. This present two main 
problems; firstly the saline can affect the solubility of the contents of the sample, 
possibly leading to some precipitation of dissolved material, and secondly, the 
electrolyte itself adds particulate matter to the sample which needs to be 
subtracted from the sample result (background reading).
The British Pharmacopoeia used the Coulter principle as the method of 
particulate matter measurement until 1998. The method was superseded in the 
1998 BP by methods based on light extinction. These methods involve the 
passing of the sample through a narrow glass tube illuminated by light on one 
side and a photodiode detector on the other. As the particles pass through the 
tube, they obscure the light, reducing the intensity of the beam reaching the 
photodiode. The change in the voltage flowing through the photodiode 
constitutes the size measurement. The number of measurements corresponds 
to the number of particles detected.
The primary advantage of this technique is that it involves no sample 
pre-treatment. The injection solutions can be analysed in exactly the form they 
would be administered, providing a true assessment of the particulate matter 
risk posed.
British Pharmacopoeia specifications
The BP (2000) contains three different tests for particulate matter within 
parenteral preparations. The first (Test A) applies to infusions or solutions for 
injection of volume over 100ml. The second (Test B) applies to infusions or 
solutions of less than 100ml. Test C applies to the testing of injections prepared 
from powders which are dissolved in a solvent immediately prior to injection.
Of these, the requirements for test C would be applied to the testing of 
the drug injection solutions. The conversion of the drug from powder to liquid 




To perform the BP assay, four samples of not less than 5ml are 
analysed, with the results for the first sample being disregarded and the average 
for the remaining three being the test result.
A preparation complies with the test if the average number of particles 
present in the units tested does not exceed 10,000 per container equal or 
greater than 10pm, and does not exceed 1000 per container equal or greater 
than 25pm.
The contents of the ‘container’ in this situation were the 130mg sample of 
heroin (when used), and the other materials which are used to prepare a single 
injection.
A single injection will not produce 5ml for analysis. Pooling of solutions is 
used to increase the volume for the BP investigations, but this was not 
considered appropriate for this work. The time taken to produce each injection 
would result in cooling of solutions before mixing. This may have resulted in 
precipitation of the dissolved solids. Additionally the effect of mixing different 
injection solutions may have resulted in precipitation, for instance due to the 
common ion effect.
Considering a typical prepared injection resulted in a volume of less than 
0.8ml, it was necessary to measure the quantity of particles in 0.1ml. In order to 
define test limits on this volume, it was chosen to equate the BP limit to that of a 
0.1ml injection. Therefore, for 10pm or greater where the BP states the limit is 
10000 per 5ml, this will be 200 particles per 0.1ml. For 25pm or greater, the limit 
is reduced to 20 per 0.1ml.
Illicit injections were not expected to conform to these limits, but the 
analyses would provide information on the particulate contamination of a typical 
injection and allow relative comparison with the limits placed on pharmaceuticals 
to present minimal ‘risk’.
The environment in which the analysis is performed is also assessed by 
the BP method. Before any sample analysis is performed, particle free water 
should be examined to ensure that less than 25 particles of 10pm or above are 
measured in 25ml of the water. If the number exceeds this, the environment is 
contributing too much particulate contamination and conditions need to be 
altered to reduce this.
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Apparatus
To perform these measurements, a Particle Measuring Systems 
Automated Parenteral Sampling System (APSS) 200 syringe sampling system 
was used. This system allows the measurement of particles in volumes of liquid 
from 0.1ml to 1000ml, and can size particles from 0.2pm to 125pm. The small 
sample volumes used by this machine make it particularly advantageous to the 
testing of the small volume injections that are produced by illicit drug injectors. 
The measurement of the particles in 0.1ml allows for the measurement of the 
number of particles in four portions (with the results obtained for the first portion 
being discarded as per the BP method) from one typical 0.8ml injection, without 
risk of drawing air bubbles through.
The APSS works by drawing the sample through a sample tube, to a 
detector, into a graduated syringe, then finally into a waste bottle. The syringe is 
motor driven by the machine and controls the sample volumes drawn into the 
sample tube. The system conforms to the BP (2000) specification, using light 
extinction as the method of particulate examination. For this purpose, the 
system uses a laser diode to produce a laser beam as the source of light.
The APSS system is controlled through a computer interface. This allows 
the configuration of every aspect of the machine. The results are displayed 
graphically as the machine conducts sample analysis and also during machine 
flushes, as a count of particles of certain sizes. The data is output in the form of 
a ‘common separated values’ (*.csv) computer file without the graphical data.
Channel data
The APSS-200 computer software allows the programming of ‘channels’ 
that can be adjusted to measure particles of different sizes. Each of the fifteen 
channels can be adjusted to count particles of a set size and above as far as the 
next channel setting. For instance, the detector can be set to measure 2pm 
particles and 3pm particles. However, the output data for the 2um channel will 
be a count of all particles between 2pm and 2.99pm in size. The 3pm channel 
count will cover particles 3pm and larger. Channels can be set to measure 
particles between 2pm to 125pm. Except for the validation (where channels 
chosen to best measure the known particle sizes were chosen), the channel
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settings were kept at the default program settings to avoid each of the laboratory 
users having to change these settings between uses. As previously stated, the 
particles studied were limited to those outlined in the BP, that is particles of 
10pm and greater, and 25pm and greater.
5.8.2 Materials
Standard equipment for injection preparation, including spoon, 1ml insulin 
syringes (B-D) and Swan® extra slim roll-up cigarette filters.
Screen wash (for cars, containing detergent, and ethanol/methanol) (Halfords) 
Water for injection (Fresenius Kabi)




The APSS was prepared for use by flushing the system using the screen 
wash solution as recommended by the APSS manufacturers, followed by 
flushes of particle free water. The flushing of the system using WFI allows the 
user to ensure the machine is producing acceptable results before every sample 
run. The flushing of the WFI washes any residual particles out of the system, 
whilst the computer output confirms low particle counts.
5.8.4 Sample preparation
The samples for analysis were placed in new centrifuge tubes for use. 
Before use, each tube was rinsed three times using particle free water. The 
sample was then placed into the tube and the tube sealed. Gas bubbles in the 




For analysis of all samples, the machine was fitted with a 1ml sample 
syringe, which enabled 0.1ml to 1.0ml sampling. The volume of the sample 
analysed depended upon the sample itself. Those in unlimited supply, for 
instance, WFI and the acid solutions, were analysed by the millilitre i.e. 1ml was 
the sample volume. For samples of limited volume, such as the prepared 
injection solutions, the sample volume was reduced to 0.1ml.
It is also important to note that the sample has to pass up a sampling 
tube before reaching the detector. This can be a problem when the volume of 
sample available is very small. The BP test stipulates that four measurements 
are taken from each sample, with the first result discarded, and the average of 
the remaining three calculated. To enable measurement of particles, the solution 
needs to be flowing through the detector during the time of measurement. 
However, given the internal volume of the sample tube, and the small volume of 
sample available, it would be possible for the measurement to be carried out on 
air instead of sample solution on the first and/or last samples.
To minimise the possibility of this, a custom modified sample tube was 
used, which was shorter than that usually used with the machine. The internal 
volume of the sample tube was approximately 0.4ml, therefore the machine 
required 4 additional sampling steps before the results could be recorded as the 
sample had yet to reach the detector. Once the method had been programmed 
into the computer it was found to work well, and produce repeatable results.
Before each sample was analysed, samples of WFI were run, and the 
output was checked to be within the range for a sample of WFI (less than 25 
particles 10pm or greater in size per 25 millilitres of solution). Once this baseline 
was established, the machine was ready to analyse a sample. Before the 
sample was run, the machine was prepared by leaving a gap of air within the 
machine to prevent any mixing of the solutions within the sample tube prior to 
analysis.
When ready for analysis, each tube was opened and the sample tube 
inserted approximately 3mm from the bottom of the sample container. The open 
neck of the container was sealed using Parafilm® to prevent particulate 
contamination from the laboratory air, or the machine operator.
The sampling procedure was then initiated using the computer program. 
Once the sampling was complete, the machine was flushed using WFI. If the
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sample under analysis produced large counts of particulates in WFI after several 
flushes, the machine would be rinsed using the screen wash solution. Further 
sample analysis would only be undertaken once WFI count levels returned to 
the acceptable limits described above.
5.8.6 Investigations
Firstly, to assess the likely background readings that would be obtained 
from the samples, particles in WFI were measured to establish limits on the 
numbers of particles that would be introduced into solutions when working with 
them, contributed by the operator and the environment. Particulate contribution 
by the equipment used during the processes was also assessed, including the 
syringes and eppendorf tubes, to measure their contribution to overall particulate 
count.
Secondly, particles present in WFI after drawing through various filters 
was measured to establish the effect the act of filtration had upon the particle 
content of injections. This was of interest as filters are used by injectors 
specifically for the purpose of removing particulate matter from their injections 
before use.
Thirdly, the first section of injection tests involved the testing of acid 
solutions without the use of drug. This provided information on the particulate 
contribution of the acids to the injection solutions.
Finally, the most important section of tests investigated the particles 
present in injections prepared in an identical matter to those of illicit injectors 
using illicit drug material.
5.8.7 Samples investigated 
Standard solutions
(Samples analysed as 1ml of solution in order to obtain more accurate results, 
and as quantity was not an issue)
Water for Injection controls (WFI)
WFI from glass beaker (control)
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WFI from rinsed centrifuge tube (control of sample container)
WFI from rinsed centrifuge tube via syringe and spoon (1ml drawn up into 
syringe, put into spoon, then redrawn up into syringe, then transferred to 
centrifuge tube) (control of injection procedure)
Filter solution controls
WFI drawn up into syringe from spoon through 173rd of Swan filter -  through 
outer side
WFI drawn up into syringe from spoon through 1/3rd of Swan filter -  through 
inner side
WFI drawn up into syringe from spoon through whole Swan filter 
WFI drawn up into syringe from spoon through 2mm circle of Marlboro® filter 
(cut from the end of the filter, leaving the cigarette intact, but with a shorter filter) 
WFI drawn up into syringe from spoon through cotton wool taken from a ‘cotton 
bud’
WFI drawn up into syringe from spoon through a Sterifilter®
Acid solutions controls
75mg of citric acid in WFI heated in spoon unfiltered
75mg of citric acid in WFI heated in spoon filtered through 173rd Swan roll 
up filter (ripped side down, outer side)
170mg of ascorbic acid in WFI heated in spoon unfiltered 
170mg of ascorbic acid in WFI heated in spoon filtered through 173rd 
Swan roll up filter (ripped side down)
Heroin injection investigations
130mg Heroin prepared with 70mg of citric acid, unfiltered 
130mg Heroin prepared with 70mg of citric acid filtered with a Sterifilter® 
130mg Heroin prepared with 70mg of citric acid filtered with a portion of 
cigarette filter
(The experimental work was conducted as part of a different investigation into 
particulate matter within injections depending on the use of different filters. The
190
work was conducted using 70mg of citric acid instead of the usual 75mg. Due to 
lack of drug the experiment could not be repeated using 75mg citric acid.)
Three solutions of each sample were analysed, each using the B.P. method of 
three measurements of each sample.
5.8.8 Validation
The APSS machine is calibrated yearly by the manufacturers, during this 
process, the machine is used to count the number of particles in a standard 
solution with known numbers of particles of known size. The results from the 
machine are used to produce a ‘calibration file’. The calibration file is used by 
the computer software during the computation of the data received from the 
detector to give the true reading of particles within the sample. It is not possible 
for people other than service engineers to perform this calibration. The APSS 
was under valid calibration certification during the period of this work.
In order to validate the output of the machine, it was possible to ensure 
that the size measurement of the machine was correct. By using solutions 
containing latex beads of a known size it was possible to assess the output of 
the machine. The latex beads are purchased as a suspension in a small dropper 
bottle. To form a solution for validation, a small drop from the bottle was placed 
into 100ml of particle free water. The number of beads in one small drop was 
adequate for achieving high, clear readings from 1 ml of the water.
During the manufacture of the standard solution the number of latex 
beads added to the diluting water cannot be controlled. Therefore, this method 
cannot be used to validate the number of particles counted by the machine. The 
size of the drop of bead solution used, the level of mixing of the bead solution in 
the dropper bottle (for instance, due to inadequate shaking), and the mixing of 
beads within the sample solution can all lead to different results.
Solutions of beads 5.0pm, 10.0pm and 16.7pm in size were available for 
use. As stated, solutions were made by dropping one drop of these suspensions 
into 100ml of particle free water. Samples of 1ml were analysed four times, with 
the first reading being discarded as per BP requirements. The size 
measurement channels were adjusted for the validation to measure the particles 
as accurately as possible given their known size. If the machine measured these 
particles as a different size, the accuracy of all of the measurements would be in
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doubt. The channels of detector were adjusted from the standard settings to 
provide a good spread around the three particle sizes in use. The channels used 
were: 2,4, 5, 6, 7, 9, 10, 11, 13, 14, 15, 16, 17, 20, 25pm.
5.9 Results
5.9.1 Validation
During validation of the APSS machine, it recorded the number of particles of 
each size as shown in the following graphs. Figure 20 shows the results for the 
5.0pm bead solution, Figure 21 the results for the 10.0pm solution and Figure 22 
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Figure 22 Particle distribution in 1ml samples of standard solution containing 16.7pm 
latex beads
The analysis of these solutions by the APSS-200 demonstrated that it 
was calibrated to measure the size of particles correctly.
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These results were consistent through both the measurement of the 
different standards and consistent on a day to day basis.
5.9.2 Sample results
The following results are presented in three forms. Firstly, the tables 
within each section display the number of particles in the injection as specified 
by the BP (numbers above 10pm and above 25pm). Secondly, these results are 
displayed graphically. Thirdly, the final sets of tables show statistics relating to 
the 10pm (10.00 to 14.99pm) channel and the 25pm (25.00 to 29.99pm) 
channel.
5.9.3 Water for Injections investigations 
WFI from beaker (control)
This served as the environmental control, in addition to the measurement of 
particles in water for injections. A 100ml glass beaker was washed three times 
with WFI, then filled with approximately 50ml of WFI and covered with parafilm. 
This was then analysed.
WFI from plastic eppendorf tube
An eppendorf tube was washed three times with WFI, then filled with 1ml of WFI 
which was sampled. This would establish the particulate contribution of the 
eppendorf tube to all samples analysed from these tubes.
WFI from spoon via syringe
An identical spoon to that which would be used to prepare injections was 
washed three times with particle free water. One millilitre of WFI was drawn up 
into a 1 ml disposable syringe. This was gently pushed back out of the syringe 
into the bowl of the spoon, then gently drawn back up into the syringe. The 
water was then gently squirted into a WFI washed eppendorf tube for sampling.
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Table 24 BP particulate limit results for WFI solutions
Particle size WFI from beaker WFI from plastic W FI from spoon via
eppendorf tube syringe
Over 10pm 0.067 0.778 3.444






WFI from spoon via syringe
Over 10pm Over 25pm
Figure 23 Number of particles in various WFI solutions
Table 25 Descriptive statistics for particulate content of WFI solutions
Sample Particle size over: Minimum Maximum Mean Std. Deviation
WFI from 10pm 0.00 0.00 0.00 0.00
b ea k e r 25pm 0.00 0.00 0.00 0.00
WFI from  tube 10pm 0.00 1.33 0.556 0.694
25pm 0.00 0.00 0.000 0.000
WFI from  spoon 10pm 1.67 5.00 3.11 1.711
via syringe 25pm 0.00 0.00 0.000 0.000
The result for the WFI from the beaker was the confirmation that the 
environmental conditions for the particulate work were suitable. The result of
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approximately 17 particles of 10pm or over per 25ml was well within the BP 
stipulated maximum of 25.
5.9.4 Water through filters
Seven different filters were used to filter WFI for analysis. For each of the 
following experiments, the tea spoon and eppendorf sample tubes used were 
rinsed three times with WFI prior to use.
WFI from spoon filtered through inner side of ripped Swan filter 
One millilitre of WFI was drawn up into a syringe, and gently squirted into the 
bowl of a spoon. Approximately 1/3rd of a Swan roll up filter was ripped off a 
complete filter and placed ripped side up into the water. The syringe was then 
used to draw the water through the filter and back up into its barrel. This water 
was squirted into an eppendorf tube for analysis.
WFI from spoon filtered through outer side of ripped Swan filter
This was performed in exactly the same way as above except, the section of
Swan roll up filter was placed ripped side down into the water.
WFI from spoon filtered through whole Swan filter
This was performed in exactly the same way as above except, a whole Swan roll 
up filter was used.
WFI filtered through 2mm slice of Marlboro 'light'filter
These samples were prepared using a 2mm thick circular slices cut from the end 
of cigarettes.
WFI filtered through cotton wool from cotton 'bud'
This sample was prepared using the cotton wool from the end of a Johnson & 
Johnson cotton bud.
WFI filtered through a Sterifilter®
This sample was prepared using a Sterifilter® from Exchange supplies.
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Table 26 BP particulate limit results for WFI passed through various filters
Particle WFI WFI WFI W FI WFI WFI WFI W FI
Size from from through through through through through through
beaker spoon Outer Inner Whole 2mm Cotton Sterifilter
via side side Swan cig slice Wool
syringe Swan Swan
Over 0.067 3.444 1.800 0.600 236.600 5.533 19.933 21.000
10pm
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Figure 24 Number of particles in WFI filtered with various filters
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Table 27 Descriptive statistics for particulate content of WFI passed through various
filters
Sample Particle size over: Minimum Maximum Mean Std. Deviation
WFI filtered 

































































Four different acid solutions were prepared for analysis:
Citric acid un filtered
75mg of citric acid was placed into the spoon, 0.85ml of WFI was added using a 
syringe and the solution heated until the acid dissolved. The sample was drawn 
up into the syringe and transferred to an eppendorf tube for sampling.
Citric acid filtered
This was prepared as above, but the solution was drawn up from the spoon 
through 1/3rd of a Swan filter placed ripped side down, as witnessed in the 
injector interviews.
Ascorbic acid unfiltered and ascorbic acid filtered
These were prepared as above, but with 170mg ascorbic acid in place of the 
citric acid.
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T a b le  2 8  BP oarticulate limit results for acid solutions
Particle Size Citric Acid Citric Acid Ascorbic Acid Ascorbic Acid
75mg/0.85ml 75mg/0.85ml 170mg/0.85ml 170mg/0.85ml
unfiltered filtered unfiltered filtered
Over 10um 8.111 9.444 336.444 314.667





I Citric Acid 75mg/0 85ml unfiltered 
I Citric Acid 75mg/0.85ml filtered 
Ascorbic Acid 170mg/0.85ml unfiltered 
I Ascorbic Acid 170mg/0.85ml filtered
Over 10pm Over 25pm
Figure 25 Number of particles in various acid solutions
Table 29 Descriptive statistics for particulate content of various acid solutions
Sample Particle size over Minimum Maximum Mean Std. Deviation
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The graph below depicts the spread of particulate matter found within 
three heroin injections prepared without filtration. This gives a baseline for the 
injections prepared using filters. The markers are spaced at the mean point of 
the channel range, and for this point it is important to note that the results placed 
at the 72.5pm range cover all particles measured above 30pm up to the APSS- 
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Figure 26 Distribution in size of particles in three unfiltered illicit heroin injections
Three illicit heroin injections were prepared for analysis. The first was unfiltered, 
the other two injections were prepared using two different filters.
Heroin prepared with WFI and 75mg of citric acid unfiltered
Heroin prepared with WFI and 75mg of citric acid filtered using 173rd Swan roll up
cigarette filter
Heroin prepared with WFI and 75mg of citric acid filtered using a Sterifilter
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Table 30 BP particulate limit results for heroin injections filtered with various filters
Particle Size Heroin Heroin Heroin
Unfiltered Sterifilter Swan filter
Over 10pm 700.000 276.667 1281.000





Over 10pm Over 25pm
Figure 27 Number of particles in heroin injections when filtered using various filters
Table 31 Descriptive statistics for particulate content of illicit heroin injections prepared 
using different filters









































The initial measurements of the WFI from the beaker confirmed that the 
conditions under which the particulate analyses were conducted were suitable 
and would introduce minimal contamination into the samples. This was also 
important as it proved that the conditions under which the injections were 
produced (in the same laboratory) would not introduce contamination. The 
majority of particles measured within samples would have been introduced by 
the materials or equipment used in the preparation process.
The WFI sampled from the plastic sample tube showed an increase in 
particulate matter by approximately ten times that of the water from the glass 
beaker. This was most likely to have been the result of particles from the inside 
of the tube passing into the solution. The tube was washed with WFI three times 
prior to use as per BP specifications, but these particles remained, to pass into 
the solution. The particle counts were still within the BP limits.
The third manipulation of the WFI gave an indication of the particles 
introduced to the WFI from the spoon, the syringe and the exposure to the air 
during its movements. The results showed that of these three experiments, the 
WFI that had been placed into the spoon had the largest particulate counts. 
These counts were within the BP limits.
The use of filters led to a significant increase in the particulate content of 
the solutions. Although filters are used to remove particles from solutions, this is 
done at the expense of contributing some.
The Swan filter that was used by the majority of interviewees was tested 
for use in three manners. Although the use of a ripped filter with the ripped side 
up was considered to result in fibres being drawn up directly into the syringe, 
this was not borne out by the results. The use of the filter ripped side down 
resulted in three times as many particles 10pm or greater within the injection 
solution than the filter used ripped side up. The ripped side up filter did however 
show some particles above 25pm in side, the first detected in the investigations. 
From the raw data results it was seen these were above 30pm in size. The use 
of both filters still produced results within the BP limit for particulate content. It 
can also be seen that the numbers of 10pm particles are less than those 
recorded from WFI from a spoon unfiltered. It appears that they are acting to 
filter particles from the solution that have been contributed by the syringe, as the 
water is drawn up and particles from the spoon.
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The use of a whole filter resulted in significantly increased particulate 
matter within the injection solution. For particles of 10pm or greater in size it 
exceeded to BP limits. This is postulated to have occurred due to the solution 
passing through more filter material, increasing the number of particles 
transferring into the solution. The number of particles within the solutions with 
the highest particle counts was significantly higher than the equivalent results for 
the ripped filters. Theoretically, the solution has to pass through 2 (3 thirds of 
filter) more layers of filter then with the ripped filters and would therefore be 
expected to contain approximately three times the amount of particles, but the 
measurements indicated significantly more than this. The reason for this is 
unclear.
The results from the use of a 2mm circle cut from the end of cigarettes 
showed an increase of the number of 10pm or greater particles over the use of 
WFI alone. Particles of 25pm or greater were also detected indicating these 
filters are both ineffective at filtering the solution and that they contribute to the 
overall particulate content.
The use of the cotton wool from a cotton bud was witnessed during the 
interviews by four participants. The use of cotton wool from this source raises 
questions about the possibility of the presence of glue used to bind the material 
to the plastic tube. This could possibly contribute particles to the solution, or 
dissolve into the injection solution. The results show a large number of 10pm or 
greater than the ripped Swan filters or WFI alone, but they were well within the 
BP limits.
The Sterifilter solution was found to contain a large amount of 10pm or 
greater particles as well having the highest counts for 25pm or greater particles 
than any of the other filters used. Both were within BP limits.
The investigation of the acid solution shows a difference related to the 
solubility of the acids. Citric acid which has the higher solubility of the two had 
low particulate counts, well within the BP limits, and the filtering of these 
solutions was seen to increase the particulate content due to the contribution 
from the filter material. The ascorbic acid had much higher counts for both levels 
of particle size, with the numbers of particles of 10pm or greater in both 
unfiltered and filtered solutions exceeding the BP limits. The filtering of the 
ascorbic acid solutions however did demonstrate that the use of the cigarette 
filter could reduce numbers of particles in both size ranges (over 10pm and over 
25pm) despite the particulate contribution of the filter. The level of both particle
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sizes in the filtered solution was less than that of the unfiltered solutions in 
contrast to that of the citric acid.
The results for the work with the heroin injections were the pinnacle of 
the work. The results for this demonstrated the effectiveness of the Sterifilter in 
respect to the use of cigarette material. The heroin injection solution that was 
unfiltered had a mean count of 700 particles for particles sized 10pm and 
greater, and 719 particles for particles of 25pm and greater. These are 
significantly higher than the BP limits, especially for the larger particle size.
The Sterifilter reduced the number of 10pm or greater particles by over 
half, although it was not able to reduce the number to meet the BP limit.
Particles of 25pm or over were significantly reduced and to under the BP limit.
The use of the cigarette filter contributed to the number of particles 10pm 
or greater in size, therefore potentially posing more risk than using an unfiltered 
injection. However, it was useful in reducing the number of larger particles to 
approximately a third of the levels of an unfiltered heroin injection.
5.10.1 Filtration of injections discussion
The more manipulations a solution is put through, the more particles that 
are found in the solution, due to particles entering the solution from the surfaces 
it comes into contact with and from the air. This is demonstrated by the first set 
of water measurements, however, for illicit injectors, these factors are almost 
irrelevant as it would be impossible to reduce them. Injection preparation within 
a particle free environment as found in the pharmaceutical industry is not an 
option or consideration. Dirty equipment and environments are likely to add to 
the numbers of particles found within injections.
The use of filters was seen to add particles to the injection solutions. 
Filters should ideally remove particles from solutions, without adding particles of 
their own. It is clear none of the filters used by injectors are ideal; however, the 
most commonly used filters- ripped sections of Swan filters and slices of 
cigarette filter- contributed lower numbers of particles than the alternatives.
The use of a whole Swan filter demonstrated that the more of the Swan 
filter material the liquid passes through, the more particles that are shed into the 
solution. The use by injectors of a whole filter was found to be uncommon during
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the interviews, probably due to its level of fluid retention. This may prove to be 
beneficial for injectors, as they will be unaware of its particulate contribution.
Cotton bud cotton wool was expected to introduce particles. The method 
of pulling the fibres off the rod with the fingers and rolling them into a ball were 
expected to add particles, and it is probable that there is glue present on the 
fibres that may pass into the solution. The high number of particles measured in 
the test solutions was expected. The use of cotton wool by injectors is already 
discouraged and this work demonstrates this is valid advice.
The testing of the Sterifilter® revealed that it does appear to shed 
particles into the injection solution, but its effect of filtering out the particles from 
the heroin injections proved to be highly superior to the filtering effect of 
cigarette material.
When the number of particles contributed by a filter to the injection 
solution is compared to those present within a prepared injection solution it is 
clear that they are a very small proportion. Therefore, the shedding of the 
particles is of less importance than the ability of the filter to remove particles 
within the solution.
The Sterifilter supplied as a sterilised package for single use is the best 
filter to recommend IDUs to use. Although it was unable to enable injections to 
pass the BP limit for particles of 10pm or greater, it made a significant reduction 
on the numbers present within an injection. More importantly it reduced the 
number of larger particles to approximately half the BP limit, and as these 
particles are more likely to lead to complications than smaller particles this is a 
crucial point. Combined with the sterility of this product, it is the ideal choice for 
use.
5.11 Laboratory investigations of injection pH
5.11.1 Introduction
During the interview stage of this project, the interviewees were found to 
use three different acidifying agents, namely citric acid, ascorbic acid and lemon 
juice. During the preparation, a range of quantities of these acidifiers were used.
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The pH of the injection solution will relate to the solubility of the drug, by 
using different concentration of acids in solution, the pH will vary, therefore the 
amount of drug in the solution will vary. The pH of the solution is also of 
importance with regard to the potential the solution has to cause to damage the 
tissue lining the blood vessels into which it is injected. Once injected into the 
bloodstream, the buffering capacity of blood and the dilution of the solution will 
change the pH to that of the blood.
This experiment intends to measure the pH of solutions covering the 
range of solution strengths that were seen in the interviews.














The interview work demonstrated use of ascorbic acid and water 
quantities that could produce solutions from 40mg/ml up to 300mg/ml. For citric 
acid, the solutions ranged from 16mg/ml up to 405mg/ml. (The 405mg/ml was
(Mettler AE 50)
(Hanna -  pH 302, with Hanna probe HI 1330B (slim probe 
for use in small eppendorf tubes containing low volumes 
of sample))




an exceptionally high value, with only two users employing solutions over 
300mg/ml). A range of solutions falling between these values were made up, 
and the pH and temperature measured.
Dilutions using lemon juice were made up in the same proportions as 
witnessed in the interviews. To account for variation in samples, the juice from 
three different Jif® lemons was tested.
The solutions were made up using distilled water and tap water drawn 
from the cold water tap in the laboratory. All solutions were made using 
temperature at room temperature, approximately 25°C.
The pH of six heroin injections was investigated. The details and 
reasoning regarding the acids quantities used to prepare these was discussed in 
section 3.6.3.
5.12 Results
Distilled water used pH 5.41 at 25.6°C 
Tap water used pH 7.76 at 25.3°C
Citric acid
The citric acid solids dissolved easily in both waters with a little shaking. 
Table 32 pH of citric acid solutions made with distilled water and tap water
Solution Distilled Water Tap Water
PH Temperature/ °C pH Temperature/ °C
15mg/ml 2.14 23.2 2.27 23.6
10Omg/ml 1.74 23.4 1.78 23.6
200mg/ml 1.61 23.2 1.55 23.7
300mg/ml 1.44 23.4 1.48 23.5
400mg/ml 1.35 23.2 1.38 23.5
Ascorbic acid
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The solutions of ascorbic acid proved hard to produce at concentrations 
above 150mg/ml as the solid acid particles required the solution to be shaken for 
a long time to allow them to dissolve.







40mg/ml 2.49 25.3 2.71 25.9
10Omg/ml 2.24 25.2 2.42 25.6
150mg/ml 2.17 25.3 2.26 25.9
225mg/ml 2.03 26.0 2.10 26.6
300mg/ml 1.91 27.7 1.96 27.2
Lemon juice 
Undiluted lemon juice
Lemon 1 pH 2.46
Lemon 2 pH 2.49
Lemon 3 pH 2.50
Diluted lemon juice results
Table 34 shows the pH of lemon juice solutions when diluted with 
distilled water and tap water.







0.3ml LJ in 1.2ml 
Water
2.62 25.2 2.74 25.2
0.4ml LJ in 0.8ml 
Water
2.57 25.6 2.62 25.4
Lemon 2
0.3ml LJ in 1.2ml 
Water
2.63 25.3 2.69 25.5
0.4ml LJ in 0.8ml 
Water
2.60 25.2 2.60 25.7
Lemon 3
0.3ml LJ in 1.2ml 
Water
2.63 25.4 2.74 25.5
0.4ml LJ in 0.8ml 
Water
2.61 25.6 2.65 25.7
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5.12.1 pH measurements of drug injections
Injections containing heroin were produced using the standardised 
preparation technique, including 130mg of heroin powder. Due to limited 
supplies of heroin at the time of production, the preparation of injections was 
limited to variation of three different quantities of citric acid, and three different 
quantities of ascorbic acid. Each was prepared using 0.85ml of water as 










Initially, lower quantities of each of the acids were attempted for use- 
25mg of citric, and 90mg of ascorbic. These were exactly half the mean 
quantities defined in the standard procedure. These quantities of acid were 
insufficient and the drug was clearly did not dissolve. Figure 28 below shows an 
injection mixture prior to heating; solids are clearly visible. Figure 29 was taken 
after an injection solution had been drawn up into the syringe. Dissolution had 
appeared to have taken place when the solution was drawn up, yet sediment 
clearly remained at the bottom of the spoon. This would most likely be 
unacceptable to any drug user, who would probably make further attempts to 
dissolve the powder.
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Figure 28 Heroin powder in mixture prior to heating
Figure 2 9  Undissolved drug m ateria l left in the cooker
The step was taken to add extra quantities of acid until the drug was seen to 
dissolve.
5.12.2 pH measurements of prepared heroin injections
The following tables display the pH of the prepared heroin injections. The 
measurements were taken directly after the preparation of the injection. All 
readings were taken at approximately 25°C.




Injection 2 i Average
50mg 2.96 2.96 : 2.96
70mg 2.63 2.60 | 2.62
140mg 1.85 1.83 I 1.84
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Table 36. pH readings for injections prepared with ascorbic acid
Ascorbic Acid quantity pH








The results from this section of the project are of importance as they give 
an insight into the effect the solutions will have the body tissues it comes into 
contact with upon injection.
The results from the measurement of pH of acid solutions are 
unsurprising; the stronger the acid solution, the lower the pH. Additionally, as the 
temperature of the solution is raised, so the pH lowers. These results were 
important for comparison with injection solutions containing drug.
When drug was used to prepare the injections it was seen that the pH of 
the lower strength acid solutions was higher than that of the acid solution of the 
same strength alone. For example, citric acid 100mg/ml solution alone was pH 
1.74, but with drug the measurement is raised to 2.64 (88mg/ml citric acid 
actually used). The results were similar for the ascorbic acid, where the 
150mg/ml acid solution had a pH of 2.26, but a heroin injection containing 
158mg/ml ascorbic acid had a pH of 2.93.
As the amount of either acid is increased in the injection solution, the pH 
draws closer to that of the acid solution alone. This demonstrates that injectors 
choosing to use large quantities of acid are at potentially at risk of pain, and 
possibly further complications, from the low pH of the injection solutions.
This concurs with current harm reduction advice, and as previous work 
has demonstrated (Scott, Winfield, Kennedy, & Bond 2000) there will be an 
optimal amount of acid required when producing an injection. The addition of 
further acid will dissolve little or no additional drug. The difficulty for the injector 
is gauging the optimum quantity to use, as there is no simple way to determine 
it, especially given the variability of illicit drug mixtures.
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5.14 Osmolality of prepared heroin injections
Osmolality was measured using the freezing point depression technique, 
using supercooling. This is the British Pharmacopoeia method (2000). To 
perform this, an osmometer is used. This was done using the Advanced 
Instruments Micro-Osmometer model 3300. The analysis performed by Dr. 
Richard Headford, at the pathology laboratory of the Royal United Hospital in 
Bath, as the facilities were not available at the University.
The osmometer requires a minimum of one millilitre of sample for 
analysis. To enable the measurement of illicit injections, two identical injections 
were prepared using each acid quantity. The resulting injections were then 
pooled together to produce the sample for osmolality analysis. This pooling was 
necessary for the osmolality measurement conduction and was considered to 
not adversely affect the samples results, for instance through any decrease in 
solubility, or precipitation of the dissolved materials within the samples.
The samples investigated were the same injections prepared for the pH 
investigation, above. Each sample was analysed twice.
5.15 Results
The following tables depict the results for the osmolality measurements 
of prepared injection solutions. The solutions analysed were those prepared for 
the pH measurements above.
Table 37. Osmolality readings for injections prepared with citric acid 
Citric acid quantity Osmolality (mOsmols)
Injection 1______Injection 2 j Average
50mg 493 490 | 492
70mg 525 533 529
140mg____________________ 1001____________ 1011______________ | 1006______________
Table 38. Osmolality readings for injections prepared with ascorbic acid
Ascorbic acid quantity Osmolality (mOsmols)
Injection 1______Injection 2________ j Average___________
135mg 1292 1266 I 1279
175mg 1559 1623 I 1591
330mg____________________n/a^_____________ n/a^_______________j_j___________________




The osmolality investigation results indicate that injections prepared 
using 50mg of citric acid, and possibly those using 70mg, are unlikely to cause 
problems when injected as the osmolality is below 550mOsmo/l. Those 
prepared using quantities of citric above this, and any quantities of ascorbic acid 
will exceed this 550mOsmol/l, leading to potential complications.
As the results demonstrated, the lowest quantity of ascorbic acid to 
suitably dissolve the heroin was 135mg. Indeed as the interviews demonstrated, 
the mean quantity used was 175mg. The injection produced using 135mg had a 
mean osmolality measurement of 1279mOsmol/l, which is over twice the 
recommended 550mOsmol/l. whereas the 175mg injection gave an even higher 
osmolality reading, a mean reading of 1591mOsmol/l.
Therefore, any injection prepared using ascorbic acid would be expected 
to cause complications upon injection. The interviews contradicted this. 
Participants claimed to prefer ascorbic instead of citric on the basis they 
considered it to be a safer acid. Additionally the burning upon injection of 
injections prepared with citric reinforced these feelings.
These results suggest that it is the pH of the injection solution that is 
related to the burning sensation upon injection. This does not mean that the 
ascorbic acid injections do not cause damage to the blood vessels as the 
osmolality results suggest it should. Further work is required to determine the 




This research project has covered a range of investigations, in areas that 
have little, or no, previous work. Investigation of the techniques used to prepare 
injections, and then their translation into a suitable laboratory method is a novel 
concept. Work of this nature is arguably long overdue. The prevalence of illicit 
injecting reinforces the need for such research.
The investigation of injection preparation, and the resulting injections are 
akin to the work conducted by Huizer (1987) on the techniques and outcomes of 
smoking heroin. Huizer’s research was conducted during the late 1970s and 
early 1980s. The fact that this work was conducted over twenty-five years ago, 
makes it surprising that equivalent work into injections has not been previously 
conducted. Advances in laboratory techniques, combined with changes in the 
constituents of street drugs and changes in smoking techniques would suggest 
that the smoking research is a suitable area for further research again.
6.1 Methodological Critique
6.1.1 Interviews
The drug injector interviews were designed to explore the manner in 
which drug users prepared drug injections, and then to explore these 
preparation methods in detail, so a lab technique could be based on this 
information.
In practice the interviews were conducted without problems, and 
recruitment for them proceeded quickly. Interviews at needle exchanges 
provided a large number of current injectors, many of whom showed willingness 
to participate in the research. Additionally, no participants withdrew during any of 
the interviews.
Recruitment for the pilot interviews in the Bath exchange was low; it is 
possible that the lack of compensation for the time spent during the interview 
was a factor. Although potential interviewees were not informed of payment prior 
to interview, the possibility that they had been told of the payment by previous
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participants was considered. This may account for the greater willingness for 
participation in the two areas where payment was made.
The interviews were conducted in preference to focus groups as 
discussed in the methodology section of the interview work chapter. The 
outcome of the interviews indicates they were a suitable choice for the 
investigation of the preparation process. Focus groups would not have provided 
the vital quantitative data. In addition to this, whether the recruitment of people 
to partake in focus groups which would last significantly longer than the 
interviews is unclear, but it would be expected to have been more difficult with 
regards to arranging attendance. The use of these interviews is considered to 
have been the best choice, and they proved to be a viable and productive 
method.
The questionnaire section of the interviews explored a range of subjects, 
from participant demographics, drug history, injecting history and injection 
preparation. This enabled a wealth of data to be recorded, although on reflection 
some was subsequently deemed superfluous to the overall object of the project 
work. Data covering areas such as drugs used, injection sites, and geographical 
variations were beyond the needs for the design of the standardised injection for 
the laboratory work. These data will however, prove useful for future 
publications.
The injection preparation demonstration was designed to record the 
preparation steps and the materials and equipment used by the interview 
participants. They achieved this aim, recording a high level of detail of each 
procedure demonstrated. Searches of the literature were unable to find any non- 
participant observation studies conducted within this field previous to this work.
The recording technique proved capable of documenting the process as 
it was performed. All details of the procedure were recorded, allowing accurate 
replication of the procedure within the laboratory setting.
Although the objectives of the interviews were met by the design, 
problems were evident. For instance, there was a recurrent problem with the 
timing the heating of the injection solutions. The stopwatch was started when the 
heating began, but the fast paced nature of the recording sometimes resulted in 
the watch not being stopped as the participant quickly moved onto the next 
stage of the process. When this occurred, no heating time was recorded for that 
interview.
To improve the interview process, the use of additional recording 
methods would increase the accuracy of the data. Although considered, but
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rejected during the interview design phase, the inclusion of audio or video 
recording could have been beneficial. Audio recording could improve accuracy 
of data especially during the questionnaire phase. Video recording would be of 
benefit through the entirety of interview, especially during that of the 
demonstration section. The use of video was rejected primarily on the grounds 
of confidentiality concerns, although non-participant observational studies 
conducted subsequently by (Taylor et al. 2004) have shown the superiority of 
this technique with regards the richness of the data recorded. This study, 
conducted in Scotland, addressed the confidentiality of this type of work and 
demonstrated that the steps can be taken to protect the participants, even 
enough to allow delegate viewing of the footage at conference events. Using the 
same procedures as Taylor et al. would be likely to satisfy ethics committee 
requirements for the use of this method in future preparation method 
investigations. Experience gained during this project would possibly endear 
ethics committees to grant approval for in-depth interviews utilising video 
recording and non-participant recording of the preparation process as further 
work.
The wording of some of the questions regarding drugs and acids ever 
used were possibly of a risky nature. It is possible that some participants had 
never known such drugs were injectable, or had never considered the use of 
some of the more questionable acidifiers, such as descalers. A risk of promoting 
risky behaviour was therefore present, which could pose ethical issues. The 
inclusion of these substances in the probes list was not ideal, however they 
were valid for the majority of participants. The decision during the interview 
whether or not to ask about the use of these substances, based on a 
combination of factors including, the injectors age, length of time injecting, drugs 
stated used and on a general feel for the overall experience of the participant. 
Due to the informal setup of the interview rooms, it was possible for the 
participants to read the options available on the list of probes, therefore, the 
riskier probes were written in strike through font, for instance buprenorphiee in 
an effort to reduce the participant’s ability to read this word upside down from 
the interviewer’s sheet.
The decision of whether to suggest the probes to some interviewees, 
whilst withholding them from others, was questionable practice. Bad judgement 
could have resulted in interviewees unsuitable being prompted inappropriately 
as was trying to be avoided. This judgement by the interviewer also potentially
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introduced a level of interviewer bias. Poor judgement may have resulted in 
participants who were suitable for probes not having then suggested. Despite 
these issues, it was difficult to address the issue in a different manner. The 
probes were required as without probing for further details, the participants may 
have forgotten to mention these drugs/acidifiers. Not using these probes would 
have adversely affected the quality of results. Removal of some of the more 
risky substances from these lists could have been possible, but to the detriment 
of the overall results.
Data analysis could have been improved through the use of SPSS 
instead of Microsoft Access, but during the initial data input it was considered 
that Access would give better data handling facilities. In consideration, the input 
of the data into SPSS in the first instance would have resulted in a better ability 
with which to handle the coded data, as well as saving time and effort which was 
subsequently used to copy data from Access into SPSS for statistical and 
graphical analysis.
6.1.2 Extrapolation of the amount of drug used
The methodology section of the interviews describes the reasoning for 
the use of ‘fake’ drug during the interviews, instead of the use of real drug. The 
observation of injectors preparing real drugs conducted by Taylor addressed the 
ethical and legal implications of the presence of non-participants within the drug 
injection environment. This was one major concern for this project as it would 
have been the first work to have incorporated the use of illicit drug material 
during interviews. It was considered too risque for the required outcome of the 
interviews. The work of Taylor did not address the injection preparation in as 
much detail as was required for this project, it was concerned primarily with 
identifying risky behaviours exhibited by injectors, particularly those of 
surrounding blood-borne virus transmission. Quantities of materials used were 
not measured, and this was critical data required for this project to allow 
reproduction in the laboratory.
To measure quantities of drugs used, two different approaches were 
considered. Either the interviewer would provide a sample of drug of known 
quantity (as done during this work with the fake drug), or the interviewer disturbs 
the participants during the preparation to measure quantities in use. The first 
method would have legal implications and could put the interviewer at personal
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risk. The second method would be hard to conduct as it would involve stopping 
the participants during the preparation to measure the quantities. They may be 
unhappy about this, and it would be likely to disrupt the flow of their preparation, 
which then may be altered to accommodate the interruption.
After the interviews were conducted, the requirement of having to use 
fake drug materials introduced the complication of converting the amount of 
‘fake’ powder used into that of real drug material. The conversion attempts made 
in the laboratory are not ideal, but were the best conceivable. They rely on the 
visual nature of the measurement of drug quantity. This is a crude conversion 
and one that is very subjective- one person’s measurement may vary from that 
of another.
The ideal method of comparing these two powders would be to get the 
users to measure both out in a similar manner during an interview, however, 
with access to real drug powder, it would make little sense to have to employ a 
‘fake’ drug. Until interviews can be conducted using real drug powder available 
for measurement these results are all that is currently available.
6.1.3 Laboratory Investigations
The basis of this work was to investigate the pharmaceutical properties 
of the injections prepared in the manner demonstrated by the interview 
participants. The work did not aim to pursue method development, but rather to 
use existing methods applying them to the area of study.
Drug content of prepared illicit drug injections
The first laboratory investigation undertaken was measurement of the 
level of drug contained within each injection. This was expected to vary 
depending on the quantity of acid used to prepare the injection, and possibly 
due to additional other factors which could have been further investigated.
Prior to the commencement of this work, the method using capillary 
electrophoresis as used by Taylor (1996), and subsequently Scott (2000), was 
the intended process by which to perform this measurement. The outlined 
problems with equipment required an unexpected and undesirable change of 
technique. Alternative methods of measurement of heroin within illicit drug
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samples were investigated, but these are either were unavailable due to lack of 
access to specialised equipment, or not suitable such as the normal phase 
HPLC method of O’Neil and Pitts (1992). These were other reasons that CZE 
had been selected for use in the first place.
To conduct these measurements, a new method had to be found and 
developed. The intention was to perform as little manipulation of the injection 
solution before analysis, so as to give as accurate measurement as possible. 
Ideally, a measurements performed on neat injection solution would be ideal but 
no current method will allow this. The use of CZE would require the sample to 
be diluted with methanol before analysis. Other methods require even further 
treatments, such as gas chromatography, which would require removal of all 
water from the samples followed by dilution within an organic solvent for 
analysis.
It is possible that a modification of the electrospray mass spectrometry 
method, as used to analyse the drug powder samples, would enable 
quantification. There are publications that prove this method can be used 
effectively (Selby 1998). Equipment availability problems prevented this work 
being conducted, although it is potential work for the future.
The use of NMR for quantification of the amount of drug within the 
samples was the application of a novel, and relatively uncommon use of NMR. 
This method was chosen for the access to the NMR equipment, and after the 
realisation that NMR could possibly be used for quantitative measurement. The 
tentative use of this method proved it was possible, but the necessity to prepare 
the injections through the process of freeze drying, followed by dissolution in 
methanol-cf3 was additional manipulation of the samples, which may have 
adversely affected them producing misrepresentative results. Additionally, once 
freeze dried, samples could have been analysed through a number of other 
means, for instance, gas chromatography using methods such as that of Kaa 
(Kaa & Bent 1986).
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Microbiological methods
The microbiology methods used proved suitable for the study of the 
injections. The use of the McLauchlin method (McLauchlin, Mithani, Bolton, 
Nichols, Beilis, Syed, Thomson, & Ashton 2002) was chosen over that of the BP 
sterility test (2000) on the basis that it would allow identification of organisms 
that were cultured from the samples. The BP sterility test would also be less 
likely to grow fastidious organisms especially the Clostridia that the McLauchlin 
method incorporated specific media for. The McLauchlin method was devised in 
response to the outbreak of Clostridium novyi that was responsible for the 
deaths of illicit heroin injectors. It was developed primarily to identify the 
existence of these bacteria within drug samples, but the design of the whole 
method allowed the isolation and identification of a wide range of different 
bacteria and fungi.
The second microbiology method used was not a published method. It 
was designed during the controls stages of the first method. The acquisition of 
cultures from the university culture collection allowed the inoculation of drug 
samples with known organisms to investigate the ability of these organisms to 
survive the preparation process. Compared to the method of McLauchlin this 
method was much less intensive with regards materials and time.
The main limitation of this section of work was the fact that the drug 
samples had already been shown by method one to contain viable organisms. 
This could have resulted in these organisms surviving the preparation process 
and growing as the dominant organism within the broth. The possibility of 
sterilising the drug samples was not an option as a process such as autoclaving, 
or dry heat sterilisation would potentially adversely affect the drug samples. Any 
growth resulting from the samples would be proof that at least one organism 
was able to survive the preparation process, even if it was not the introduced 
organism.
General Microbiological Investigation Problems
Two main issues were raised during this area of work. The first involved 
the use of micro-organisms with specific handling requirements. Recent
220
changes in handling procedures and regulations led to delays in clarification with 
safety officers over the possible use of certain organisms, notably Clostridium 
botulinum, which the McLauchlin method required as a control. The use of this 
organism was ruled out by the Pharmacy department after a delay, even though 
the use of a technique that would specifically culture the organism, had it been 
present within the illicit samples, was authorised.
The second issue was that of organism identification. During the 
planning phases, the identification of any cultured organisms down to species 
level was envisaged. Although this is possible using equipment such as API test 
kits, it was found to be prohibitively expensive. Further consideration of the 
McLauchlin paper makes it apparent how difficult this identification is, even for a 
specialist microbiology unit such as the PHLS. Their main work was conducted 
in a number of locations including the Public Health Laboratory Service (PHLS) 
Food Safety Microbiology Laboratory in North London. Limited identification 
could be conducted there, and specialist identification was required for the 
anaerobes and Staphylococcus sp. produced. These included sending cultures 
to the PHLS Anaerobe reference unit in Cardiff, and the Laboratory of Hospital 
Infection (CPHL) in Colindale, London. Third party identification would have 
been possible for this project, but again was beyond its financial scope.
Further to these issues, the amount of microbiological work conducted 
was limited by the cycle time required for the conduction of one set of 
experiments. The microbiology experiments were one of the latter stages of 
work and this was necessary due to the requirements for the injection 
investigations, and the acquisition of drug samples.
The work carried out ideally required repetition to a larger degree than 
was actually conducted for complete validity. In actuality, each experiment was 
conducted once, although in some cases repeats were run concurrently, for 
instance, during the identification of the organisms present within the drug 
samples which was felt to be of particular importance. Identification was 
conducted by colony examination, haemolysis patterns on blood plates, 
microscopic examination, including Gram staining, and catalase testing.
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Particulate Content of injections
The method selected for this analysis was that of the then current British 
Pharmacopoeia (2000) at the start of the PhD project. This method was the 
method of choice for the detection and characterisation of particles present 
within injectable pharmaceutical preparations. The use of the BP method has 
provided results which are directly comparable with those for a pharmaceutical 
product.
The work produced clear results, with the only limitation being the lack of drug 
material available.
Additional Laboratory Investigations 
pH
pH measurements of the injection solutions were conducted using typical 
laboratory grade pH measurement apparatus to measure the pH of a prepared 
injection solution identical to that which would be injected.
The pH of injections may vary from that of blood (venous blood pH 7.36), 
but the effect they have on the vessel/tissue into which they are injected would 
vary on the buffering capacity of the vessel/tissue. The effect the injection has 
upon the injection site is dependent on the injection site, and the blood has the 
capacity to adjust the H+ ion concentration of an injection solution to a large 
degree, whereas the injection into muscle and subcutaneous tissue has a lower 
ability as they do not have haemoglobin present to augment the bicarbonate 
buffering system.
Although the pH effects of injection solutions depend highly on the type 
and site of the injection, this work only aimed to record the measurements found 
in typical injections. These relatively simple measurements, which are performed 
routinely on pharmaceutical injections, had not been conducted on illicit drug 
injections to date. The work recorded the ranges of values that can be expected 
to be found in typical injection solutions. The actual outcome of injection of these 
solutions is a more important, but unclear, factor which remains an important 
area for future work.
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Osmolality
This was measured using the standard technique and apparatus used to 
confirm pharmaceutical products compliance with BP standards. The use of this 
method would make the measurements of the resulting injections comparable 
with those for a pharmaceutical product.
ES-MS
The use of this technique was conducted to investigate the constituents 
of the illicit heroin material. Use of this technique for this investigation was 
chosen through knowledge of the methodology. The paper of the work by 
Guilhaus et al. was found subsequently, and demonstrated that it had been 
employed previously for quantitative analysis of laboratory prepared opiate 
mixtures.
The method enabled relatively easy identification of the compounds 
present within the illicit samples. While it appears to be a suitable method for 
this analysis, validation would have to be conducted using another method to 
verify the contents of the samples. This was not possible during this project. 
Additionally, it remains to be seen how robust the method is with regard to the 
nature of the samples analysed. During the work, control samples of 
phenobarbitone and lactose were submitted for analysis, alongside the other 
standards. Both of these compounds produced highly complicated spectra with 
many peaks. From the output spectra of the illicit samples, it was clear neither of 
these compounds were present as there were limited numbers of peaks at m/z 
ratios, and they could be identified. Had either, or both, of these compounds 
been present within the samples, interpretation of the spectra would be highly 
complicated, potentially impossible, making the technique of little value. As it 
stands these results, along with those from Selby (1998) demonstrate the 
technique is of value, but if compounds that complicate the interpretation of the 
spectra are present in illicit samples (as they have been in the past (Kaa 




6.2.1 Limited drug supply
The main component of all the laboratory investigations conducted 
during this work was the illicit drug material. It was critical to all the experiments. 
Previous work by Scott (2000) in Aberdeen using similar drug materials was 
conducted using a plentiful supply of seized illicit drug material obtained from the 
police with relatively little difficulty.
In the time since this work was conducted, the rules governing all 
aspects of controlled drugs have come under scrutiny during the inquiries into 
the activities Dr. Harold Shipman.
This affected the nature of this work to a great extent. Firstly, a Home 
Office licence had to be obtained for the storage and the work using the illicit 
drug material. Once this was obtained the police could be approached for 
supplies.
The police were very wary of supplying quantities of illicit drug to the 
research team, even though both members are registered pharmacists, with 
direct access to pharmaceutical grade controlled drugs. Before making the initial 
supply, criminal background checks were conducted.
Once these checks were finalised, illicit drug samples were supplied.
Due to destruction requirements placed on the police in the light of the Shipman 
Inquiries, the quantity of heroin they had available for supply was very limited 
(Approximately 2.5grams). As each experiment involving the preparation of an 
injection of heroin would use 130mg, it is clear this limited the amount of 
investigations that could be conducted considerably. Additionally, some of this 
quantity was required for investigations into filters and preparations using 
different types of water, which were not part of this research project.
6.3 Limitations of findings
The main limitation of this project is the lack of depth in the majority of 
laboratory investigations. Given larger quantities of illicit drug material, access to
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particular equipment, and aspects of specialist expertise, for instance in 
microbiology, the majority of work could be expanded. This leaves a large 
potential for future work to be conducted in this area. As has been outlined, the 
risks posed by the injection of illicit drugs are real and they are not going to 
diminish with time.
The injection preparation procedure used within the laboratory used a 
generalised method formed from the amalgamation of the interview participants. 
It does not take into account extreme procedures, for instance those using very 
large quantities of acid. Additionally the procedure used was formed using the 
preparation techniques of injectors from the South West of England. Different 
techniques maybe found in more distant regions, for instance Scotland. On a 
wider scale, the preparation techniques will vary regionally, even where 
acidifiers are required, such as different areas of Western Europe.
The results of the investigations using illicit drug samples are limited by 
the nature of the drug samples used. The use of different illicit samples with 
different compositions would potentially produce different results. Given the 
nature of illicit drugs, this limitation is impossible to overcome, as the 
composition changes from batch to batch.
The final limitation of the results depends on changes over time. 
Changes are likely to occur both in the preparation techniques of the injectors, 
as well as the composition of the drug material. It is possible that a change in 
one will change the other, for instance if heroin became available as the 
hydrochloride salt, injectors may abandon the use of acidifiers during the 
preparation process. Such a change would make the majority of this work 
irrelevant and require new investigations to be conducted.
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6.4 Overall conclusions of the project work: revisiting the 
original research questions
6.4.1 How are injections produced?
There are a clear set of steps for the production of injections of each
drug.
Heat is always used to prepare heroin containing injections.
The quantities of drug, acid and water used to prepare injections appear 
to be unrelated and vary from injector to injector.
6.4.2 What acids do injectors use ?
An acid is always used to prepare the injections of heroin and crack 
cocaine
Citric and ascorbic acid are the most popularly used acids.
This study has recorded the spectrum of acids in use by injectors, the 
first time by a study.
6.4.3 What filters do injectors use ?
All injections are filtered.
If Swan type filters are used, a thin strip is ripped and used, rather than 
the whole filter.
The standardised injection preparation method was derived based on the 
methods observed during the interviews. Although based on the ‘average’ 
injector’s procedure, it represents a model for investigating the properties of illicit 
drug injections.
6.4.4 What is the drug content of prepared injections?
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A method using quantitative NMR has been proposed for the 
measurement of the content of all components within an illicit heroin injection, 
although it needs further refinement.
6.4.5 What are the microbiological risks posed by illicit injections?
B. cereus and S. aureus were not inactivated during the preparation 
process using water and acid.
Organisms were found in injections prepared with drug material and citric 
acid. S. aureus appears to survive the injection preparation process using drug, 
the B. cereus result was less clear, although it appeared a related organism 
(possibly from the drug material) was present within the prepared injection.
Microbiological organisms are able to survive the injection preparation 
process. This concurs with previous work that has shown that organisms, 
including fungi and Clostridia have survived the injection preparation and been 
injected leading to infections.
6.4.6 Particulate matter within injections
Preparation of WFI in a manner similar to that of illicit injectors does not 
add significant particulate matter to an injection solution, indicating the method 
of preparation of injections does not pose much risk of particulate contamination, 
but this will be dependent on the environment.
The filters used by drug injectors add particulate matter to the injection 
solution, although the solutions produced remain within the limits specified by 
the BP, in most circumstances.
Preparation of injection with heroin resulted in large quantities of 
particulate matter within the solutions. The use of cigarette material did little to 
filter the injection suitably, but the use of Sterifilters lowered the particulates 
within the injections to almost with BP standards.
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6.4.7 Summary
There are a number of areas in which the preparation of injections can 
be improved.
The use of sterile acids to reduce the possibility of the introduction of 
micro-organisms into injections through the use of contaminated acidifiers.
The use of lemon juice was commonly reported during interviews as 
having been used by injectors and it was reported as a reserve option when the 
acid of choice was unavailable. The use of this is actively discouraged, but it still 
appears to be prevalent, therefore education of injectors engaging with services 
is still necessary.
The use of better filters needs to be encouraged. Ideal filters are of the 
Sterifilter® type, or as a second line choice, clean Swan type filters ripped 
carefully before use.
Overall, it appears that the laboratory investigations conducted so far 
support current advice currently given to IDUs. The use of citric and ascorbic 
acids, although recommended on the ground of safety, was not supported by 
any scientific evidence. The work of this project has found no evidence to 
suggest that these acids could be responsible for problems from the given 
results.
6.5 Findings with respect to drug injectors
The characterisation of the preparation on procedure conducted during 
the first stage of this project is important for drug users for two main reasons. 
Firstly, this information can be disseminated to those working with drug injectors 
to aid care for injectors. Knowledge of, and understanding of the preparation 
method is important. A drug worker who is unaware of the way that injections 
are usually prepared will not be able to identify errors that may have arisen 
through problems in the method used to prepare injections.
The ripping of filters before use presents the risk of introducing micro­
organisms from the injector’s hands directly into the solution immediately prior to
228
injection. This presents the opportunity for intervention by workers who should 
ideally suggest that the injectors should wash their hands prior to handling the 
filter (ideally before starting the preparation) and also to encourage the use of 
only new, clean filters.
Secondly, the laboratory work conducted during this project was novel 
and it has investigated some of the pharmaceutical aspects of illicit injections. 
Through laboratory investigation, risks presented by illicit injections can be 
identified and suggestions introduced to prevent complications that might result.
The crucial starting point for work to improve injection safety would be 
study the effect of the injections upon the injectors. This would possibly take the 
form of in vitro investigations of the effect of the injection solution upon venous 
tissue. The effect of doses of citric and ascorbic acid could be investigated in 
vivo, comparing the effect of doses on drug injectors and healthy subjects.
As a health care professional regularly engaging with drug injecting 
clients, it is felt that the project outcomes are less than ideal, but it is possible 
that this was expecting too much. The project has taken the first tentative steps 
into the investigation of the pharmaceutics of illicit drug injections. It is hoped 
that further work will be conducted to realise the benefits that such investigations 
could produce, reducing harm to drug injectors, reducing risks and costs to 
society and reducing NHS expenditure on treating injectors with possibly 
preventable complications.
Once recommendations are in place to guide safer injection preparation, 
it will be important to educate users about the injection preparation process, to 
reduce their risks. This task will rest with drug workers, and through the use of 
leaflets available at needle exchanges and other drug services.
6.6 Findings with respect to pharmacy
Community pharmacists have unique contact with drug injectors. They 
may be involved in needle exchange, in which case they are intimately involved 
with the local injecting population. Pharmacists do not have to provide a needle 
exchange service to interact with drug injectors, some pharmacies sell syringes 
to injectors, others will sell citric acid to injectors requesting it. It is possible that 
these injectors are not in contact with local drug services. In addition to this, 
drug users on maintenance prescriptions may still continue to inject.
229
Pharmacists selling citric acid to persons also requesting needles and 
syringes are in an ideal position to provide advice on the use of acids. The 
outcomes of this work are of great importance to pharmacists involved in the 
care of the injectors they come into contact with. Dissemination of the results of 
this work could educate pharmacists to enable them to improve the care they 
provide. Now that all registered pharmacists are required to undertake 
compulsory continuing professional development, this work could be 
incorporated into training materials on drug misuse.
It would be of use to pharmacists to be aware of the methods that 
injectors use to prepare drugs for injection, which could possibly allow them to 
make interventions if they were aware of problems in the injector’s preparation 
method. As suppliers of the acids to injectors, it is important that pharmacists 
understand the reason for their use. Recent unpublished research reveals that 
55% (277 out of 503 surveyed) of community pharmacists do not understand the 
reason for the use of acid (Personal communication, Rachel Britton, 2005). 
Pharmacists should know which are the safer acids to use, and those which to 
discourage the use of. This could also potentially include advice on the use of 
filters too. Most importantly of all, pharmacists should monitor the injectors 
health as best as is possible, and they should understand common injecting 
problems (Scott & Bruce 1998) and encourage the injector to seek medical 
advice regarding complications.
In addition to educating qualified pharmacists about the work, and given 
the likelihood that they will be providing care for illicit drug injectors, it would be 
important to incorporate this work into the undergraduate pharmacy MPharm 
degree course. The work would teach them about the methods that drug users 
employ to prepare injections, the chemistry behind the process, and the role of 
the pharmacist in the care of drug injectors.
This project has successfully tied together the work of pharmacy practice 
and laboratory based science. It has demonstrated the contribution that can be 
made by researchers skilled in both sociological research methods, including 
interviewing, and laboratory investigation methods including separation 
techniques such as capillary electrophoresis and HPLC, and microbiology.
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6.7 International considerations of the work
The preparation methods of heroin injectors investigated within this work 
are only applicable to areas where users prepare and inject the base form of 
heroin. This means the work is of little value in North America and Australasia. 
This however does not belittle the value of this work in these regions. The 
interview and laboratory investigation techniques used during this work could be 
applied to investigate local preparation techniques and injection samples 
prepared using the local methods. This would provide insight into the risks from 
those injections and allowing an international comparison of the risks posed to 
illicit heroin injectors.
Crack and freebase cocaine exist as the same form in all countries, 
therefore work conducted on this would be directly comparable. The variations in 
methods used to prepare crack in different countries would be the important 
sections of this work were it to be conducted.
6.8 Further Work
The laboratory investigations conducted during this project should serve 
as a starting point for future work into illicit drug injections.
The microbiology investigated would benefit from further work within a 
dedicated microbiological department or facility. This would provide equipment 
and staff with appropriate specialised training. This would result in the ability to 
conduct work on a greater scale and allow accurate identification of a greater 
range of organisms.
The particulate matter investigations suggest that a portion of the 
particles within the samples were contributed by the filters used during the 
preparation process. Identification of the matter within the injection solutions 
would provide a clearer understanding of this. Such investigations could 
potentially be conducted through the use of Raman mapping techniques.
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Identification could enable the identification of the particulate content and allow 
tracing its source.
The effect of the injection solutions upon the tissues into which they are 
injected is a logical progression on from the study of the injection solutions 
themselves. It is important to understand the effects they produce on them and 
which properties of the injections are responsible for these effects. Such work 
will further guide injection preparation advice provision to IDUs.
These effects could be investigated in a number of ways. Models for 
investigating the effects of infusion induced phlebitis have been developed that 
use the effect of the injection solution upon buffer solutions, without the use of 
animal tissue. Alternatively, the use of cultured cell lines, or venous tissues from 
animals could be used and histological examination used to assess the effects 
of the drug solutions.
The use of citric and ascorbic acids by IDUs to prepare injection 
solutions have unknown biological and pharmacokinetic effects. It is postulated 
that the acids pose no risk and are metabolised by the body without problem, 
but this is unproven. If this metabolism does not occur there would exist the risk 
of ascorbate and citrate levels increasing within the body. In vivo studies using 
health volunteers could be used to investigate the consequences of regular 
dosing with these substances to confirm that their use by IDUs poses no risks in 
this respect.
The interviews conducted investigated the preparation of crack and 
‘speedball’ injections, along with that of heroin. Crack was unavailable for use 
during the laboratory stage of the project, so injections were not investigated. 
The interviews were lower in number than those for the heroin which indicates 
further interviews into the preparation of crack containing injections may need to 
be conducted. This will then enable laboratory work to investigate the properties 
of the injection solutions. Investigations of the same nature, and the same 
technique, where applicable, would provide information on the risks posed by 
these injections.
The microbiology of crack is especially of interest, given that it is 
commonly carried orally or rectally by drug dealers. This will lead to the 
possibility of the drug or its wrapping material being contaminated with bacteria
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from the oral or rectal cavity. This may result in the organisms transferring to an 
injection solution.
Finally, future work educated IDUs on the safest method of injection 
preparation would be the ultimate goal of work within this area. This would see 
the transfer of the results of this project as a whole being transferred into the 
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Ethics approval letters and 
Hereford PCT approval letter
Royal United Hospital Bath
BATH LOCAL RESEARCH ETHICS COMMITTEE
Direct tel/fax: 01225 825725 email: research.ethics@ruh-bath.swest.nhs.uk
NHS Trust
Mr R Ponton 
Research Pharmacist
19 April 2002





Department of Pharmacy & Pharmacology 
University o f Bath 
Bath BA2 7AY
Dear Mr Ponton
BA242 ((please quote th is reference on a l l  correspondence)
Illicit drug injection preparation procedure investigation using a questionnaire and 
practical demonstration
Thank you for your letter dated 16 April 2002 enclosing a revised volunteer information 
sheet. It was the Committee’s view that it would not be necessary for you to obtain 
written consent from the volunteers because of the anonymised nature o f the study. The 
Committee also did not think that the option whereby the volunteer marks or initials the 
consent form would have any legal basis. I am pleased to confirm that you have fulfilled 
the requirements of the Committee and your study has full approval to proceed. I would 
be grateful if  you could reference the revised information sheet ‘Bath version April
This Committee is organised and operates according to ICH/GCP Guidelines and the 
applicable laws and regulations. Any changes or extensions to the protocol, or additional 
investigators should be notified to the Committee for approval. Serious and unexpected 
adverse events should also be notified to the meeting May we remind you of the Data 
Protection Act 1998 and the need to conduct the trial in accordance with the Good 
Clinical Practice Guidelines.
The Committee is required to audit progress o f research and to produce a yearly report to 
the Health Authority and Department of Health. You are therefore required to provide a 























E V ID E N C E -B A S E D  HARM  R E D U C TIO N  (STAG E ONE):
I am pleased to confirm that the Herefordshire District Ethics Committee considered 
your application in respect of the above study at its meeting on 20th June, 2002.
Following discussion, the Committee gave its approval to your study and a report on 
its outcome would be welcomed in due course.
The Committee did request that your attention should be drawn to its concern at 
some of the wording on the first page of the “Information for Patients” Sheet in that 
the wording of the requirements for “Part Two” were not clear.
Please accept my apologies for not responding sooner -  I hope that your face has 
returned to normal now following your operation!!
Yours sincerely,
Mrs. J. P. Dickinson, 
Administrative Services Manager.
Trust H eadquarters, B e lm ont Abbey, B elm ont, H ereford  HR2 9RP - Tel: (01432) 344344  Fax: (01432) 363900  
Ted W illm o tt  CB OBE (C hairm an) Paul Bates (C hief Executive)
Herefordshire
Primary Care Trust







C J T /M A W  23rd Ju ly , 2002
M r. R hys P onton,
Research P harm acist,
U n iv e rs ity  o f Bath,
D ep t, o f P harm acy and  P harm aco logy,
B ath, B A 2 7A Y
D ear M r. P onton,
T hank yo u  ve ry  m u ch  fo r  co m p le tin g  the  fo rm  on Research G overnance. I  apo log ise  i f  th is  seem ed a ra th e r 
b u re a u cra tic  p rocedure  b u t I am  a fra id  it  is n o w  G ove rnm en t re q u ire m e n t th a t a ll research pro jects unde rgo  
p a rtic u la r s c ru tin y  to  ensure th a t s tandards and  o th e r aspects o f governance are be ing  m a in ta in e d .
I have read th ro u g h  the  in fo rm a tio n  yo u  have p ro v id e d  and  c o n firm  th a t as fa r as 1 can te ll y o u r research 
does co m p ly  w ith  a ll o f the  Research G overnance standards th a t are expected. Y o u r research a lso seems to  be a 
ve ry  in te re s tin g  and e x c itin g  p ro je c t and  I ve ry  m uch  w is h  yo u  success w ith  it. I note th a t yo u  are w o rk in g  
c lose ly w ith  D anny M o rris , b u t i f  I  can be o f any assistance in  h e lp in g  yo u  w ith  y o u r research w h ils t yo u  are 
ca rry in g  i t  o u t in  H e re fo rd sh ire  do  n o t hesita te  to  con tact m e.
I  have to  in fo rm  y o u  th a t as p a rt o f the  Research G overnance p rocedure  i t  is  possib le  th a t d u rin g  y o u r 
research e ith e r I o r one o f m y  colleagues m ay con tac t y o u  to  check th a t the  standards are b e in g  m a in ta in e d . T h is 
is ro u tin e  p rocedure  and co u ld  a p p ly  to  any research ca rrie d  o u t w ith in  the  H e re fo rd sh ire  reg io n .
F in a lly , because y o u r research does seem so in te re s tin g  and o f g rea t va lue  to  m en ta l h e a lth , I  w o u ld  be ve ry  
g ra te fu l i f  I  co u ld  have a copy o f any p u b lic a tio n  th a t re su lts  fro m  th is  research. I t  m ig h t also be ve ry  in te re s tin g  
i f  yo u  w o u ld  be p repa red  to  g ive  a p re se n ta tio n  on  the  re su lts  o f y o u r research a t som e stage in  the  fu tu re  to  the 
H e re fo rd sh ire  p syc h ia tric  depa rtm en t.
W ith  best w ishes,
D r. C h ris  Thom as 
C o n su lta n t P sych ia tris t
Trust H eadquarters, B e lm ont Abbey, B elm ont, H ere fo rd  HR2 9RP - Tel: (01432) 344344  Fax: (01432) 363900  
pctoo4 Ted W illm o tt  CB OBE (C hairm an) Paul Bates (C hief Executive)
UBHT Headquarters  
Marlborough Street 
Bristol B S 13N U United Bristol HealthcareTel: 0117  9 2 8  3613  
Fax: 0117  9 2 8  3 724 NHS Trust
Email: naaz.nathotX3iubht.swest.nhs.uk
25 October 2002
Mr R Ponton 
Research Pharmacist
Department of Pharmacy & Pharmacology 
University o f Bath 
Bath 
BA2 7AY
Dear- Mr Pori ton
E5450 Illic it drug injection preparation procedure investigation using a questionnaire and 
practical demonstration (RECIPROCAL)
Thank you for your email communication dated 21st October 2002. Your comments have been reviewed by 
a a Sub-Committee of the UBHT LREC who are now happy to grant full approval to the above study.
We wish you success with the research and look forward to knowing the outcome in due course.
In accordance with Good Clinical Practice Guidelines of the European Community and the standard 
operating procedures required by NHS(E), the LREC is required to monitor research. The International 
Conference on Harmonisation Tripartite Guideline requires an annual, as well as end-of-study report.
Please complete the enclosed project report at the end of the study or after each year from the beginning of 
the study and return it to us. Continued approval depends on the receipt of these reports.
This Committee is compliant with ICH/GCP Guidelines except when illness or lack of resources prevent this. 
Any changes or extensions to the protocol, or investigators should be notified to the Committee for 
approval. Serious and unexpected adverse events should also be notified.
Investigators who undertake research within the Trust and subsequently leave the Trust are reminded that 
they must not take with them patient information unless it is anonymised such that individual patients 
cannot be identified without reference to the Trust.
Reminder: The title will be published in national and Trust registers. I t  should not contain confidential 
information that you or any sponsors of this research would not wish published.
Yours sincerely
D Grier
Chairman to the Research Ethics Committee
United Bristol Healthcare NHS Trust 
Tel 0117 923 0000 Minicom 0117 934 9869 www.ubht.nhs.uk
IN V E S TO R  IN  PEOPLE
Appendix 2
Questionnaire
U N I V E R S I T Y  OF Evidence-based 
y - y  ml p w i  y  nr harm reductionp A ln
Se c tio n  I
I n j e c t io n  Pr o c e d u r e  
I n v e s t ig a t io n  Q u e s t io n n a ir e
Site  C o de  _  
I n te r v ie w  n o .
D e m o g r a p h ic  D e t a il s
1. How old are you? Sex: M
D r u g  h is t o r y
2. What is your main drug used by injection? Heroin
Crack
Heroin + Crack (Speedball)
Other:..................................
3. How long have you been using your main drug (in total)? years mths
4. How much do you use per day?
No. of bags/rocks












In je c t in g  H ist o r y
6. How long have you injected? years mths
1





Heroin + Cocaine (Speedball)
Amphetamine









8. How many times a day do you inject your main drug?
9. Where do you inject on the body?
10. How did you learn to prepare drugs to inject?
2
THEN PROMPT: Were you given specific details/quantities to use, or did you learn through ‘trial 
and error’ ?




Heroin + Cocaine (Speedball)
Amphetamine









12. Where did you learn to do this?
[locality and country]
In je c t io n  P r e p a r a t io n
13. How much drug do you usually inject for each ‘hit’?
14. Do you use an ‘acid’ to prepare your injection?
3
Yes No
15. Why do you add an acid? Please explain
16. Which acidifier do you prefer to use?
17. What acidifier do you normally use?
18. Where do you obtain this?
19. What do you use when you run out, or can’t get hold of your usual acid?






















BATH reductionu n i v e r s i t y  o f  Evidence-based harm
Checklist Questions
1. What do you place in the spoon firs t?
2. How do you judge how much drug to use?
3. What do you use to measure this amount?
4. Do you do anything to the drug powder before you prepare it?
PROMPT: Crush it?
I f  so using what?
I need to understand the decisions that you make when adding the acid-
5. Can you explain any fa c to rs  that lead you to use more o r  less acid?
6. H ow  do you decide how much ac id  you need to use?
7. When do you know you need to add more acid?
8. Does amount change with amount/quality o f drug?
I f  so, by how much?
9. Is acid added to drug powder in cooker? Before Water?
10. Which acid would you choose to use?
11. How do you gauge the amount o f  acid to use?
12. Does amount change with amount/quality o f drug?
13. I f  so, by how much?
Double?
Triple?
14. Water added to drug in cooker?
15. When do you add water?




17. I f  Syringe is used- what size?
I f  Needle is fitted- what size?
18. What is your normal source o f water?
19. How much water do you use to prepare an average injection fo r  one person?
20. How long is solution usually heated?
21. When is the solution ready?
When solution goes clear?
After boiling for a certain time?
22. Is solution allowed to cool after heating at all?
23. What do you use as your ‘cooker’ ?
24. Do you heat the mixture?
25. Do you s tir the mixture before heating ?
26. Do you s tir the mixture during/after heating?
27. What do you use to s tir it?
28. What do you use fo r  the heating?
29. Do you f i lte r  the injection?
( I f  Applicable)
30. What do you use to f i lte r  it?
31. Do you reuse fdters?
32. How long do you store them fo r?
33. Do you change the needle before injection ?
2
Appendix 4
Information sheet for 
volunteers
U N I V E R S I T Y  OF  Evidence-based 
Y"v gk f  ■  ^y  *T harm reductiono A lri
Information for Volunteers 
Safer Injecting Study
About the study
This is a harm reduction project. It aims to study the injection preparation 
process and prove the safest ways to prepare drug injections so injectors can be given 
accurate advice. You are invited to help with the work.
When you prepare injections of drugs, you follow a procedure that is still not 
fully understood by non-users. You may have been doing it for years and it may be 
second nature to you now, but to non-users the details are largely unknown. This 
means that any problems that might occur during or be caused by the process might 
not be recognised because drugs workers don’t understand the technique.
To help drug workers give accurate advice, this project aims to study 
the process and identify any potential problems that it may cause- we can then issue 
advice to users on how to improve things. This interview is the first part of the 
project- to learn how people prepare injections, then the second part will be done in 
the laboratory to copy the process and test the injections made. The safest injection 
preparation technique tested will then be published in safer injecting leaflets.
The interview will be divided into two parts :
-Part ONE will be a short questionnaire.
-Part TWO will be a practical demonstration by you of your 
process for the researcher. This part can also be 
completed without the demonstration like part 
one, if you prefer.
Part One- The Questionnaire
This consists of some questions to establish some background information 
about your injecting habits. This information is concerned with some details, such as 
how long you have used drugs and which ones you use. As the study is centred 
around the problems associated with injection preparation, there are then questions on 
where and how you learned to prepare injections, and also what equipment you use to 
do it.
Part T w o - The Demonstration
In this part of the interview you will be asked to demonstrate the preparation 
of an injection using fake drug powder.
Whilst you do this, the researcher will record the way you do things, such as 
how much water you use and what order you carry it out. You might also be asked 
questions about what is done.
The information that is collected from you and other people will then be used 
to recreate the preparation process in the laboratory, so that scientific tests can be 
performed, for example to find out which acidifier presents the least risk to health.
This understanding of user techniques and the problems that can occur will 
then enable us to develop safer injecting information for drug workers and guides for 
drug users.
Confidentiality
All information you provide, or that is noted during your demonstration will 
not be marked with anything that can identify you. Your name will not be asked 
during the interview. After the study is finished, all records will be destroyed.
At any point during the interview you can choose to leave, you do not need to 
give a reason. Leaving an interview or refusing to take part will not affect the 
treatment you receive at the needle exchange. Any information you disclose will not 
be given to the workers at the exchange or any other person.
If you have any questions about taking part, ask a member of agency staff who 
will be able to pass questions on to me, or ask me on the days I am at the agency.
Thanks very much for your time.
Rhys
PhD Student 
University o f Bath
Appendix 5 
Demonstration checklist





















Other .............  □
C ooker:
Other.










































How is amount of drug gauged:
- used as bought quantity 
£50  £1(0 £2(0 Other
- poured □
- using device -spatula □  
-Other □
Is anything done with the drug before it is used: Yesd No □
Is it crushed in any way? YesG NoO  




Added to drug powder before water? YesGNoG
Amount of acid used:
- poured (guessed) □
- pinched with fingers □  No. of pinches:........
- using utensil- spatula □
-Other..........................................
Are the powders mixed at all? YesG No □
W A TE R
Drawn up in syringe? Yes □
Amount drawn up:.......................................
For use by one person only ?G No? How Many:..........................
Water added to drug in cooker? YesG NoG
IF added to drug before acid, is solution:
Stirred G  
Heated □
C O O K IN G
Is heat applied to solution? YesG NoG
Is solution stirred before heating? Yes G  NoG
Is solution stirred during/after heating? Yes G  NoG
How long is solution usually heated? ...................................................
When is the solution ready?
When solution goes clear?G
After boiling for a certain time? G  ......................... seconds
Is solution allowed to cool after heating at all? Yes G  No G
F IL T E R IN G
Is solution filtered before use? YesG No G
Is needle changed on the syringe before drawing up? YesG No G
How much of material is used for filtering?..............................................
Is filter kept for reuse later? Yes G  NoG  
If  yes, ASK for how long:..........................
Is needle changed on syringe before injection? YesG NoG
Appendix 6
Research Protocol
U N I V E R S I T Y  OF Evidence-based 
-y ^  *  F W 1 T  T  harm reductionpA ln
Injection preparation process investigation interview
protocol
Suitable volunteers will be recruited from the selected needle exchange agency by 
being made aware of the work through the 'information for volunteers' sheets. These will 
be available from the agency for at least one week before the interview work commences. 
During this time, the users will be informed by agency staff of when and where the 
interviews will take place. The potential interviewees will be able to ask questions that 
will be answered by the researcher who the agency staff will be able to contact.
The Interviews will take place on the specified dates at the agency, in a room that 
has specifically been set aside for that purpose during the time.
On the dates of the interviews, prospective volunteers will be asked if they have 
read the information sheet, and if they still wish to take part. It will then be checked that 
they meet the inclusion criteria- that they are over eighteen years old, that they have 
injected for over three months and that they prepare their own injections.
If they are suitable, exact details about the interview will be explained. They will 
be informed what is required of them and the aims of the work will be set out. It will be 
explained that the work is voluntary and that they can refuse to take part. They will also 
be told if they agree to participate, they can withdraw at any point without giving a 
reason. They will be informed that declining to take part or withdrawal will not affect the 
way they are treated by the service. It will be pointed out that the practical nature of the 
optional second part of the interview might induce craving. If they then feel this might be 
a problem for them, they will be given the option of just answering questions to fill in the 
checklist, without seeing the props. If they feel it will not be a problem using the props, 
they will be reminded they can pull out of the interview at any point.
Verbal consent will be obtained from them, and be recorded as having been given.
The first section of questions will then be asked.
After completion of these questions, they will then be asked if they still wish to 
proceed with the prop work. If they do, they will be presented with some water, fake drug 
and various acidifying agents. They will also have other equipment available to use such 
as spoons, syringes, and various filter materials. They will be asked to follow the 
technique they normally use to prepare an injection of the fake drug. The researcher will 
observe this and mark the procedure steps they follow on the checklist.
If they choose not to use the props, they will be asked about the procedure they 
would follow verbally.
The interview will then be concluded.
The volunteer will be thanked for their time. A selection of currently available 
harm reduction guides relating to safer injecting and injection preparation will be on 
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Appendix 8
NMR Spectra
NMR spectra of compounds commonly found in illicit heroin
mixtures




Figure 2. 1H NMR spectrum (400 MHz, CD3OD) of acetylcodeine
Figure 3. 1H NMR spectrum (400 MHz, CD3OD) of 6-monoacetylmorphine
Figure 4. 1H NMR spectrum (400 MHz, CD3OD) of papaverine
Figure 5. 1H NMR spectrum (400 MHz, CD3OD) of noscapine
2
3.26
Figure 6. 1H NMR spectrum (400 MHz, CD3OD) of paracetamol




Heroin injection -  Its preparation steps and user variations
Background/Objectives
In the UK, most heroin and crack cocaine is in an insoluble form. This 
requires conversion to a soluble form before it is injected. To accomplish this, users 
add weak acids e.g. lemon juice, vinegar and citric acid. There is little information in 
the literature examining the preparation steps in detail. A better understanding would 
inform safer injecting research and practice. This work explored user preparation 
procedures and investigates techniques in depth.
Methods
A novel two part method was used with needle exchange attendees at three 
locations. Saturation technique determined numbers. Part one was a semi-structured 
interview, and part two a preparation simulation using imitation drug. This was 
observed by the interviewer and the procedure details recorded. All steps employed, 
and the amount of drug, acid, water and heat used were recorded.
Results
Information from 65 IDUs was collected. The main preparation steps were 
similar in all interviewees. They all added the acid to the drug in the heating 
equipment (cooker) then added water. This was heated, and filtered before injection. 
However, within each step, there was variation e.g. equipment chosen, and the 
proportions of drug, acid and water used.
Conclusions
This work shows a great amount of variation within one common procedure. It 
highlights areas of injection preparation that can be targeted in harm reduction 
information and research. The interview procedure could be used in the future for 
further insight into the injecting of other drugs. The results will be used to inform 
laboratory work to conduct a theoretical risk assessment of injection preparation
Heroin and Crack -  Injection preparation and user variations
Rhys Ponton and Jenny Scott i f i l  S'
dA I i iClinical Pharmacy and Pharmacy Practice Research Group, The University of Bath, UK.
Introduction
The complete process of preparing drugs for injection is poorly reported in the 
literature and has only been investigated by one paper to date1.
This work investigates the process injectors use to prepare water insoluble 
drugs for injection and identifies aspects for further laboratory study.
Methods
Heroin and crack injectors were interviewed at three needle exchange facilities 
in the United Kingdom. The interview consisted of a questionnaire and the 
preparation of a inert ‘fake’ drug substance to demonstrate the methods 
normally used to prepare injections
Results
Most users followed the same core steps to prepare an injection 
Crack PreparationHeroin Preparation Heroin with Crack Preparation
Heroin powder 
placed into cooker
Rock of Crack 
placed In cooker
Acid added to drug 
powder in cooker
Acid added to drug in 
cooker
Water drawn up in 
syringe and added 
to cooker
Water drawn up in 
syringe and added 
to cooker
Heat applied Crack rock crushed 
into solution







Acid added to drug 
powder in cooker
Water drawn up in 
syringe and added 
to cooker
Heat applied
I Crack added to 
solution and crushed
Solution Filtered
Technique used by Technique used by
96% of interviewees 75% of interviewees
(n=45) (n=6)
In total, 65 injectors were interviewed
SOLUTION READY 
FOR INJECTION
Technique used by 
all interviewees (n=10)
Variations
Many of the interviewees used different equipment and materials to perform 
each step of the procedure.
Injectors use various acidic substances to help dissolve the drug. The risks of 
injecting these acids is unknown, and is an identified area for further study to 
quantify the risks.
The source of the water used by injectors is important with regard to its 
cleanliness and possible bacterial and/or pyrogenic content. This is a further 




□  Lemon Juice
85% (n=55) 
1 2 %  (n=8)
3% (n=2)
Water Used
@■  From Tap 66% (n=38)■  Bottled 19% (n=n)□  Boiled and Cooled 12% (n=7)■  Ampoules 1.7% (n=i)■  Toilet 1.7% (n=i)
Conclusions
This work demonstrates that there are core steps in preparing an injection 
that varies little between most injectors interviewed. This is important 
information for harm reduction workers who need to understand the 
techniques injectors use so they are able to advise users effectively.
The injection preparation techniques learned in these interviews will be used 
to produce injections under laboratory conditions. These will then be 
analysed and the risks they pose quantified. The final outcome will be an 
understanding of the relative risk and safety of the common acids and water 
sources used.
Reference
Scott J, Winfield A, Kennedy E, Bond C. Laboratory study of the effects of citric and ascorbic acids on 
injections prepared with brown heroin. Int.J.Drug Policy 2000;11:417-22
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The microbiology of prepared heroin injections
Rhys Ponton, Jenny Scott
Background/Objectives
Sterility is a critical property of injections. Injecting by-passes the defences of 
the body, therefore any organisms either viruses, bacteria or fungi, present in 
injections can gain uninhibited systemic access, potentially causing complications. 
This work investigated the presence of bacteria and fungi in illicit heroin samples, 
and then identified the types of organisms that were still viable after the preparation 
of the drug sample for injection.
Methods
Heroin injections were prepared in the manner of illicit drug injectors as 
established in our previous work. Using a method adapted from McLaughlin et al. 
these injections were then prepared and cultured to investigate the growth of any 
viable organisms. Heroin samples were also spiked with cultures and the prepared 
injections tested for growth of these organisms.
This work was part of a greater study into the effects of using acids in the 
preparation of drugs for injection, therefore this method involves the use of acids in 
the injection preparation.
Results
Samples of the illicit drug material supplied by the UK Police showed growth 
of organisms after broth inoculation. The organisms were identified, and the risk of 
infection assessed. Changes to the preparation method, including varying amounts of 
acid and altering heating time assessed the ability to reduce micro-organisms within 
prepared injections.
Conclusions
The injection of these bacteria poses a potential risk, but the use of acids and 
heat during the preparation could potentially lower this risk. The effect of the acid and 
the heat on the injection and the injector however also need to be considered.
The Microbiology of Prepared Heroin Injections
Rhys Ponton and Jenny Scott ^ IVaR^» t°tBATHClinical Pharmacy and Pharmacy Practice Research Group, The University of Bath, UK.
Introduction
The spread of blood borne viruses through the injection of illicit drugs often overshadows 
the effects of infections caused by bacteria and fungi. These infections can cause severe 
morbidity and mortality, and unlike viral infections, they do not require the presence of other 
injectors to occur. These infections can be transmitted from injection materials (drug, 
acidifier or water), dirty equipment, the environment, or the users themselves- for instance, 
from their skin.
The outbreak of Clostridium novyi infections in the UK and Ireland in 2000 was the result of 
drug material contaminated with this bacterium.
Methods
To assess the bacterial and fungal content of heroin samples, McLauchlin et al.1 devised a 
microbiological culture method that would isolate a wide range of organisms. This method 
proved useful in identifying organisms present within samples, but did little to explain the 
actual risk they pose. This project repeated the work, but used prepared injections as the 
samples. Injections were prepared in the manner investigated through previous work2. 
Further work was conducted that involved the introduction of known potentially harmful 
organisms to samples, and then assessed their ability to survive the preparation process. 
The culture method involved two main parts- the first studied aliquots of raw sample 
(including drug), the second involved a procedure to remove heroin from the samples on the 
basis that it inhibits microbial growth. To culture any organisms present, eight different agar 
plates were inoculated and incubated under different conditions to encourage growth.
Examples of 
agar plate results:
The plate on the left 
shows the colour 
change produced by 
the growth of 
Bacillus cereus
The plate on the left 
shows the organisms 
produced on culture 
of the heroin sample
The culture of unprepared heroin samples demonstrated that they were unsterile. The 
samples contained at least three different organisms.
Cultures of heroin prepared for injection resulted in no growth.
Additionally, no growth was seen from the filters used in the preparation after inoculation into 
nutrient broth and incubation.
Injections inoculated with Staphylococcus aureus and Bacillus cereus before the heating 
stage showed no growth of these organisms after preparation.
‘Injections’ prepared with acid and heating, but without drug material, resulted in growth of 
the inoculated organisms.
Controls to ensure growth under the incubation conditions were conducted at all times.
Conclusions
The absence of growth from cultures of injections containing drug indicates that the 
presence of heroin during the preparation neutralises S. Aureus and B. cereus. This is of 
importance firstly, as McLauchlin et al. found B. cereus to be the most prevalent organism 
within their samples, and secondly, as both organisms are pathogenic.
Further Work
Investigation of the organisms present in illicit drug material and any that can survive the 
preparation process is warranted. This would apply to all drugs, but particularly those that 
are commonly reported to be produced in outside environments, where they are likely to 
have come into contact with soils and animals. Such work would ultimately result in better 
medical treatment of injectors presenting with these infections.
References
1. J. Mclauchlin, V. Mithani, F.J. Bolton, G.L. Nichols, M.A. Beilis, Q. Syed, R.P. M. Thomson, J.R. Ashton. An investigation Into the microflora
of heroin. J Med Microbiol. (2002);51(1l):1001-8.
2. R.Ponton, J Scott. Injection preparation processes used by heroin and crack cocaine injectors. Journal of Substance Use. (2004); 9(1): 7-
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The flow charts on the right 
show the steps used to 
prepare samples for 
culture.
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Injection preparation processes used by heroin and 
crack cocaine injectors
RHYS PONTON & JENNY SCOTT
Department o f Pharmacy and Pharmacology, University o f Bath, Bath, U K
Abstract
Background In the UK, most heroin and crack cocaine is not soluble in water alone. They require 
conversion to a soluble form before they can be injected. To accomplish this, users add weak acids, 
for example citric acid, lemon juice or vinegar. There is litde information in the literature examining 
the preparation steps in detail. A better understanding would inform safer injecting research and 
practice.
A im  To investigate the preparation of insoluble illicit drugs for injection with identification of the 
common procedures, materials and equipment used.
Methods A novel interview design was used. This incorporated a semi-structured questionnaire in 
combination with a practical demonstration of preparation of fake drug material. The preparation 
steps, materials and equipment used were recorded.
Results Sixty-five injectors were interviewed at three needle exchanges. The preparation of heroin, 
crack cocaine and ‘speedbalF injections was characterized. The steps to prepare injections were 
similar in the majority of cases. Each participant used acid in the preparation. Heroin and ‘speedball’ 
injections were heated; crack injections were not. Each injection was filtered. The equipment chosen 
and the proportions of drug, acid and water used varied.
Conclusions This work indicates that the basic steps used by the sample of injectors were similar, but 
the details within each step varied. It highlights areas of injection preparation that can be targeted in 
harm reduction information and research. Further work could determine the prevalence of these 
techniques.
Keywords: Citric acid, injecting paraphernalia, heroin, drug preparation.
Introduction
Illicit drug injectors prepare injections using items known as ‘injecting paraphernalia’. 
Items used include water to dissolve the drug, acids (e.g. citric acid) to convert insoluble 
base drugs into soluble forms, and filters to remove insoluble particles from the prepared 
solution. The processes and equipment used by illicit drug injectors to prepare their 
injections has not been systematically studied and reported in the literature. M ost 
information takes the form o f descriptions in harm reduction leaflets (H IT  2001, Lifeline 
2001) and drugs worker training materials (Derricott et al. 1999).
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Som e published studies have included information on aspects o f the preparation process 
but have not systematically examined the whole process from selection o f starting 
materials to finished ‘product’, i.e. the injection. In 2000, Gaskin et al. interviewed 
injectors about their sharing o f water and filters, recording the sources o f water and type 
of filters used (Gaskin et al. 2000). Within their cohort, they found that the most popular 
water used to produce injections was tap water, and the most popular filter material 
derived from filter-tip cigarettes. Previous work by Scott (Scott et al. 1997) has also 
investigated the types o f filters used by injectors. In addition to this work in the UK , work 
carried out in the U SA  by Koester et al. (1990) has shown that injectors there also use 
cigarette filter material as well as cotton wool to filter injections. This work also noted the 
use o f spoons or bottle caps as the main forms o f ‘bowls’ for mixing and heating drugs.
T he use o f acids by injecting users o f heroin has been documented since the m id-1980s 
(Huizer 1987), after the emergence o f the base form o f heroin on the illicit market (Strang 
et al. 1997), but it is unclear how users preparing it for injection came to start using acids 
(Strang et al. 2001). Along with the U K , the base form o f heroin is also found in Holland 
(Huizer 1987), Spain, and Denmark (Kaa 1994), and the use o f acids has been recorded 
in Spain (Page and Fraile 1999) and Australia (Gallo et al. 1985). Previous work in this 
area (Scott et al. 2000, Strang et al. 2001) has recorded which acids injectors use, and 
with which drug. The types and the forms o f the drugs used by injectors were correlated 
with the preparation technique with regard to acid requirement, and it was seen that the 
use o f acid was dependent on the solubility o f the form o f the drug used. However, neither 
the way the acids were used nor how they fit into the whole procedure was investigated.
There are several benefits to systematically examining the preparation process. 
Information on the choice and source o f equipment (e.g. choice o f acids used to dissolve 
insoluble base drugs) could inform the delivery o f harm reduction information and add 
research support to anecdotal reports that already exist. Such information would also 
allow preparation methods to be copied in the laboratory so their impact on health and 
risk could be studied in detail. The aim o f this study was to report the process o f injection 
preparation used by a nonrandomly selected sample o f injectors and to describe the types 
of paraphernalia used.
Methods
T o investigate the injection preparation process, current injectors would need to be 
interviewed. The process that injectors use to prepare an injection is followed regularly 
and they know almost instinctively how to complete it. This interview intended to make 
the participants consider the steps and the equipment required to perform the procedure. 
In order to characterize the method in detail, it was decided to devise a situation where 
the participant could demonstrate the process they follow using a fake drug substance. 
During the procedure, they would have access to any equipment and materials required, 
but they would have to request them from the interviewer. This impelled the participants 
to recall each detail o f their usual process and avoided distortion o f the results caused by 
prompting.
The data-collection process consisted o f two parts. First, a semi-structured interview 
gathered data on demographics, drug use and injecting histories. It also explored in detail 
the participants’ use o f acids for dissolving drugs. T he responses were recorded in writing 
by the interviewer on a prepared form.
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The second section o f the data-collection process involved the participant demonstrating 
their usual preparation technique using the inert chemical substance in place o f a drug. 
They were asked to prepare an injection o f the inert chemical as if it were their real drug 
o f choice. The inert substance used was derived from heated and ground paracetamol 
tablets, modified to give visual characteristics similar to illicit heroin base and crack 
cocaine.
T o document the process, the options o f audio recording, video recording and visual 
assessment (with note taking) were considered. As the procedure was o f most importance, 
audiotape would be o f little value. The option o f video recording the process was 
discarded to prevent recruitment problems caused by concerns about confidentiality and 
to prevent any effects o f having a camera present, for instance anxiety o f being filmed 
or ‘performing* for the camera. After careful consideration, it was decided that the 
preparation technique would be observed by the researcher, and recorded on a checklist.
The recording checklist included selectable options described in safer injecting leaflets 
and the literature (Derricott et al. 1999, H IT  2001, Scott et al. 2000) and space for noting 
unpredicted actions. Paraphernalia for the preparation the process were available upon 
request from the interviewer. T o prevent bias in prompting the users, the equipment was 
kept out o f sight in a box until requested. Table 1 lists all the equipment that was available 
to the participants.
The fake inert chemical substance, the citric acid and the ascorbic acid were issued in 
preweighed quantities. These were reweighed after use to allow the amounts used to be 
calculated. The amount o f water used and heating time, if  used, were also recorded.







A varied selection of 
syringes and needles, incl.
Inert substance with similar physiochemical properties to heroin 
or crack cocaine. This was made from paracetamol tablets. 
Ascorbic acid (500 mg in eppendorf tube)
Citric acid (500 mg in eppendorf tube)
Lemon juice -  Jif lemon 
A real lemon 
Bottled vinegar
Sachets of baby bottle sterilizer 
Descaler sachets
The participants were asked where they usually obtained this.
Teaspoon
Dessert spoon
Crimped beer bottle caps
Empty drinks can (to enable use of bottom)
Hand rolling cigarette filters






Pre-injection swabs (for burning if that is usual practice)
0.5-ml and 1-ml insulin syringes (with fitted needles 29G 
(0.33 mm))
2.5ml and 5ml syringes
Orange (25G (0.5 mm)), blue (23G (0.6 mm)) and green 
(21G (0.8 mm)) needle
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Participants were asked to follow their usual procedure without any deviation. They  
were not interrupted during the process unless absolutely necessary, for example if  they 
performed a unique action and clarification was required. Interruption was kept to a 
minimum to prevent distracting the participant, which could possibly induce errors. Once 
the preparation was complete, all used equipment was collected and the prepared fake 
injection disposed of.
N eedle exchanges in the city o f Bristol and the town o f Hereford, England, were used as 
interview locations. Piloting o f the methods was undertaken at a needle exchange in Bath. 
Prior to commencing work at each facility, approval for the study was gained from the 
Local Research Ethics Committee for the area.
Users o f the exchanges were made aware o f the study through posters and leaflets that 
outlined the study and what would be required o f participants. Users were also informed 
of the work during the needle-exchange process and, if  willing, introduced to the 
researcher (RP) by the exchange workers. The researcher explained the study, confirming 
that the potential participant was an injector o f either heroin, crack cocaine, or both. The  
researcher stated that participation was voluntary and would not affect the service received 
from the exchange agency. H e also eliminated anyone who did not prepare their own 
injections, as it was considered that they may not be able to provide detailed information. 
The participant was given the opportunity to ask questions. The researcher then obtained 
the verbal consent o f willing participants. Names o f participants were not asked or 
recorded in keeping with the practice o f the exchange agencies. Therefore, consent was 
obtained verbally from each participant as asking them to sign a consent form would  
breech this anonymity. The interviews were conducted in a private room with only the 
researcher and the participant present. All data were collected by the same researcher for 
consistency.
During the consenting procedure, participants were warned that the preparation 
demonstration could possibly induce cravings, and, if this was felt to be a problem, then a 
semi-structured interview could be conducted instead. Participants were informed that 
they could leave the room at any point without giving a reason. At the close o f  the 
demonstration, participants were thanked with a £ 1 0  gift voucher for their time and 
participation. This reward was not made known during the recruitment or consenting 
procedures.
Results
Sixty-five injectors participated in the study: two people in Bath, 28 in Hereford and 35 in 
Bristol. All participants chose to complete the interview and the practical demonstration.
O f the participants, 80% (« =  52) were male, 20% (« =  13) were female (ratio 4:1). The  
mean age o f the male participants was 29.1 years (range 20-46  years); o f the females it 
was 25.8 years (range 18-38 years). Thirty-four per cent (« =  22) o f the participants were 
under 25 years old; 66 % (n  =  43) were 25 years old or older. The length o f time injected 
for ranged from 3 months to 18 years, the mean being 6.38 years.
All 65 participants had injected heroin ever. Forty-five o f the participants had injected 
crack ever, and 39 o f the participants had injected the combination o f the two (as a 
‘speedbaH’).
A wide range o f other drugs had been injected by the participants, including: 
amphetamine (« =  46), cocaine powder (w =  24), diazepam (including Valium® ampoules;
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n =  10), temazepam (« = 1 1 ) , ‘ecstasy’/M D M A  (« =  13), Diconal® (dipipanone with 
cyclizine tablets; « = 1 0 ) ,  Palfium® (dextromoramide tablets; n =  8), LSD  (« =  5), 
dihydrocodeine (n  =  4) and cyclizine (« =  4).
All 65 participants stated they used an acid to prepare their injections. Thirty-four 
(52%) stated that they preferred to use citric acid. The remaining 31 (48%) stated their 
preferred acid was ascorbic acid. However, the acid used by the participants on a day-to- 
day basis was different from the preferred stated acid. Fifty-six (86%) o f the participants 
usually used citric acid, with only five (8%) using ascorbic acid. Tw o participants said that 
they used either lemon juice or citric acid, each on an equal basis. The remaining two said 
they had no preference for what they used or used ‘whatever was available*.
Alternative substances that had been used as acidifiers included vinegar, appliance 
descaler preparations, vitamin C tablets, fruit juices including orange, grapefruit and lime, 
and the coatings from ‘fizzy* sweets, which contain citric acid.
T he preparation o f heroin was demonstrated by 47 participants, the preparation o f  
crack cocaine by eight participants and the preparation o f ‘speedballs* by 10 participants. 
The preparation o f heroin was demonstrated at all three sites, but the injection of crack 
cocaine and ‘speedballs’ was confined to Bristol.
Steps o f  the preparation process
Com m on steps were identified that formed the basic technique used by most participants. 
However, within each step there was variation, for instance with the equipment used to 
perform it. The specific detail for each drug will now be discussed:
Heroin. O f the 47 participants who demonstrated heroin preparation, 45 (96%) 
followed the same five basic process steps. These are shown in Figure 1. This shows 
the drug being mixed with the acid first, and then the addition o f the water. The two 
participants who did not follow these steps demonstrated variation in the order they 
mixed the drug, the acid and the water. One o f these added the water to the drug 
powder, before adding the acid powder. The second choose to measure out the acid 
powder, and then add the drug powder to it.
T he equipment used by the participants refers to the paraphernalia used, including the 
needle/syringe, the cookers, the heat sources and the filters. ‘Materials’ refers to the water 
(defined by its source) and the acid used. For the heroin injections, the choice o f acid used  
was the first main point that divided this group. The majority o f participants chose to use 
citric acid (« =  37, 79%), eight (17%) chose ascorbic acid, and two (4%) chose lemon  
juice. Water was the second dividing factor. Thirty (64%) used water from the tap, seven 
(15%) used water from bottles (including bottled mineral waters and tap water stored in a 
bottle), six (13%) used boiled water and one (2%) stated using sterile water from 
ampoules (source o f these unknown). Data on water are missing for three participants.
‘Cookers* used included teaspoons, dessertspoons and the bottom o f used drinks cans. 
Forty-five participants (96%) chose to use a spoon o f either size; the other two used the 
bottom of a drinks can. T o filter their injections, 29 (62%) o f the participants used 
material from filters made for hand-rolled cigarettes, 14 (30%) used material from filter- 
tip cigarettes and four (8%) used cotton wool.
Tables 2 and 3 depict the quantities o f the drug substitute, the acid powder and the 
water used during the demonstrations. T o remove any influence that the insolubility o f









Water drawn up in 
syringe and added to 
cooker
Figure 1. Steps shown by 96% (« =  45) of heroin injectors as the usual method used to prepare heroin 
injections.
the drug substitute may have exhibited, the data from any participants were removed from 
the results before the below values were calculated. Therefore, the figures indicate the 
quantity o f acid and water the participants would use for a given volume o f drug.
T he participants were asked during the process how much the drug substitute they were 
using would be sold for on the illicit market. For the citric users, the fake drug quantities
Table II. Quantities used in heroin injection preparation using citric acid (n =  28, corrected to remove partici­
pants who added extra acid during or after heating, and those who spilled powder from the tubes during the 
interview).
Heroin substitute (g) Citric acid (g) Water (ml)
Mean 0.122 0.079 0.85
Min. 0.053 (quoted as £10 in value) 0.018 0.50
Max. 0.284 (quoted as £10 in value) 0.284 1.50
Insoluble drug injection preparation 13
Table III. Quantities used in heroin injection preparation using ascorbic acid (n =  7,  corrected to remove 
participants who added extra acid during or after heating).
Heroin substitute (g) Ascorbic acid (g) Water (ml)
Mean 0.169 0.175 0.91ml
Min. 0.070 (quoted as £10 in value) 0.194 0.45
Max. 0.287 (quoted as £20 to £25 in value) 0.335 2.20
used ranged from £ 5  to £ 4 0  in value. The mean value was £12 .71 , and the most 
commonly used amount was the amount o f a £ 1 0  ‘bag’, which was used by 15 o f these 28 
participants.
O f the seven participants who used ascorbic acid, the value o f the fake drug used ranged 
from £ 1 0  to £ 2 5 -3 0 . The mean quantity used was £17 .14 , with three o f the seven using 
the quantity they expected to obtain in a £ 1 0  bag.
Acid added to drug in 
cooker
Rock o f Crack placed 
in cooker





Water drawn up in 
syringe and added to 
cooker
Figure 2. Steps shown by six out of eight crack cocaine injectors as the usual method used to prepare crack 
cocaine injections.
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Crack cocaine. Eight participants demonstrated the preparation o f crack cocaine for 
injection. Six o f the eight participants followed the same order o f steps, depicted in 
Figure 2: The other two added the acid after adding the water to the drug in the ‘cooker’:
All crack cocaine injectors (n =  8) chose to use citric acid for their preparation. Water 
source varied, with three using tap water, one using ‘boiled and cooled’ water from the 
kettle, one using bottled water, and one using water obtained from a toilet. Data on water 
are missing for two participants. Seven used spoons as cookers; one used the bottom o f a 
drinks can. T o  filter, all eight used material from filter-tip cigarettes.
T he crack substitute used by the participants would range from £ 4  to £ 1 0  in value on 
the illicit market. The mean value was calculated as £ 8 .8 6 , with five o f the seven stating 
the amount they used was worth £1 0 . Table 4 details the quantities o f the materials used 
in the crack user interviews.
Table IV. Quantities used in Crack injection preparation demonstrations (n =  7, corrected to remove partici­
pants who added extra acid during or after heating).
Crack substitute (g) Citric acid (g) Water (ml)
Mean 0.099 0.069 0.58
Min. 0.039 (quoted as £4  in value) 0.025 0.40
Max. 0.155 (quoted as £10 in value) 0.128 0.80
Heroin +  crack cocaine: ‘speedball3. T en participants demonstrated the preparation of  
‘speedballs*. All 10 followed the same procedure for preparing their injections; a 
procedure that was seen to be an amalgamation o f the heroin and the crack 
preparation processes (see Figure 3). First, the heroin was prepared as in Figure 1, then 
the crack cocaine was added to the heroin solution and crushed. This was then filtered 
prior to injection.
All the speedball injectors who participated used citric acid for their preparation. Five 
used tap water and three used bottled water. Data on water are missing for two 
participants. As cookers, eight used spoons, while the other two used the bottom o f a 
drinks can. T o  filter, eight speedball injectors used material from filter-tip cigarettes, and 
the remaining two chose material from roll-up cigarette filters.
The quantities o f drugs used in a speedball were usually o f equal value for both drugs, 
for instance £ 1 0  o f heroin, with £ 1 0  o f crack. The most common combination was £ 1 0  
heroin with £ 1 0  crack, which was used by five o f the eight participants. The cost o f heroin 
used by the participants ranged from £ 5  to £ 1 0 -1 5  worth. The cost o f crack used ranged 
from £ 5  to £2 0 . Table 5 details the quantities o f the materials used in the speedball 
preparations.
Table V. Quantities used in ‘Speedball’ injection preparation demonstrations (n =  8, corrected to remove 
participants who added extra acid during or after heating).
Heroin+ crack substitute (combined weight g) Citric acid (g) Water (ml)
Mean 0.207 0.115 0.81
Min. 0.105 (quoted as £10 of heroin and £10 of crack in value) 0.044 0.50
Max. 0.406 (quoted as £10 to £15 of heroin and £20 of crack in value) 0.286 1.00









Crack added to 
solution and crushed
Water drawn up in 
syringe and added to 
cooker
Figure 3. Steps followed by all participants («= 10) to prepare a ‘speedball’ injection.
General find ings
At all three locations, each participant (except one) used only a portion o f the filter 
specified as used. Strips were tom  vertically from the roll-up cigarette filters for use. Filter- 
tip cigarette filter material was either pulled out o f the end for use, or a horizontal slice 
was cut off the filter with a pair o f scissors. Cotton wool was used in small balls measuring 
approximately 3 mm  in diameter.
Although not specifically explored, it was observed that choice o f acid, filters and 
syringes/needles used by the participants appeared to be influenced by the availability of 
these items at the needle exchange. The Hereford needle exchange supplies both citric
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and ascorbic acids to its users, the Bath needle exchange only supplies citric acid, whereas 
the Bristol exchange supplies neither. The Hereford and Bath exchanges also supply 
filters, but Bristol did not at the time o f the interviews. Where items were available at the 
exchange, the users were usually seen to choose to use it rather than an alternative 
obtained elsewhere. Only one user at the exchanges where acids were issued stated they 
obtained their acid elsewhere. Similarly, only two users out o f 28 who attended the needle 
exchanges that supplied filters chose not to use those available.
D iscussion
T he interviews have recorded the injection preparation technique used by a non-random  
sample o f injecting drug users. They enabled the characterization o f the preparation 
process o f heroin, crack cocaine and ‘speedballs’. Out o f the 65 participants, 47 
demonstrated the injection o f heroin, making the results for this the most reliable. The 
lower numbers o f the crack and speedball injectors produced less reliable but nevertheless 
interesting results. The investigation o f the preparation o f these injections is a potential 
source o f further work. The choice o f three interview locations has also demonstrated the 
similarities, as well the differences between them. The findings o f this research correlates 
with that o f previous work, which has reported some steps o f preparation procedures 
(H IT  2001, Scott et al. 2000), the acids used (Kinzly 1997, Scott et al. 2000, Strang et al. 
2001), waters used (Gaskin et al. 2000), and the filters used (Scott et al. 1997). This work 
extends these articles by observing the process as it is performed and recording the 
complete process in detail, including all steps, materials, equipment and quantities used. 
The participants were not just asked questions regarding their preparation; there are, 
therefore, fewer reliability issues in respect o f the recall o f their actions.
The basic steps o f the process were com m on amongst the majority o f users. These were 
clearly defined and easily identified. The evolution o f this sequence o f steps is o f interest 
and would be an interesting area o f exploration. It is unclear why the majority o f users, 
though recruited from two distinct locations and the pilots recruited in Bath, follow the 
same sequence.
The addition o f the acid to the drug before the addition o f the water suggests that 
injectors are making a judgement o f how much they need to dissolve the drug before they 
have even tested its solubility in water. The application o f heat was witnessed in all 
preparations involving heroin. Strang et al. (2001) found that this was dependent on the 
type o f heroin used (brown as opposed to white), and this would correlate since the 
substitute heroin used in this work was brown in colour. The drug content o f injections 
that have been heated during preparation has yet to be investigated; however, research by 
Clatts et al. (1999) indicates that heating injections can inactivate HIV, and Collignon  
and Sorrell (1983) have suggested that the heating o f heroin injections can prevent 
systemic candidal infections.
The filtering o f the injection solution was universal amongst all 65 participants. 
Particulate matter contained within injections can cause phlebitis; therefore, this step may 
have a protective role. However, the use o f inappropriate material may lead to different 
health complications, for example from particle shedding. Filters o f a high quality should  
be available from needle exchanges to reduce the numbers o f injectors resorting to less 
suitable materials.
The use o f acids was also common to all participants. All o f them used one o f the three
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main types o f acid available: citric acid, ascorbic acid, or lemon juice, which contains both 
citric and ascorbic acids. N one chose to use vinegar or kettle descaler sachets that, 
according to anecdotal reports, are used, although participants did report having used 
them before. This probably indicates that they are acidifiers o f ‘last resort*. Lemon juice 
has been implicated as the cause o f systemic candidal infections (Bisbe et al. 1987, Dally 
et al. 1983, Gallo et al. 1985, Mellinger et al. 1982) and candidal endopthalmitis 
(Shankland et al. 1986, Shankland and Richardson 1989); therefore its low level o f use 
(two o f the 65 participants) was encouraging and may suggest that safer injecting 
messages are getting through. It is also important to note that the two users who 
demonstrated the use o f lemon juice only used it half o f the time for injection preparation, 
and they also reported being aware o f potential dangers in its use. Citric acid was the most 
commonly used acid (85%, n =  55); however, the long-term health implications o f its 
injection are still unknown. Acute effects from citric acid injection can include burning in 
the peripheral veins and thrombophlebitis, and these dissuade some injectors from using 
it.
T he results for the quantities o f the materials used were interesting, but there appears to 
be little correlation between the quantities used. There are no apparent links between the 
amount o f drug, acid or water used. In any event, the sample sizes for the heroin-ascorbic, 
the crack and the ‘speedball’ users are too small to draw any valid conclusions.
The interview design used for this work was devised specifically for this work and has 
never been used before. Some limitations in this work are apparent.
Alternative demonstration designs were considered, but were dismissed, for instance the 
use o f  real drugs, including participants using their own drugs. This was discounted on 
numerous grounds. First, interviews were carried out on drug service premises, which, for 
legal and ethical reasons, forbid the preparation and consumption o f illicit drugs. Second, 
having prepared the drug, the user would want to inject it, or receive recompense. The use 
o f the drug would carry risks o f overdose, and payment would raise legal and ethical 
issues. Last, taking the drug from the interviewee would have constituted an illegal supply 
o f a controlled drug and have put the interviewer in unlawful possession.
The inability to use real drug materials may have led to differences in the procedure 
used, for example changes to the heating time. The addition o f extra acid by the injectors 
during the preparation process was possibly related to the slightly higher insolubility o f the 
fake substitute, but it gives a valuable insight into the procedure. The use o f real drug 
materials would probably have caused technical and legal issues that would probably 
prove complicated to resolve, and therefore this technique, even with its limitations, has 
proved workable.
T he technique o f recording the process using a checklist worked to a large extent. It was 
found, though, that a number o f results were missing, for instance with regard to water 
source and heating time. These were missed on account o f the speed o f the process and 
the difficulty in noting all points quickly. The water was provided in a beaker and the 
participants were asked to state where they normally acquired their water; this could be 
remedied in further work by the use o f different water sources actually being available, 
for instance bottles and ampoules. This would most likely improve the recording rate for 
this category. The heating time was difficult to measure whilst still monitoring the 
participants’ process. In a large number o f cases the timing was lost owing to the 
interviewer forgetting to stop the watch as the procedure progressed into the filtering 
stage.
It is important to understand that this work is not o f universal relevance. Heroin on
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illicit sale in the U K  is usually in the base form (King 1997). ‘Crack’ or freebase cocaine is 
the base form o f cocaine. The base forms o f these drugs are insoluble and require 
preparation for injection involving the application o f acids. The addition o f an acid to the 
base form o f the drug forms the ‘acid salt’. Heroin and cocaine in the acid salt form have 
very high water solubilities. This conversion enables the drug to be injected. In other 
countries, heroin is predominantly found in the hydrochloride salt form and therefore 
does not require the use o f an acid during injection preparation. Crack always requires the 
use o f an acid to prepare it, independent o f location. The use o f acids by crack/ffeebase 
cocaine injectors in geographical areas where heroin is sold in the soluble hydrochloride 
salt form would be o f value for comparison to the results o f this work.
Conclusions
T hese interviews enabled the characterization o f the steps and equipment used by the 
participants to prepare their injections. The interview design succeeded in recording the 
required information.
This work provides information that has been unavailable before. Previous work has 
looked at the equipment used by injectors, including the water and acids, but the process 
o f the preparation o f an injection from insoluble bases has never been outlined, nor have 
the quantities used been recorded.
T he preparation styles o f the majority o f the participants were very similar. This gives 
scope for the aims o f improving the health implications from the injection o f illicit drugs. 
The understanding o f the injection preparation process is essential to the reduction o f the 
harm that arises from injecting. If harm reduction workers focus on minimizing the harm 
involved in this technique, then the majority o f users should easily be able to 
accommodate the benefits into their technique with little change.
The work highlights that practices such as injecting bottled mineral waters and the use 
o f lemon juice still occur. It indicates that there is work still to be done in the field o f harm 
reduction, and that these practices have still yet to be eliminated.
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